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ABSTRACT
Phosphoproteins interact with calcium minerals in numerous biological systems but despite
the importance of this phenomenon it is little understood. The interaction of phosphoproteins with
calcium minerals is observed in milk where caseins interact with calcium phosphate to form micelles.
Further understanding of this interaction was sought through two approaches. First, the adsorption
isotherms for binding of the casein B-CN A and its N-terminal phosphopeptide (B-CN (fl-25)) to
crystalline dicalcium phosphate dihydrate (DCPD) were measured. Secondly, attempts were made to
grow co-crystals of calcium ions with phosphopeptides or with phosphoserine.
A method of measuring phosphoprotein and phosphopeptide adsorption to DCPD was
developed. From the adsorption isotherms the affinity and capacity of adsorption could be determined
using a model of the adsorption process. Adsorption isotherms for B-CN A were all described using a
simple Langmuir model of adsorption, adsorption occurring to identical and independent sites on the
DCPD crystals. B-CN (fl-25) appears to adsorb to the same adsorption sites as B-CN A and also to a
second family of adsorption sites which have a lower intrinsic affinity but which are more abundant.
Adsorption isotherms for B-CN (fl-25) were described using a modified version of the Langmuir model
in which there are two sets of adsorption sites. A term was included to allow for cooperative
adsorption to the second set of adsorption sites.
The effects of methylation of lysyl residues, buffer pH, incubation temperature, the presence
of 6.0 M urea in the buffer and of crystal size were all examined. The adsorption of B-CN (fl-25) to
DCPD crystals appears to be athermal since the measured isotherm does not change significantly with
temperature (over the measured range), requiring that adsorption is due to an entropy gain.
Comparison of the results of the B-CN A and B-CN (fl-25) adsorption experiments suggests that
adsorption probably occurs via the N-terminal region of B-CN A, consistent with the hypothesis that
the binding of phosphoproteins to calcium minerals occurs primarily through their phosphoseryl
residues.
The phosphopeptide Ser(P)-Ser(P) was prepared by chemical synthesis for use in
crystallisation and binding studies, so that a model of phosphoprotein/calcium mineral adsorption
might be developed. Several methods of phosphorylation were investigated. However, the synthesis
was not completed in time to allow adsorption or crystallographic studies to be performed.
Co-crystals of calcium ions and phosphoserine were produced but, because of their small
size and instability, these crystals were not suitable for structure determination by conventional X-ray
diffraction techniques. However, conventional X-ray diffraction techniques were used to solve the
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List of Abbreviations and Symbols
The abbreviations used here are those described as 'accepted' in the instructions
to authors of the Biochemical Journal (Biochem. J. (1988), 249, 1-20) and of the
Journal of Biological Chemistry (IUPAC-IUB Commission on Biochemical
Nomenclature Symbols for Amino-Acid Derivatives and Peptides Recommendations
(1971); J. Biol. Chem. (1972), 247,977-983), with the following additions.
A area occupied by an adsorbed molecule
acidic PRP's acidic proline-rich-phosphoproteins
BET Brunauer, Emmett and Teller
c equilibrium, free concentration of adsorbate
c° solubility of adsorbate




DCPD dicalcium phosphate dihydrate
DMF dimethyl formamide
DPPC diphenylphosphoryl chloride
T adsorbed amount per unit area
k, 1 affinity constants
m, n number of adsorption sites per unit area
MCP micellar calcium phosphate






a, b, c unit cell axial lengths
O o
A angstrom unit (1 A = 0.1 nm)
1-ATN l-aza-5-oxa-6-(r,3'-dithianyl)-7,8-benzo-9-oxobicyclo[4.3.0]nonane
d distance between adjacent planes in the crystal
Dcaic calculated density
F(M/)>F> F(ooo)The structure factor for the unit cell, for the reflection hkl. It is the
ratio of the amplitude of the wave scattered by the entire contents of
the unit cell to that scattered by a single electron. A phase angle for
the scattered wave is also involved. F(qoo) *s thus equal to the total
number of electrons in the unit cell.
/Ci i Miller indices of a reflection
5-HT1A 5-hydroxytryptophan receptor 1A
I intensity (on an arbitrary scale) for each reflection
1 -MPP 1 -(2-methoxlphenyl)-4-[4-(2-phthalimido)but-2Eynyl]piperazine
NAN-190 l-(2-methoxlphenyl)-4-[4-(2-phthalimido)butyl]piperazine
R discrepancy index, R = {SIF0^scrved ~ FcalculatedIM^"observed)
Rw weighted discrepancy index,
Rw=((eight* [Fobserygd - }/{EWeight* [FQ^^jyg^j]^}) t/2
S S = |EW (IFobsgrveul - |Fcaicuiatedl)^ ^ (m " n)l^
x, y, z atomic coordinates as fractions of a, b, and c
Z number of molecules in a unit cell
a, P, y Interaxial angles between b and c, a and c and a and b respectively
X wavelength
a standard deviation
0 the Bragg angle
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Biomineralisation is a complex process. The products and processes of
biomineralisation have been partly elucidated over the past few decades and the
range of organisms and the diversity of minerals known to be involved in this
process is still expanding. The majority (two thirds) of known biomineralisation
products are calcium minerals, almost two thirds are hydrated and one quarter consist
of colloidal material (Lowertstam, 1981; see Table 1.1).
Two fundamentally different processes of biomineralisation have been
identified. Firstly, in some bacteria and in various green and brown algae, bulk
extracellular and/or intracellular mineral formation is observed. This process results
in polycrystalline aggregates of the mineral constituents, of random orientation
(Borowtzka et al., 1974; Bohn et al., 1978). The second system of
biomineralisation, the "organic matrix-induced" process, is more elaborate and
specific than the first and is observed in numerous animal species. The organism
"builds" an organic frame (the extracellular matrix) into which appropriate ions are
introduced and then induced to form crystals which then grow. The mineral type,
orientation of crystallographic axis and microarchitecture all appear to be under close
control. Examples of this system of biomineralisation include bone (Spector and
Glimcher, 1973; Hauschka et al., 1975; Cohen-Solal et al., 1978; Glimcher, 1984;
Romberg et al., 1986), teeth (Butler et al., 1972; Lee et al., 1977; Glimcher et al.,
1979; Termine et al., 1979; Zanetti et al., 1981), the shells of molluscs (Borbas et
al., 1991) and the avian egg shell (Silyn-Roberts and Sharp, 1986). Examination of
the protein constituents of the extracellular matrix (the "organic matrix") of the
mineralised tissues (e.g. teeth and bone) of mammals has shown that the
non-collagenous, organic fraction contains various phosphoproteins. These
phosphoproteins are a heterogeneous group which includes: the phosphophoryns of
teeth, the bone phosphoproteins, the caseins of milk, statherin and the acidic proline-
rich-phosphoproteins (PRP's) of saliva, osteonectin, the phosphoproteins of egg and
mollusc shells, the phosphoproteins of urine and the egg phosvitins.
2








































Gypsum CaS04 Jelly fish larvae (gravity
device)
*Includes a range of magnesium-substituted calcites
Table 1.1 The Types and Functions of the main Calcium Minerals found in
Biological Systems (Mann et al.. 19891
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Phosphoproteins play a very important role in the biomineralisation process;
helping to determine mineral type, crystallinity and growth. Phosphoproteins are
also important in several, calcium-saturated, exocrine secretions, such as milk and
saliva, where part of their function is maintaining the integrity of the secretion.
In spite of the widespread interaction of phosphoproteins with calcium
minerals the mechanism and process is little understood and little is known at a
fundamental level of the stereochemistry, kinetics or thermodynamics of the
interaction. This is undoubtedly due to the inherent problems associated with then-
study. Such problems include: difficulty in obtaining the phosphoproteins in a pure
form, lack of precise secondary and tertiary structural information and the fact that
biological calcium phosphates themselves are not easy to define (chemical
composition, the levels of impurities and the degree of crystallinity are all variable).
The two most extensively characterised phosphoprotein/calcium mineral
systems in biology are, arguably, the acidic proline-rich-phosphoproteins of saliva
and the caseins of milk. This thesis is mostly concerned with the adsorption of
bovine (3-casein A ((5-CN A) and its tryptic peptide derivative ((5-CN (fl-25)) to the
calcium phosphate mineral dicalcium phosphate dihydrate (DCPD; Chapter 3). In
addition, investigations into the general features of phosphopeptide/calcium
phosphate mineral interaction were undertaken. An attempt was made to grow
co-crystals of phosphoserine with calcium ions (Chapter 4) and a phosphoiylated
dipeptide was synthesised (Chapter 2) which could be used in adsorption
experiments and for co-crystallisation with calcium ions. The background to these
three separate approaches is contained in the relevant chapter introductions. Thus
by combining the results of these studies it was hoped to gain an understanding of
the phosphoprotein/calcium mineral interactions which would give information
about the formation and structure of casein micelles.
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CHAPTER TWO




The preparation of peptides by chemical synthesis enables the production of
large quantities (milligrams or even grams) of highly-pure, highly-specific peptides.
The more conventional methods, such as enzyme digestion or acid hydrolysis of a
purified, parent protein, are often inferior to chemical synthesis in both quantity and
purity. Furthermore, tailor-made (chemically synthesised) peptides are useful for
the production of chemical analogues (e.g. peptides that contain non-naturally
occurring amino acids) which may be used to investigate the relationship between
chemical structure and biological function. Synthetic peptides are also useful for
the unambiguous assignment of structures to their naturally-occurring counterparts
and as simplified, experimental models of proteins.
In the present study, a phosphorylated dipeptide was synthesised in order to
examine both its binding to a calcium phosphate phase and its crystal structures (in
the presence and absence of calcium ions). Fundamental information (such as the
stereochemistry and thermodynamics of its binding) obtained would give some
insight into the more complex binding of phosphoproteins to calcium phosphate
phases.
22. General Conditions for Reactions of Peptide Synthesis
Peptide synthesis is the joining together of chiral amino acids to form chains
of pre-determined length and sequence. Formation of a peptide bond consists
simply of condensing the carboxyl group of one amino acid to the amino group of
another with the elimination of water. However, the dipolar nature of amino acids
renders this elimination reaction thermodynamically unfavourable and the
excessively high temperatures required would undoubtedly lead to a mixture of
peptides together with cyclised, racemised and polymerised reaction products. In
order to synthesise a specific peptide in the laboratory, three conditions must be
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fulfilled. Firstly, the dipolar nature of the reacting amino acids must be destroyed.
Secondly, as amino acids are di- or poly- functional, the amino or carboxyl group
must be differentiated from the other functional groups. The specific coupling of
the carboxyl group of one amino acid to the amino group of another can only be
achieved by protecting the functional groups we do not wish to react. Thirdly, the
carboxyl group must be activated to allow formation of a peptide bond. The first
two requirements are met by the use of suitable protecting agents (R and P in Fig.
2.1; considered in section 2.3), many of which have been developed both for amino
groups and carboxyl groups (as well as for the functional groups occurring on the
side chains of amino acids). For a protecting group to be suitable it must a) be easy
to introduce into the amino acid or peptide, b) protect the functional group under the
conditions of amide bond formation and c) be easily removed to leave the peptide
bonds intact. The third requirement is met by the introduction of an electronegative
substituent (X; see Fig. 2.1) and/or a coupling agent (considered in section 2.4) to
enable peptide bond formation to occur with a high efficiency and under mild
conditions. In the present case, protecting groups must also be stable under the
conditions used for phosphorylation of the peptide, and their removal (deprotection)
must leave the phosphate ester bond intact. Lastly, it is necessary to consider the
methods available for phosphorylation of synthetic peptides (at serine, threonine or
tyrosine residues; section 2.5). Overleaf is a schematic diagram showing the
essential features of peptide synthesis (Fig. 2.1).
2.2.1 Assembly of the Peptide - Strategy of Synthesis
After careful consideration of the protecting groups to be used and the
method of coupling it is essential to consider the method of assembling the peptide.
There are three basic strategies available (reviewed by Bodanszky, 1984), each with


























Figure 2.1 Schematic Diagram of Peptide Synthesis
8
1) Stepwise elongation starting from the C-terminal amino acid.
2) Stepwise elongation starting from the N-terminal amino acid.
3) Fragment condensation - the joining together of smaller peptides.
11 Stepwise Elongation from the C-terminus
This strategy, beginning with the C-terminal residue of the peptide (first
amino acid protected at the carboxyl group) is probably the most commonly applied
strategy of peptide synthesis. It has the great advantage of producing racemate-free
peptide, especially if the protecting groups Z- (benzyloxycarbonyl; see section
2.3.1.1) or Boc- (rerf-butoxycarbonyl; see section 2.3.1.2) are used. The procedure
is shown overleaf (Fig. 2.2).
In addition, this strategy is the one employed for solid phase synthesis of
peptides (Merrifield, 1963, 1969). The solid phase method has proved to be
extremely important for the synthesis of longer peptides (of more than about 15
amino acids) when solution phase becomes impractical due to low yields, increased
risk of racemisation and poor solubility of the peptide.
21 Stepwise Elongation from the N-terminus
This strategy is comparable to that which occurs during protein synthesis
in vivo. The N-terminal, protected amino acid is activated at the carboxyl group and
then coupled to the second amino acid. Elongation proceeds in this manner until the
peptide is completed (see Fig. 2.3). Deprotection of the amino group and any side
chain protecting groups completes the synthesis.
This strategy assumes that the carboxyl group of the amino component is
protected by the addition of a base, by converting the zwitterion form of the amino
acid to a salt and thus leaving the amino group free to act as a nucleophile in the
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Figure 2.3 Peptide Synthesis - Stepwise Elongation from the N-terminus
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reduced to a minimum. However, racemisation can occur at the C-terminal residue
of the intermediate peptide during activation and coupling. This strategy is of
limited value in practical peptide synthesis.
31 Fragment Condensation
As its name implies, this strategy involves taking pre-formed fragments of
the peptide and coupling them together. However, care must be taken, as the risk of
racemisation is high because it is the carboxyl group of the peptide which has to be
activated rather than the protected amino acid (see section 2.6). Racemisation can
be minimised by adding of N-hydroxysuccinimide (Zimmerman and Anderson,
1967) or 1-hydroxybenzotriazole (Konig and Geiger, 1970; see section 2.4.1). Due
to the inherent problems of racemisation this method is rarely used.
As the peptide to be synthesised in this study was a dipeptide there will be no
further consideration of the above strategies.
2,3 Protecting Agent? for the Functional Groups pf Aminp Acids
At present, the choice of protecting agents for amino, carboxyl and side chain
functional groups is vast. Final selection depends upon consideration of several
factors: the ease of introduction, the extent of protection provided, stability during
peptide bond formation and any amino acid side chain modification, protection of
the adjacent chiral centre from racemisation and, lastly, ease of removal upon
completion of synthesis. For a more complete discussion of protecting agents the
reader is referred to the reviews of Schroder and Lubke (1965), Gross and
Meienhoffer (1979a) andBodanszky (1984).
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2.3.1 Amino-protecting Groups
The amino group can undergo several reactions unless it is protected. It can
be acylated or alkylated and is able to form Schiffs bases and salts. The following
sections describe three popular amino-protecting groups.
2,3,1,1 BenzylQxycarbonyl grQup (Z-)
The introduction of the benzyloxycarbonyl (Z-) group by Bergmann and
Zervas (1932) marked the beginning of modern peptide synthesis.
N-Benzyloxycarbonyl derivatives have several virtues: they are stable compounds
which are readily obtainable in high yields, they protect the amino acid from
acylation (Folsch, 1967) and, perhaps most importantly, they protect the amino acid
from racemisation.
Another advantage of Z- derivatives is that there are several alternative
methods for deprotection: hydrogenolysis (Bergmann and Zervas, 1932; Bergmann
et al., 1935), reduction with liquid ammonia (Sifferd and du Vigneaud, 1935),
treatment with hydrochloric acid solutions (White, 1934), or solvolysis with
hydrogen chloride (Albertson and McKay, 1953) hydrogen bromide (Ben-Ishai and
Berger, 1952) or hydrogen iodide (Waldschmidt-Leitz and Kuhn, 1951) in acetic
acid. Solvolysis in hydrogen bromide or hydrogenolysis are the most commonly
used of these methods.
There are some limitations in using N-benzyloxycarbonyl protection, namely
sensitivity to alkali, where formation of hydantoin derivatives may result if the
protected amino group is adjacent to a glycine residue (MacLaren, 1958). Also,
hydrogenolysis fails if sulphur-containing amino acids are present in the peptide (due
to catalytic poisoning). However, these problems can be overcome, to some extent,
by the use of dry liquid ammonia as solvent (Kuromizu and Meienhofer, 1974).
Other side reactions are possible, such as the formation of N-carboxyanhydrides if
13
acid chloride derivatives of Z-amino acids are heated (Bergmann et al., 1935). In
addition, de-methylation and subsequent benzylation of methionine residues occur if
hydrogen bromide in acetic acid is used for Z-group removal (Albertson and McKay,
1953; McKay and Albertson, 1957; Guttmann and Boissonnas, 1958).
Nevertheless, the success of the N-benzyloxycarbonyl group and a number of
modified versions (halo- and nitro- substituted forms) make it the first choice of
amino-protecting group for peptide synthesis.
2.3.1.2 tert-Butoxvcarbonvl group (Boc-)
The t-butoxycarbonyl group was first reported by Carpino (1957) as a general
amino protecting group and its application to peptide synthesis followed soon after
(Anderson and McGregor, 1957; McKay and Albertson, 1957). Formation of Boc-
amino acid derivatives is not as simple as that of Z- derivatives because of the
temperature sensitivity (at temperatures above -10°C) of the protecting agent
t-butylchloroformate (described by Woodward et al., 1966). However, several
alternative methods do exist for the synthesis of Boc- amino acids, in which a more
temperature stable protecting agent is employed (Schwyzer et al., 1959; Schwyzer
and Rittel, 1961). For example the azide method, which utilises t-butyloxycarbonyl
azide as protecting agent, is the most commonly used. Unfortunately this method is
not simple and careful temperature control is still required (reaction kept below 5°C)
or explosion is likely (Schnabel, 1967).
The Boc-group, unlike the Z-group, is stable to hydrogenolysis and resistant
to hydrolysis by alkali but it is easily cleaved by mild acid. Thus Z- and Boc-
groups can be used in conjunction on the same molecule allowing selective
protection and deprotection. This adds versatility to the synthesis scheme for a
complex peptide. Since Boc- groups can be removed with hydrogen bromide in
acetic acid, the simultaneous removal of both Z- and Boc- groups is also possible.
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2.3.1.3 Trifluoroacetvl group ("TFA-1
The TFA- group was first used in peptide synthesis by Weygand and Csendes
(1952); protection of the amino acid being achieved by the action of trifluoroacetic
acid anhydride on the amino acid. However, there is a great danger of racemisation
which can be overcome by performing the reaction in ethyl thiotrifluoroacetic acid in
aqueous solution at pH 8-9 (Schallenberg and Calvin, 1955). Sodium, barium or
ammonium hydroxide or pyridine solutions are commonly used to deprotect the
amino group (Schallenberg and Calvin, 1955).
Summary
The three amino protecting groups discussed above are those most commonly
used by peptide chemists, although many others have been reported (Schroder and
Lubke, 1965; Gross and Meienhoffer, 1979a; Bodanszky, 1984). Each protecting
group has its own individual qualities and selection depends ultimately upon the
sequence of the peptide to be synthesised.
2.3.2 Carboxvl- protecting Groups
The prime objective of the substitution of the carboxyl group is not
protection but rather release of the amino acid from its zwitterion state. Carboxyl
groups can be protected in three general ways: 1) by esterification 2) by hydrazide
or amide formation or 3) by salt formation. The most important type of substitution
is esterification, three of which are discussed below.
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2,3,2.1 Benzyl ester (QBzl-)
Bergmann et al. (1935) introduced not only the benzyloxycarbonyl group but
also the benzyl ester group. Esterification of the amino acid with benzyl alcohol has
the advantage of being a relatively simple procedure resulting in good yields
(Brenner and Huber, 1953). The esterification reaction is acid-catalysed;
commonly used catalysts being thionyl chloride, p-toluenesulphonic acid and
benzenesulphonic acid (Schroder and Lubke, 1965). The reaction is greatly
enhanced if the water which forms during the reaction is removed by azeotropic
distillation (Lutz et al., 1959). The OBzl- group can be removed by catalytic
hydrogenolysis (Haussler, 1960), by treatment with hydrogen bromide in acetic acid
(Ben-Ishai, 1954) or by treatment with sodium in liquid ammonia (Roberts, 1954).
However, it is not possible to cleave benzyl esters selectively in the presence of
N-benzyloxycarbonyl- groups (Z- groups; see section 2.3.1.1). Two modified
benzyl ester groups are available; the p-nitrobenzyl (Schwyzer et al., 1959) and
p-methoxybenzyl group (Weygand and Hunger, 1962). These groups have the
advantage of being stable to hydrogen bromide in acetic acid, which allows selective
cleavage of the ester. In addition, the p-nitrobenzyl esters tend to be readily
crystallisable which can aid their purification (Schroder and Lubke, 1965).
2.3.2.2 Methvl and Ethvl esters
Along with the benzyl ester group, methyl and ethyl esters are probably most
widely used to protect the carboxyl group of amino acids or amino acid derivatives.
Moreover, methyl and ethyl esterification is arguably the most convenient method
for carboxyl group protection. Esterification is achieved simply by mixing
methanol or ethanol with thionyl chloride (which acts as a catalyst) and then adding
the amino acid (Brenner and Huber, 1953). Alternative catalysts include
phosphorus pentachloride, p-toluenesulphonic acid and sulphuric acid. Carboxyl
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groups are usually deprotected by hydrolysis of the alkyl ester with mild alkali in an
organic solvent such as methanol, dioxane or acetone. The main disadvantage of
these protecting groups is that the use of excess alkali during deprotection may result
in cyclisation, racemisation or the formation of urea or hydantoin derivatives
(MacLaren, 1958). These esters also form intermediates in the synthesis of peptide
bonds via the azide method (see section 2.4.2).
2.3.2.3 Tertiarv-Butvl Esters (QlBul
The introduction of t-butyl esters for use in peptide synthesis (Anderson and
Callahan, 1960) was a very important development in protecting group
methodology. The t-Butyl esters of amino acids have several advantages over the
methyl, ethyl and benzyl esters including their greater stability which allows storage
and distillation of the protected amino acid. The OlBu- amino acid derivatives can
be easily hydrolysed in acidic conditions whereas the other esters described above
(see section 2.3.2.2) require more vigorous treatment to achieve hydrolysis. t-Butyl
esters are prepared by an acid-catalysed, addition reaction of isobutane either to the
free amino acid in dioxane (Roeske, 1959) or to N-protected amino acids in
dichloromethane (Anderson and Callahan, 1960). The t-butyl ester can be cleaved
in several ways: with hydrogen bromide in acetic acid, p-toluenesulphonic acid in
benzene or with trifluoroacetic acid.
2,3.3 Protection of Amino Acid Side Chains
If an amino acid side chain contains an active functional group then
consideration must be given to its protection. The peptide to be synthesised in this
study contained only serine residues, which have free p-hydroxyl groups. Hie
[3-hydroxy1 group of serine can undergo several undesirable side reactions:
elimination reactions, condensation reactions, O-acylation reactions, acid-catalysed
17
N - O acyl shifts and reactions with other amino acids (Schroder and Lubke, 1965;
Folsch, 1967). The P-hydroxyl group is usually protected, if the completed peptide
is intended to have a free hydroxyl group, by the formation of a benzyl ether
(Schroder and Lubke, 1965). Protection of serine derivatives, that are to be
O-phosphorylated, would require additional reactions for the selective removal of the
P-hydroxyl-protecting groups to allow subsequent phosphorylation. In the reaction
scheme which I chose (Fig. 2.9 in section 2.7), the P-hydroxyl group was not
protected for the above reason and because side reactions (during peptide bond
formation) involving the free hydroxyl group can be avoided if care is taken. As the
P-hydroxyl group of serine was not protected during this study no further comment
will be made on protection of amino acid side chains. The reader is referred to the
reviews of Schroder and Lubke, (1965) and Gross and Meienhoffer, (1979a).
2.4 Formation of the Peptide Bond
The principal reaction of peptide bond formation is acylation of the amino
group of an amino acid by the carboxyl group of a second amino acid. A multitude
of methods has been developed for peptide synthesis under mild conditions
(reviewed by Gross and Meienhoffer, 1979a). Without exception, these methods
activate the carboxyl group of an amino protected amino acid or peptide. Activation
is the enhancement of the electrophilicity of the carboxyl carbon by introduction of
an electronegative substituent (X), which allows peptide bond formation under mild
conditions. Three of the most commonly used methods for peptide bond formation
are discussed below.
2.4.1 N.N-Dicyclohexylcarbodiimide (DCCI)
This coupling agent was first used to form a peptide bond by Sheehan and
Hess (1955). DCCI gives good yields in a relatively short time and has the great
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advantage of very little tendency to cause racemisation. The by-product of peptide
bond formation is N,N-dicyclohexylurea which is insoluble in most of the solvents
used in coupling reactions and therefore is easily removed by filtration. DCCI is
usually used to produce N-protected, amino acid, active esters (Elliot and Russell,
1957; Bodansky and du Vigneaud, 1959). The mechanism of coupling was first
investigated by Khorana (1955) and was re-investigated by DeTar and Silverstein
(1966). These workers proposed that the addition of the N-protected amino acid to
the reagent (DCCI) forms an O-acylisourea intermediate (see Fig. 2.4) which can
then undergo several reactions.
Firstly, the peptide bond can form as a result of reaction of the amino
component of the C-protected amino acid with the intermediate. Secondly, in the
presence of acid, addition of a second proton may occur resulting in the formation of
a symetrical anhydride together with disubstituted urea which then may acylate the
amine. Finally, O - N acyl migration can occur, with the formation of N-acylurea.
However, the latter, undesirable by-product can be avoided if the reaction is
performed in dichloromethane or acetonitrile (Sheehan et al., 1956).
Use of DCCI as coupling agent may, in some instances, cause racemisation,
especially if acyl peptides are being activated. To help avoid this
N-hydrosuccinimide (Weygand et al., 1966; Wunsch and Drees, 1966),
1-hydroxybenzotriazole (Konig and Geiger, 1970) or ethyl-2-hydroximino-2-
cyanoacetate (Itoh, 1973) can be added to the reaction and the commonly used
solvent dimethylformamide (DMF) should be avoided (Bodanszky and Birkhimer,
1960; Schroder and Lubke, 1965).
2.4.2 The Azide Method
This is probably the most highly regarded method for peptide bond formation
(Hofmann et al., 1960). The reaction has several steps. The acylamino acid ester is
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O-acylisourea intermediate
Figure 2.4 N.N-Dicvclohexvlcarbodiiniide as Coupling Agent
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The azide is then reacted with the amino acid that is to form the peptide bond under
Schotten-Baumann conditions to form the acyldipeptide (see Fig. 2.5). However,
problems do exist with this reaction, as the acylazide formed is unstable and can
undergo Curtius re-arrangement to form the isocyanate (Curtius, 1904).
Nevertheless, this method remains very popular for coupling both peptides and
amino acids.
There are a number of methods available for preparing the hydrazide
intermediate (e.g. Hofmann et al., 1950; Sheehan and Hess, 1955) but care must
always be taken to avoid formation of by-products. Favourable conditions for this
reaction are a low temperature, a homogenous solution, high acidity and the presence
of organic nitrite such as t-butyl nitrite or nitrosyl chloride.
2.4.3 The Mixed Anhydride Method
The mixed anhydride method (Wieland et al., 1950), being compatible with
many protecting groups, is used when a rapid coupling reaction is necessary. The
mixed anhydride method has several attractive features: high reaction rates at low
temperature, ease of manipulation, comparatively high purity of product and readily
available and inexpensive reagents (Vaughan and Osato, 1951, 1952). However,
unless care is taken, there is a risk of racemisation, but this can be minimised by use
of a tertiary base (Anderson et al., 1967).
Formation of the peptide bond, by the mixed anhydride procedure, involves
two separate stages: 1) activation of the carboxyl group, i.e. generation of a mixed
anhydride, and 2) coupling with the amino group (peptide bond formation). Stage 1
is carried out by addition of carbonic acid monoalkyl ester chloride (Wieland and
Bernhard, 1951) to a cold solution of the amino protected amino acid in the presence
of tertiary base (e.g. triethylamine or N-ethylmorpholine; Fig. 2.6A). Anhydrous
conditions are required; commonly used solvents include toluene, chloroform,









































Figure 2.6A The Mixed Anhydride Method - Stage 11 Activation of the Carhnwl Group
R1 o R1 oI * . | ||
z-nh—ch—c + h2n-r »- z-nh—ch—c—n—r3
I H
c=o
Jr -o r2-oh + co,
Figure 2.6B The Mixed Anhydride Method - Stage 2) Peptide Bond Formation
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directly in the acylation reaction (stage 2) simply by adding the second amino acid.
Peptide bond formation is usually rapid with the liberation of both carbon dioxide
gas and the corresponding alcohol as by-products (Fig. 2.6B).
2.5 Phosphorylation of the p-hvdroxvl Group of L-serine
Phosphoproteins are widespread in biological systems. Characteristically,
they yield their phosphate groups as O-phospho-L-serine (Ser(P)) and, to a lesser
extent, O-phospho-L-threonine (Thr(P)), after acid hydrolysis (Donella et al., 1976).
Due to the difficulties encountered in the purification and structural determination of
the natural phosphopeptides subsequent workers have attempted to obtain peptides
containing Ser(P) (and Thr(P)) residues by chemical synthesis (Folsch et al., 1959,
1965, 1966; Theodoropoulos et al., 1960; Alewood et al., 1981; Perich et al,
1986a,b; 1987a,b; Schlesinger et al., 1987; Perich and Johns, 1988a,b,c).
Riley et al. (1957) were the first to phosphorylate successfully
N-carbobenzyloxy-L-serine ethyl ester with diphenylphosphoryl chloride (DPPC),
and the synthesis of Ser(P)-containing peptides soon followed (Folsch, 1959). The
original phosphorylation methods used aryl- or alkyl- phosphoryl chlorides as
phosphorylating agents. However, due to inherent problems associated with these
phosphorylating agents, new methods and agents were developed. These include
aryl- or alkyl- phosphochloridites and aryl- or alkyl- phosphoramidites (see section
2.5.4). All of these phosphorylation reactions must be carried out under strictly
anhydrous conditions.
Synthesis of phosphopeptides is theoretically possible by use of at least two
different approaches:
1) Unprotected or suitably protected O-phosphoserine is coupled with
amino acid or peptide derivatives.
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2) The protected peptide whose sequence includes serine with a free
P-hydroxyl group is first synthesised. The hydroxyl group is then
phosphorylated and the protecting groups are finally removed.
2,5,1 Coupling pf Q-phosphoserine to an Aminp Acid or Peptide Derivative
Approach 1) has been little used, mainly due to problems incurred with the
special solubility and reactivity properties of Ser(P) and its derivatives. L-serine
was first phosphorylated by Levene and Schormuller (1934) using phosphorus
oxychloride and phosphorus pentoxide. This method has since been refined
(Plimmer, 1941; Posternak and Grafl, 1945; Neuhaus and Korkes, 1958). Direct
amide bond formation, with the readily available Ser(P), would be of great value
since it would eliminate many of the laborious protection steps and also possibly
allow phosphopeptides to be synthesised by solid phase methods (Merrifield, 1963,
1969; Atherton and Sheppard, 1989).
However, addition of amide- or carboxyl- protecting groups to Ser(P) has
proved to be very difficult (Folsch, 1967). Esterification of the carboxyl group of
Ser(P) can be achieved (Brenner and Huber, 1953; Folsch, 1967) but attempts to
prepare the benzyl ester have failed (Folsch, 1967). In addition, side reactions
involving the unprotected phosphate group, such as elimination reactions and the
formation of some types of amide, are suspected (Riley et al., 1957; Folsch, 1967).
This route, therefore, was not considered practical for the synthesis of
phosphopeptides, and indeed almost all synthetic peptides of Ser(P) reported have
been synthesised by approach 2) (namely the phosphorylation of the peptide after
synthesis) of which the chemistry has been investigated extensively (reviewed by
Folsch, 1967). Even though synthetic phosphopeptides have been produced for
some 32 years, their successful synthesis, in good yields, still requires a great deal of
care and experience and a certain degree of luck.
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2.5.2 Phosphorylation of L-serine-containing Peptide Derivatives
Methods for the phosphorylation of serine (see section 2.5.1) use the
advantage of the acid stability of Ser(P) and so cannot be used for compounds
containing acid labile bonds such as the peptide bond. The first successful synthesis
of a peptide derivative of phosphoserine (the second approach outlined in section
2.5) was by Folsch in 1959 who used dibenzylphosphoryl chloride as the
phosphorylating agent. There are now a number of phosphorylating agents
available which are suitable for peptides, but for many years the two most commonly
used were dibenzylphosphoryl and diphenylphosphoryl chloride.
2.5.2.1 Diphenvlphosphorvl chloride (DPPO
Diphenylphosphoryl chloride (DPPC) appears to be a more powerful
phosphorylating agent than its benzyl analogues as triester yields of about 90% are
obtainable (as opposed to yields of 40-60%; see section 2.5.2.2). The great
advantage of DPPC is its stability, allowing phosphorylation to be carried out at
room temperature in pyridine solution. However, its major drawback is the
slowness of the hydrogenolytic removal of the phenyl groups. Typical reaction
conditions are a pure hydrogen atmosphere (at 138 kPa and at room temperature)
80% acetic acid solution as solvent with 1.1 mmol platinum IV oxide per mmol of
phenyl group as catalyst (Perich et al., 1986a; Perich and Johns, 1988a). Therefore,
the major drawbacks to using DPPC are the expense of the reaction and the need for
specialist equipment.
2.5.2.2 Dibenzvlphosphorvl chloride (DBPC1
DBPC suffers from several disadvantages compared to its diphenyl analog
(DPPC). DBPC is an unstable compound and must be prepared fresh for each
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reaction as it decomposes during storage (Atherton et al., 1945, 1948). Triester
yields are generally lower than with DPPC, being about 40-60%, and to achieve even
these yields the reaction needs to be maintained at -20° to -40°C. The low yields
are due to DBPC decomposing during the reaction (Alewood et al., 1984) and to the
formation of pyrophosphate analogs of the peptides (Folsch, 1959; Alewood et al.,
1984).
However, DBPC has the great advantage that its protecting groups are easily
removed. Removal requires palladium on carbon (10%) catalyst, 85% ethanol as
solvent (with a few drops of acetic acid) and a pure hydrogen atmosphere for
approximately four hours (Folsch, 1959, 1967; Koehn and Kind, 1965). These
conditions are relatively mild compared to those required for DPPC.
Summary
Both DPPC and DBPC have several drawbacks as phosphorylating agents for
peptides and work is continuing to find more efficient methods and agents. The
major disadvantage with both DPPC and DBPC is the low yields after catalytic
hydrogenolysis; typically 50 - 60%. Also with large and multi-phosphorylated
peptides, incomplete phosphorylation is frequently observed (Johnson and Coward,
1987) which is thought to result from steric hindrance by the bulky protecting groups
on the phosphate group (Folsch, 1967; Perich and Johns, 1988a). After catalytic
hydrogenolysis a mixture of products results (unphosphorylated, partly
phosphorylated and partly deprotected peptide). In addition, the low yields of
phosphopeptide(with DPPC is used as phosphorylating agent) are thought to result
from pyridine mediated dephosphorylative rearrangement during the product
isolation procedure (Perich and Johns, 1990a), resulting in the formation of diphenyl
hydrogen phosphate. The rate of dephosphorylation by this route is influenced by
the nature of the N- and C- terminal protecting groups (Perich and Johns, 1990a).
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2.5.2.3 Bis-C2.2.2-trichloroethvDphosphorvl chloride (TCPC)
TCPC is a phosphorylating agent that was first used to phosphorylate
nucleosides by Eckstein and Scheit (1967). Since then it has been used to
phosphorylate nucleosides (Franke et al., 1968; Owen et al., 1976),
phosphonamides and phosphoramides (Thorsett et al., 1982) and inositols (Cooke
et al., 1989). TCPC has not been used to phosphorylate serine-containing peptides
but has been successfully used to phosphorylate Boc-Ser-OBzl (Paquet and Johns,
1990). Removal of the phosphate-protecting (2,2,2-trichloroethyl) groups can be
achieved in three ways: by using zinc dust in 80% acetic aacid, by using zinc/copper
dust in dimethylformamide (Eckstein and Scheit, 1967) or by using sodium in liquid
ammonia (Cooke et al., 1989).
As the phosphate protecting groups can be removed by the relatively simple
and inexpensive method of zinc dust in 80% acetic acid (cf. DPPC derivatives which
require platinum IV oxide catalyst and high pressure hydrogen atmosphere, see
section 2.5.2.1) which has been used (Paquet and Johns, 1990) to phosphorylate
Boc-Ser-OBzl, TCPC was chosen as a novel, alternative phosphorylating agent for
the dipeptide Z-Ser-Ser-OBzl.
2.5.3 New Methods for Phosphorylation of Peptide Derivatives
In 1979, Okawa et al. proposed an alternative method for synthesis of
phosphopeptides: the aziridine ring opening reaction. This method requires the
aziridine peptide to be prepared (Okawa et al., 1975) which is then phosphorylated
with either dibenzylphosphoric acid or with 85% phosphoric acid. This method
gives good yields of about 70%, but because of the added complication of having to
prepare the aziridine peptide before proceeding, this method has proved to be
unpopular. Therefore, until 1986, dibenzyl- and diphenyl- phosphoryl chloride
featured prominently in the synthesis of phosphopeptides on account of the ready
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availability or preparation of these phosphorylating agents and of the relatively
simple phosphorylation procedure.
In 1982, Alewood et al. introduced a novel method for phosphorylation of
peptides using diethylphosphochloridite as phosphitylating agent. This method also
allowed the rapid synthesis of a protected phospho-amino acid, suitable for
incorporation in solution or solid phase peptide synthesis (previous methods required
phosphorylation to be performed at the end of peptide synthesis, see section 2.3.3).
However, the drastic reaction conditions required to remove the diethyl- protecting
groups (Kitas et al., 1988) make this phosphitylating agent unsuitable for
phosphopeptide synthesis. More recent investigations have given rise to two new
methods of phosphopeptide preparation, using either phosphite triesters or
phosphoramidites as phosphitylating agents.
Perich and Johns (1987b) reported the extremely efficient reactions (yields
> 90%) of primary, secondary and tertiary alcohols with N,N-diethyl dibenzyl
phosphoramidite as phosphitylating agent. Soon after, de Bont et al. (1987) used
this same method to phosphorylate protected serine and threonine derivatives which
were then successfully coupled to Boc-Ala with final yields of approximately 80%.
Several similar phosphitylating agents have also been reported, these include:
bis[2,2,2-trifluoroethyl] phosphite (Gibbs and Larsen, 1984) dimethyl-,
diphenyl- and diethyl- phosphochloridite (Perich et al., 1986b),
S,S-diphenyl phosphorodithioate (Kuyl-Yeheskiely et al., 1987, 1988),
N,N-diethylphosphoramidite (Perich and Johns, 1988b), diisopropyl phosphite (Ji
et al., 1988), N,N-diethylamino-dibenzylphosphoramidite (de Bont et al., 1988)
di-t-butyl N,N-diethylphosphoramidite (Bannworth and Tzeciak, 1987; Perich
and Johns, 1988c, 1990b; Staerkaer et al., 1991) and dibenzyl
N,N-diethylphosphoramidite (Perich and Johns, 1990c)
These new developments in phosphorylation techniques have allowed
previously impractical methods to be exploited. For example, the synthesis of a
phosphopeptide entirely by solid phase methods (Lacombe et al., 1990) and the
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coupling of protected phosphorylated amino acids to pre-existing peptides (Perich
and Johns, 1988b,c; Meggio et al., 1991). However, most of these phosphitylating
agents have to be synthesised prior to each reaction as they decompose upon storage.
These new methods also appear to overcome one of the major problems of peptide
phosphorylation (using DPPC or DBPC): obtaining the phosphopeptide in a pure
form.
2.6 The Problem of Racemisation
To produce a biologically active peptide it is essential to maintain a high
degree of optical purity throughout synthesis as, unfortunately, racemisation can
occur at every stage of synthesis. To prevent racemisation, careful selection of
protecting groups and coupling agents is essential. Loss of optical purity during
synthesis has lead to extensive investigations into possible mechanisms and hence to
knowledge of how racemisation may be overcome (reviewed by Bodanszky and
Ondetti, 1966; Gross and Meienhofer, 1979a,b; Bodanszky, 1984). Such
investigations have lead to the proposal of two possible mechanisms: a) base-
catalysed racemisation and b) the formation of a 5-oxazolone intermediate which can
undergo internal nucleophilic attack and so racemise.
Withdrawal of a proton from the chiral a-carbon tends to occur in amino
acids or Z-amino acids that have an electronegative group in the (3- position (i.e.
phenylalanine, cysteine, serine or threonine). These amino acids can undergo base-
catalysed racemisation (Bohak and Katchalski, 1963; Liberek, 1963). The
functional group at the (3-carbon facilitates proton abstraction from the a-carbon
atom and so removes the chiral centre (MacLaren et al., 1958; see Fig. 2.7).
The second mechanism proposed involves the formation of a 5-oxazolone
intermediate. This can occur if an N-acyl-a-amino acid derivative is sufficiently



















Figure 2.7 Base Catalysed Racemisation
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Figure 2.8 Formation of the 5-Oxazolone Intermediate
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to cause the loss of a proton and the resonance-stabilised, oxazolone intermediate
anions form (Barrass and Elmore, 1957; see Fig. 2.8).
There are several strategies that can be adopted in order to reduce the
problem of racemisation: using the step-wise strategy for peptide synthesis (see
section 2.2.1) or the azide method for coupling (see section 2.4.2), or glycine or
proline as the carboxyl component (which is not always possible) and, finally,
certain additives can be used when N,N-dicyclohexylcarbodiimide is the coupling
agent (see section 2.4.1).
2.7 Methods Adopted for Peptide Synthesis
To synthesise the dipeptide Ser(P)-Ser(P), the method of Folsch (1959) was
followed with a few modifications to improve overall yields and final purity.
Essentially, the amino group of one sample of serine was protected with the Z- group
and the carboxyl group of another, with the OBzl- group. The resulting Z-Ser and
Ser-OBzl were then coupled using N,N-dicyclohexylcarbodiimide (DCCI) as
coupling agent. This protected dipeptide was then phosphorylated with either
diphenylphosphoryl chloride (DPPC) or bis-(2,2,2-trichloroethyl)phosphoryl
chloride (TCPC). Deprotection was then effected by catalytic hydrogenolysis, or in
the case of the TCPC derivative, by treatment with zinc dust in 80% acetic acid.
The method used is illustrated in the schematic diagram overleaf (see Fig. 2.9)
2.7.1 General Materials and Methods
All chemicals were purchased from Aldrich Ltd. unless otherwise stated.
Melting points were determined in open capillaries in a Gallenkamp melting point
apparatus and are uncorrected.
iH-n.m.r. spectra were recorded on a Bruker WP-200 (80 MHz) spectrometer





































Department of Chemistry, University of Edinburgh and interpreted with the help of
Mr. D. Will, Department of Chemistry, University of Edinburgh. 31P-n.m.r. spectra
were recorded on a Jeol FX-90Q spectrometer by Mr. D. Will, Department of
Chemistry, University of Edinburgh.
Fast atom bombardment (FAB) mass spectra were recorded on a Kratos MS
50 TC mass spectrometer by Mr. A. Thomas, Department of Chemistry, University
of Edinburgh.
C,H,N analysis was performed by Butterworth Laboratories Ltd., Middlesex.
Thin layer chromatography (t.l.c.) of the protected peptide was performed on
pre-coated silica plates of silica 60 (220-440 mesh ASTM) and 0.2 mm thickness (by
Merck), purchased from Fluka, eluting with the following solvent systems:
a) Dichloromethane/Methanol (9:1 v/v)
b) Dichoromethane/Ethyl acetate (1:1 v/v)
c) Dichoromethane/Ethyl acetate (3:1 v/v)
d) Hexane/Ethyl acetate (1:1 v/v)
e) Dichloromethane/Methanol/Acetic acid (10:2:1 v/v)
f) n-Butanol/Acetic acid/Water (3:1:1 v/v/v)
Thin layer chromatography (t.l.c.) of the deprotected peptide was performed
on pre-coated cellulose plates (Art. 5577 DC-Plastikfolien Cellulose) of 0.1 mm
thickness, purchased from Merck, eluting with:
g) Pyridine/Water (8:2 v/v)
h) n-Butanol/Acetic acid/Water (4:1:5 v/v/v)
i) Ethanol/Water (7:3 v/v)
The protected peptide was visualised by u.v. absorption,
potassium permanganate or with 1% (w/v) ninhydrin in ethanol.
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or with 0.5 mM
The de-protected
peptide was visualised with 1% (w/v) ninhydrin in ethanol. Protected
phosphorylated peptide was purified by column chromatography using silica gel 60
(230-400 mesh ASTM), of particle size 0.04-0.063 mm, purchased from Fluka.
2.7.2 Synthesis of L-Servl-O-benzvl ester-p-toluenesulphonate dl
Synthesis of (1) was by the technique of azeotropic distillation as described
(Miller and Waelsch, 1952; Folsch, 1959). Briefly, 4.2 g (40 mmol) of serine
(Sigma Chemical Co.) and 8.0 g (42 mmol) of p-toluenesulphonic acid were
dissolved in 20 ml of hot benzyl alcohol (Cipera and Nicholls, 1955). Hot carbon
tetrachloride was added and the solution distilled until no more water was formed
(approximately 3-5 hr). The ester salt (1) was then precipitated with dry diethyl
ether, and after about 18 hr at 4°C was collected by filtration.
Crude (1) was then purified by re-crystallisation from methanol/diethyl ether,
after which analysis by t.l.c. in solvent systems a (Rf 0.31) and b (Rf 0.2) showed
one spot indicating a single compound. Yields were approximately 72% and the
melting point range was 115-117°C. The following analytical results were obtained
for (1):
lH-n.m.r. '5H (p.p.m.) [200.130 MHz, D6-DMSO] 7.78-7.04 [9H, m, (Ar//)]
5.19 [2H, s, (bzl CH2)] 4.05-4.13 [1H, t, (ocC//)] 4.04-3.93 [2H, d, (pC//2)]
2.32 [3H, s, (CH3)]
2.7.3 Synthesis of N-Benzvloxvcarbonvl-L-serine (21
Synthesis of (2) was by the method of Baer and Maurukas (1955). Briefly,
12.5 g (0.31 mol) of magnesium oxide and 10.5 g (0.1 mol) of serine were mixed
with 175 ml of water and 80 ml of diethyl ether in a flask (on ice). To the flask,
26.4 g of benzyl chloroformate was added, dropwise. After 2 hours the flask was
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removed from the ice bath and the reaction allowed to continue for a further 30 min.
The magnesium oxide was then removed by filtration, and the aqueous phase washed
with diethyl ether. The aqueous phase was then chilled to 4°C, acidified to pH 3.44
with 5 M hydrochloric acid and, after 12 hr, a precipitate of crude (2) was isolated
by filtration. Crude (2) was purified by re-crystallisation from ethyl acetate/light
petroleum spirit (40-60°C), and t.l.c. in solvent systems a (Rf 0.76) and b (Rf 0.42)
showed one spot indicating a single compound. Yields were approximately 70%
and the melting point range was 119-120°C. The following analytical results were
obtained for (2)
lH-n.m.r. '8H (p.p m.) [200.130 MHz, D6-DMSO] 7.36-7.2 [5H, m, (AiH)]
5.1 (2H, s, (bzl CH2)] 4.38-4.19 [1H, m, (aC//)] 3.94-3.81 [2H, t, (pCH2)]
2.7.4 Synthesis of N-Benzvloxvcarhonvl-L-servl-L-serine-O-benzvl ester (31
Synthesis of (3) was by two methods, that of Schlesinger et al. (1987) and
that of Folsch, (1959) both of which use N,N-dicyclohexylcarbodiimide as coupling
agent.
2.7.4,1 Method of Schlesinger et al. (19871 for Preparing (31
A total of 20 mmol of (1) was dissolved in 30 ml of dimethylformamide
containing 20 mmol of triethylamine. 20 mmol of (2) was dissolved in 50 ml of
dimethylformamide containing 20 mmol of N,N-dicyclohexylcarbodiimide. The
two solutions were mixed at 0°C and the reaction was allowed to continue overnight
at room temperature. The dicyclohexylurea formed was removed by filtration, the
solvent was evaporated and the oily residue dissolved in ethyl acetate. The residue
was then washed successively with 1) 10% (w/v) potassium hydrogen sulphate (three
times), 2) water, 3) 10% (w/v) sodium bicarbonate (three times) and 4) water. The
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ethyl acetate solution was then dried over anhydrous magnesium sulphate. The
crude product was re-crystallised from ethyl acetate/light petroleum spirit (40-60°C),
and analysis by t.l.c in solvent systems a (Rf 0.56) and c (Rf 0.38) showed one spot
indicating a single compound. Yields were 61% and the melting range for (3) was
152-154°C. The following analytical results were obtained.
^-n.m.r. '8H (p.p.m.) [200.130 MHz, Dg-DMSO]
8.20 [1H, d, NH, Jnh-Pch = 7.7 Hz] 7.35-7.27 [11H, m, (NH), (Ar-//)]
5.17-5.03 [5H, m, (bzl- CH2), (OH)] 4.91 [1H, t, (OH), J0h-PCH2 = 5.6 Hz]
4.43 [ 1H, d of t, (a-CH), JacH-pCH2 = 4-3 Hz, JaCH-NH = 7.7 Hz]
4.23-4.13 [1H, m, a-CH] 3.83-3.37 [obscured by H2O signal, m, (P-C//2)]
13C-n.m.r. '8C (p.p.m.) [50.130 MHz, D6-DMSO] 54.65 (CH), 56.98 (CH),
61.17 (CH2), 61.71 (CH2), 65.43 (CH2), 65.86 (CH2), 127.49 - 128.29
(Ar-CH, overlapping), 135.83 (Ar-C), 136.85 (Ar-C), 155.88 (CO),
170.22 (CO), 170.29 (CO)
FAB mass spectra for C^H^I^Oy calc.: 416.16616 found: 416.16614
(< 1 p.p.m.)
2.7.4.2 Method of Folsch (19591 for Preparing G)
A total of 20 mmol of (1), 20 mmol of triethylamine and 20 mmol of (2)
were dissolved in 150 ml of tetrahydofuran : acetonitrile (1:1 v/v) and then cooled to
0°C. To this solution was added 20 mmol of N,N-dicyclohexylcarbodiimide. The
reaction was then allowed to continue overnight at room temperature. The
following day the precipitated dicyclohexylurea was removed by filtration and the
filtrate poured into 3.0 litres of ice-cold water. After 12 hr at 4°C the precipitated
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(3) was removed by filtration and dried in vaccuo. Crude (3) was further purified
by re-crystallisation from ethyl acetate/light petroleum spirit (40-60°C), and analysis
by t.l.c. in solvent systems a (Rf 0.56) and c (Rf 0.38) showed one spot indicating a
single compound. Yields were 71% and the melting point range was 152-154°C.
The following analytical results were obtained.
iH-n.m.r. '8H (p.p.m.) [200.130 MHz, D6-DMSO]
8.20 [1H, d, NH, Jnh-Pch = 7.7 Hz] 7.35-7.27 [11H, m, (NH), (Ai-H)]
5.17-5.03 [5H, m, (bzl- CH2), (OH)] 4.91 [1H, t, (OH), JoH-pCH2 = 5.6 Hz]
4.43 [ 1H, d of t, (a-CH), JaCH-pCH2 = 4.3 Hz, JacH-NH = 7.7 Hz]
4.23-4.13 [1H, m, a-CH] 3.83-3.37 [obscured by H20 signal, m, (p-C//^]
13C-n.m.r. '8C (p.p.m.) [50.130 MHz, D6-DMSO] 54.65 (CH), 56.98 (CH),
61.17 (CH2), 61.71 (CH2), 65.43 (CH2), 65.86 (CH^, 127.49 - 128.29
(Ar-CH, overlapping), 135.83 (Ar-C), 136.85 (Ar-C), 155.88 (CO),
170.22 (CO), 170.29 (CO)
FAB mass spectra for C21H24N207 calc.: 416.16616 found: 416.16614
(< 1 p.p.m.)
Anal. calc. for C2iH24N207 (Mr 416.17): C 60.6, H 5.81, N 6.73, found:
C 60.31, H 5.69, N 6.65
2.7.5 Phosphorylation of N-benzvloxycarbonvl-L-seryl-L-serine-O-benzyl ester (3)
Two methods of phosphorylating (3) were compared. The first used
diphenylphosphoryl chloride following the method of Folsch (1959). The second
method used Bis-(2,2,2-trichloroethyl)phosphoryl chloride according to the method
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of Eckstein and Scheit, (1967) for the phosphorylation of nucleosides (see section
2.5.2.3).
2.7.5.1 Phosphorylation nf (31 with diphenvlphosphorvl chloride (DPPO.
To a solution of 10 mmol of (3) in 10 ml of anhydrous pyridine (on ice) was
added, dropwise, 22 mmol of diphenylphosphoryl chloride. The solution was kept at
0°C for 2 hr and then at room temperature overnight. Excess acid chloride was
destroyed with water, the solution was then mixed with ethyl acetate and the aqueous
phase was discarded. The ethyl acetate phase was then washed successively with 1)
20% (w/v) citric acid (three times), 2) water, 3) saturated sodium bicarbonate
solution (three times) and 4) water. The ethyl acetate solution was dried over
anhydrous magnesium sulphate, the solvents were then evaporated leaving a pale
yellow oil (4). Yields were 90%. Crude (4) was further purified by flash column
chromatography (Still et al., 1978) using silica gel 60. The solvent system that gave
the best purification was found to be dichloromethane, eluting with a 2.5-20% (v/v)
methanol gradient. Afterwards, analysis by t.l.c. using solvent systems a (Rf 0.77)
and c (Rf 0.66) showed one spot indicating a single compound. The following
analytical results were obtained for (4):
!H-n.m.r. '5H (p.p.m.) [200.130 MHz, CDC13] 7.47-7.04 [30H, m, (Ar-//)]
5.16-5.02 [4H, m, (bzl CH2)] 4.79-4.75 [1H, m, (a CH)]
4.60-4.05 [5H, m, (a-CH, P~C//2)]
31P-n.m.r. '8p (p.p.m.) [CDCI3] -11.579
FAB mass spectra for C45H44N2°13P2 calc.: 880.22402 found: 880.22407
(< 1 p.p.m.)
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2.7.5.2 Phosphorylation of (3) with
Bis-(2,2.2-trichloroethvl)phosphorvl chloride (TCPC1.
To a solution of 25 mmol of Bis-(2,2,2-trichloroethyl)phosphoryl chloride in
3.0 ml of anhydrous pyridine (on ice) was added dropwise 10 mmol of (3) in 4.0 ml
of anhydrous pyridine. After 2 hr at room temperature, water was added, and the
solution mixed with ethyl acetate. The aqueous phase was then discarded and the
ethyl acetate phase washed with 1) 20% (w/v) citric acid (three times), 2) water, 3)
saturated sodium bicarbonate solution (three times), and 4) water. The ethyl acetate
solution was dried over anhydrous magnesium suphate and the solvent evaporated to
leave a pale red oil (5); yields were 90%. Crude (5) was further purified by flash
column chromotography (Still et al., 1978) using silica gel 60. The solvent system
that gave the best purification was found to be dichloromethane eluting with a
2.5-20% (v/v) ethyl acetate gradient. After this, analysis by t.l.c. using solvent
systems a (Rf 0.82), c (Rf 0.61) and d (Rf 0.41) showed one spot indicating a single
compound. The following analytical results were obtained for (5):
lH-n.m.r. '5H (P-P-m.) [CDC13] 7.52-7.25 [10H, m, (Ar-//)]
5.25-5.07 [4H, m, (bzl-C//2)] 4.87-4.82 [1H, m, (a CH)]
4.71-4.41 [13H, m, (a-CH, p-CH2, Cl3C//2)]
3ip-n.m.r. '5P (p.p.m.) [CDC13] -3.5, -4.038
FAB mass spectra for C29H30Cl12N2O13P2, calc.: 1101.74752
found: 1101.74751 (<1 p.p.m.)
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2.7.6 Hvdrogenolvsis of Protected. Phosphorvlated Dipeptide
The next step in the synthesis of O-phospho-L-seryl-O-phospho-L-serine was
to remove the protecting groups from (4) and (5). This was achieved by catalytic
hydrogenolysis.
2.7.6.1 Hvdrogenolvsis of Diphenvlphosphorvl Chloride Derivative: (41
3.7 mmol of (4) was dissolved in 10 ml of propan-2-ol:watenacetic acid
(50:5:0.5 v/v/v) and 200 mg of palladium on carbon (10%) catalyst was added.
These were then maintained in a pure hydrogen atmosphere for 3 hr or until
hydrogen consumption ceased (Folsch, 1959). The catalyst was removed by
filtration though celite, and the solvents evaporated. The residue was found to
contain, by t.l.c. analysis (in solvent systems a (Rf 0.07), e (Rf 0.52) and f) and by
^-n.m.r., O-diphenylphosphorylated peptide (see section 2.5.2.2). The residue was
therefore re-hydrogenolysed by dissolving in 80% acetic acid with 1.1 mmol of
platinum (IV) oxide catalyst (Adams type) in a pure hydrogen atmosphere (138 kPa)
for 16 hr (Perich and Johns, 1986a; see section 2.5.2.1). Then the catalyst was
removed by filtration through celite and the solvents were evaporated, leaving a
white solid (6). Analysis of (6) by t.l.c using solvent systems g, h and i indicated
the presence of at least three componants. Therefore (6) was purified by ion-
exchange chromatography (see section 2.7.7).
2.7.6.2 Deprotection of big-(2,2,2-trichloroethyl) Derivative; (5)
The deprotection of derivative (5) required two independent steps in order to remove
the protecting groups; first, catalytic hydrgenolysis to remove the Z- and OBzl-




3.7 mmol of (5) was dissolved in 50 ml of propan-2-ol:watenacetic acid
(50:5:0.5 v/v/v) and 200 mg of palladium on carbon (10%) catalyst was added,
which was then maintained in a pure hydrogen atmosphere for 3 hr (or until
hydrogen consumption ceased). Then the catalyst was removed by filtration
through celite, and the solvents evaporated to leave a white solid (7). Analysis of
(7) by t.l.c. in solvent system f showed one spot (Rf 0.64).
2.7.6.2.b Removal of (2.2.2-trichloroethvlV groups from (71
3.7 mmol of (7) was dissolved in 30 ml of 80% acetic acid with 44.4 mmol
(12 equivalents) of zinc dust (Eckstein and Scheit, 1967). This was then stirred at
room temperature for 4 hours. Analysis of the mixture by t.l.c. (in solvent system f)
indicated the complete removal of 2,2,2-trichloroethyl- groups. The remaining zinc
dust was then removed by filtration through celite and the solvents evaporated to
leave a white solid (8).
2.7.7 Purification of SerfPl-SerCPl bv Ion-exchange Chromotographv
The fully deprotected dipeptide Ser(P)-Ser(P) was purified from the crude
samples (6) and (8) by ion-exchange chromatography using Dowex 1-X2 resin
(Strid, 1959). Dowex 1-X2 resin was first converted to the formate form by
equilibration in 2.0 M sodium formate buffer pH 5.5 as described by Strid (1959).
The resin was then re-suspended in 0.1 M formic acid and a column formed
(26 x 230 mm) according to the manufacturer's instructions.
Crude dipeptide ( (6) or (8)) was applied (100 mg samples) to the column,
the flow rate being 3.4 mlh^cnr2, and elution was effected by a linear gradient of
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pyridine formate, from 0.0 to 1.25 M (pH 4.5), of 600 ml volume. Fractions of
6.0 ml were collected which were analysed for the presence of amide bonds using
the ninhydrin assay described by Moore and Stein (1954 a,b).
The elution profiles obtained from samples (6) and (8) are shown in
Figs. 2.10, 2.11. For crude dipeptide sample (6) two peaks were detected, and for
crude dipeptide sample (8) three peaks were detected with the ninhydrin assay.
Fractions were pooled as indicated, discarding any overlapping fractions, and the
solvents evaporated. A small amount of water was then added and the final traces
of pyridine removed by use of Dowex 50(H+) resin by the batch method (Folsch,
1959; Strid, 1959). Each sample was then lyophilised and analysed by FAB mass
spectrometry. In each case, the peak eluting at 0.9 M pyridine formate, was found
to be the dipeptide Ser(P)-Ser(P), and final yields were approximately 50%. In
every case the peak eluting at approximately 0.9 M pyridine formate was analysed
by t.l.c. in solvent systems g, h and i (Folsch, 1959; 1966), and their Rf values
standardised against phosphserine, i.e.
RSer(P) =
Rf for phosphoserine
The RSer(P) f°r Ser(P)-Ser(P) was found to be 0.5 (in solvent system g).
Analytical results for Ser(P)-Ser(P) are given below:
SeriPVSerCPl phosphorvlated with DPPC
iH-n.m.r. '5H (P-P-m-) [80.131 MHz, D20]
4.70 - 4.69 [obscured by H20 signal, m, (aC//)]
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Figure 2.10 Dowex 1X-2 lorvexchange Column Elution Profile for Sample (61
Crude dipeptide sample (6) was applied to the Dowex 1X-2 ion-exchange column as
described in section 2.8.6. Eluant was analysed for the presence of amine bonds
using the ninhydrin assay (section 2.8.6) which gave the elution profile at A 570^
• indicates absorbance at A 570 nm
■ indicates pyridine formate concentration (M)
The horizontal bar indicates the fractions pooled
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Figure 2.11 Dowex 1X-2 Ion-exchange Column Elution Profile for Sample ("81
Crude dipeptide sample (8) was applied to the Dowex 1X-2 ion-exchange column as
described in section 2.8.6. Eluant was analysed for the presence of amine bonds
using the ninhydrin assay (section 2.8.6) which gave the elution profile at A 570 nm-
■ indicates absorbance at A 570 nm
■ indicates pyridine formate concentration (M)
The horizontal bar indicates the fractions pooled
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iH-n.m.r. 'SH (p.p.m.) [360.132 MHz, H20:D20 (9:1 v/v)]
9.041-9.021 [1H, d, (NH)\ 4.955-4.864 [obscured by H20 signal, m, (aCH)]
4.630-4.522 [1H, d of d, (aCH)]
4.399-4.156 [4H, m, (pC//2)]
FAB mass spectra for C6Hi5N2OnP2, calc.: 352.01510, found: 352.01509
(< 1 p.p.m)
SerfPVSerfP) phosphorvlated with TCPC
iH-n.m.r. '8h (p.p.m.) [360.132 MHz, H20:D20 (9:1 v/v)]
9.032-9.010 [1H, d, (N//)] 4.933-4.812 [obscured by H20 signal, m, «xCH)]
4.403-4.106 [4H, m, (pC//2)]
^-n.m.r. '6^ (p.p.m.) [360.132 MHz, D20]
4.933-4.506 [4.893-4.871, d of d, (aC//)] 4.414-4.388 [1H, d of d, (aC//)]
4.358-4.158 [4H, m, (pCH2)]
31p-n.m.r. '5P (p.p.m.) [360.132 MHz, D20] 0.8040,0.4597
FAB mass spectra for C6H15N2011P2, calc.: 352.01510, found: 352.01508
(< 1 p.p.m.)
2.8 Discussion
The original incentives for the production of the dipeptide Ser(P)-Ser(P)
were a) to provide a simple model for the binding of phosphoproteins to a calcium
phosphate phase (see chapter 3) and b) to enable co-crystallisation with calcium ions
and hence give stereochemical information about phosphoprotein/calcium ion
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binding. These experiments require large quantities of peptide (approximately 2 g)
in a highly pure form. Therefore Ser(P)-Ser(P) was prepared essentially by the
method of Folsch, (1959) with a few modifications that would improve yields and
purity.
The L-seryl-O-benzyl ester-p-toluenesulphonate (1) was synthesised as
described (see section 2.7.2) utilising the method of azeotropic distillation first
reported for the esterification of glycine by Cipera and Nicholls (1955). The benzyl
ester was synthesised instead of the more popular methyl and ethyl esters for two
reasons. Firstly, the OBzl- group can be removed under the same conditions as the
Z- group and so the number of reaction steps can be reduced. Secondly, alkali
treatment is required to remove methyl- and ethyl- protecting groups (see section
2.3.2.2) and this may cause dephosphorylation of the dipeptide by (i-elimination
(Longenecker and Snell, 1957; Riley et al., 1957), whereas OBzl groups can be
removed by catalytic hydrogenolysis. Moreover, if the OBzl group is used the
p-toluenesulphonate salt is formed during the reaction which renders serine soluble
in benzyl alcohol and so improves the yield of the ester (Millar and Waelsch, 1952).
N-Benzyloxycarbonyl-L-serine (2) was synthesised as described following
the method of Baer and Maurukas, (1955; see section 2.3.1.1). The Z- group is a
useful protecting group for this synthesis as not only is it readily removed under the
same conditions as the OBzl- group but it also confers stability against racemisation
on the N-terminal residue.
Coupling of (1) and (2) to form N-Benzyloxycarbonyl-L-seryl-L-serine-O-
benzyl ester (3) utilised N,N-dicyclohexylcarbodiimide (DCCI) as coupling agent
(see section 2.4.1). This coupling agent has three advantages: it can be used to
couple serine and threonine derivatives that have free (5-hydroxyl groups (Sheehan
et al., 1956), it has a low potential for causing racemisation and the coupled peptide
is easily purified.
Of the two methods investigated that of Folsch (1959) was adopted primarily
because of improved yields and ease of preparation (see section 2.7.4). The higher
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yields obtained by the method of Folsch, (1959) are probably due to the reduced
formation of the by-product, N-acylurea (see section 2.4.1). N-Acylurea can form
as a result of O - N acyl migration (Folsch, 1967) but can be prevented if the
reaction is carried out in acetonitrile (Sheehan et al., 1956).
Z-Ser-Ser-OBzl (3) was then phosphorylated using either DPPC (see section
2.5.2.1) or TCPC (see section 2.5.2.3). The DPPC derivative, (4), was deprotected
as described (see section 2.7.6.1) and then purified by ion-exchange chromatography
(see section 2.7.7). The elution profile of the ion-exchange column (see Fig. 2.10)
showed two major peaks. Each peak was analysed by tl.c in solvent system g, h
and i and showed one spot indicating a single compound. The Rser(P) f°r the peak
eluting at approximately 0.9 M pyridine formate was found to be 0.5 (in solvent
system g), which is that determined for Ser(P)-Ser(P) by Folsch (1959). The peak
eluting at approximately 0.9 M pyridine formate was confirmed to be Ser(P)-Ser(P)
by tH-n.m.r and FAB mass spectral analysis. Further purification of the peptide
was not considered necessary.
Several preparations of the DPPC derivative were found, by tH-n.m.r, to
have a phenyl protecting group remaining on a phosphate residue after deprotection
(results not shown; see section 2.5.2). Such samples eluted from the ion-exchange
column at a similar pyridine formate concentration (0.9 M) as the dipeptide
Ser(P)-Ser(P). This situation has been reported by several authors (Alewood et al.,
1981; Schlesinger et al., 1987; Perich and Johns, 1988a). Before the peptide can
be used in adsorption studies this phenyl group must be removed. The material
would therefore have to be re-hydrogenated (see section 2.7.6.1) and the product
re-purified by ion-exchange chromotography (see section 2.7.7).
The use of DPPC as a phosphorylating agent for peptides suffers from several
disadvantages (see section 2.5.2). In brief these include: incomplete
phosphorylation caused by steric hindrance, incomplete deprotection (as observed
above), difficulty in purifying the deprotected phosphopeptide, low yields and the
expense of large scale production of phosphopeptides. Therefore, alternative
phosphorylating agents were investigated in an attempt to circumvent some of the
disadvantages associated with DPPC.
Diisopropyl-(2-cyanoethyl) chlorophosphine was investigated as a potential
phosphitylating agent for Z-Ser-Ser-OBzl. This phosphitylating agent was
developed for DNA synthesis (Sinha et al., 1984) and has been used extensively as a
phosphitylating agent for inositols (Cooke and Potter, 1987; Cooke et al., 1987,
1988; Hamblin etal., 1987a,b,c; Billington, 1989). However, due to the instability
of the phosphitylated intermediate and the large number of reaction by-products
(results not shown) the use of this agent was abandoned.
The phosphorylating agent TCPC (see section 2.5.2.3) was also investigated.
Z-Ser-Ser-OBzl (3) was successfully phosphorylated using this agent (see section
2.7.5.2) in high yields (>90%). Deprotection of the phosphorylated derivative (5)
was a two step procedure; first, catalytic hydrogenolysis (see section 2.7.6.2a) and
secondly removal of (2,2,2-trichloroethyl)- groups with zinc dust (see section
2.7.6.2b).
The crude dipeptide sample (8) was then purified by ion-exchange
chromotography (see section 2.7.7). Again, each peak was analysed by Ll.c in
solvent system g, h and i, the Rser(P) f°r the peak eluting at approximately 0.9 M
pyridine formate was found to be 0.5 (in solvent system g), indicating Ser(P)-Ser(P).
The peak eluting at approximately 0.9 M pyridine formate was confirmed to be
Ser(P)-Ser(P) by tH-n.m.r and FAB mass spectral analysis.
The elution profile (see Fig. 2.11) obtained from the ion exchange column
(see section 2.7.7) with the TCPC derivative showed an increase in the amount of
reaction by-products compared to the DPPC derivative (see Fig. 2.10). This may be
the result of partial dephosphorylation of the TCPC derivative during catalytic
hydrogenolysis (see section 2.7.6.1). Similar observations have been reported by
Yajima et al. (1971) and by Paquet and Johns (1990). This problem may be
overcome by the use of hydrogen bromide in acetic acid (see section 2.3.1.1 and
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2.3.1.2) to cleave the Z- and OBzl- groups or by using different protecting groups
for the N- and C- terminal.
The use of TCPC as phosphorylating agent had no advantage over DPPC as
regards final yield of the dipeptide Ser(P)-Ser(P) (approximately 50% in both cases).
However, yields might be improved by using a different deprotection strategy
(e.i. zinc/copper dust in DMF or sodium in liquid ammonia; see section 2.5.2.3).
The main advantages of TCPC as a phosphorylating agent are that the specialised
equipment employed for high pressure hydrogenolysis is no longer required and that




P-CN A AND P-CN (fl-25) TO
DICALCIUM PHOSPHATE DIHYDRATE CRYSTALS
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3,1 Adsorption <?f Proving at the Solid/Liquid Interface
Since the 1930's, studies of protein adsorption (at the solid/liquid,
liquid/liquid or liquid/gas interface) have been reported regularly in the literature
(Lindau and Rhodius, 1935; Strain, 1949; Zittle, 1953; Cumper and Alexander,
1951; Silberberg, 1962; James and Augenstein, 1966; Hoeve, 1971; MacRitchie,
1972; 1978; 1978; Kamyshnyi, 1981; Lundstrom, 1984; Lyklema, 1984; Giaever
and Keese, 1987). The original studies aimed to determine molecular weight (at the
liquid/gas interface) as well as to investigate electrophoretic and chromatographic
behaviour (reviewed by Zittle, 1953; James and Augenstein, 1966). Later, more
emphasis was placed on the adsorption mechanism, with particular attention paid to
the occurence of structural re-arrangements (Cumper and Alexander, 1951;
Silberberg, 1962; Hoeve, 1971; MacRitchie, 1972, 1978).
3-1,1 Importance <?f Protein Adsorption at the gplid/Liquid Interface
The behaviour of proteins at interfaces is of relevance both in natural and
technical processes. Many proteins are associated with the biological membrane
(either intrinsically or extrinsically) where they interact with both an aqueous and
non-aqueous environment. Such interactions are essential for their biological
function. There are also many medical and technical instances, where the
interaction between protein and interface may have significant consequences. For
example, the relationship between protein adsorption and biocompatability of the
sorbent material has been investigated (Kamyshnyi, 1981; Lundstrom, 1984;
Lyklema, 1984; Giaever and Keese, 1987; Horbett 1987). Proteins are frequently
used as emulsifiers and/or stabilisers in colloid dispersions for cosmetics,
pharmaceuticals and food products. However, undesirable events occur, known as
"bio-fouling", in food processing equipment, artificial kidney devices and on the
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artificial materials used as prostheses (reviewed by Brash and Lyman, 1971;
Morrissey and Stromberg, 1974; Giaever and Keese, 1987).
The adsorption process at the solid/liquid interface involves the transfer of a
protein molecule from solution to the sorbent surface, with a concomitant
displacement of solvent molecules and possibly other components from that surface.
Adsorption of proteins at the solid/liquid interface depends upon the relative
affinities of the solvent and the protein for the sorbent, which are determined by the
properties of the protein and the nature of the interface. The interplay between the
components of the system determines the environmental change upon adsorption
and, therefore, the change in structure and biological functioning of the protein
molecule. The following sections will review some of the general principles
governing protein adsorption at the solid/liquid interface.
3.1.2 Protein Structure and Adsorption Behaviour
Proteins are co-polymers of some twenty different amino acids of varying
hydrophobicity and, as a consequence, proteins are amphiphilic. The tertiary
structure of a protein molecule is determined by the interactions of specific amino
acid side chains, for example hydrogen bonds, van der Waals, ionic and hydrophobic
interactions and disulphide bridges (reviewed with respect to adsorption behaviour
by Norde, 1986). The protein molecule in solution is a complex structure with
hydrophobic (mainly in the interior of the molecule and thus shielded from water),
hydrophilic and charged regions (usually located on the periphery of the molecule).
The three dimensional structure of the protein is the net result of intramolecular
interactions and interactions between the protein molecule and its environment.
Proteins can be divided into three main classes according to their tertiary structure:
1) molecules that are highly solvated and flexible, resulting in a "random
coil" -like structure (e.g. the caseins).
55
2) molecules that have adopted a regular structure, like an a-helix or a
(3-sheet (e.g. keratin, silk fibroin and collagen).
3) compact molecules that may contain helix, ^-structures and unordered
segments: the globular proteins (e.g. enzymes and immunoglobins).
The adsorbed state of each class of protein is depicted in Fig 3.1, of which part A
depicts a highly solvated molecule. Several small portions of the molecule, referred
to as 'trains', attach to the sorbent with the remainder of the molecule forming loops
and tails dangling free in the solution (Silberberg, 1962; 1971; Hoeve, 1971). As
more protein adsorbs, the attached fractions (trains) reduce and hence a larger
portion of the molecule protrudes into the solution. The fibrous proteins (Fig. 3.1B)
can adsorb in a number of orientations with little change in conformation. As more
protein adsorbs the orientation of the molecules can change to form a more closely
packed system. Globular proteins (Fig. 3.1C) , which may adsorb in any
orientation, making one or more points of contact, may undergo varying degrees of
conformational change upon adsorption (Morrissey and Fenstermaker, 1976; Mitra
and Chattoraj, 1978). As more protein adsorbs the orientation of protein molecules
can change to form a more close-packed system. Further loss of native protein
conformation may occur as the adsorbed layer becomes compressed (Morrissey and
Fenstermaker, 1976). However, compact molecules such as globular proteins rarely
unfold completely to form a loose, loop and tail-like adsorbed layer (Fig. 3.1A;
cf. liquid/gas interface; Cumper and Alexander, 1951; James and Augensteun,
1966). In some instances, protein conformation does not appear to revert to their
'native' conformation upon desorption (Soderquist and Walton, 1980; Norde et al.,
1986).
To begin to understand the interaction between protein and sorbent,
knowledge of certain properties of the surface of the sorbent is helpful. The
chemical composition of the sorbent is important especially if groups are present that
can react with the protein. Knowledge of whether the surface is homogenous (as in
56
Figure 3.1 Schematic Diagram of the Adsorbed State
of the Three Protein "Classes" at the Solid/Liquid Interface
Part A) Adsorbed state of class 1) proteins; highly flexible and
solvated molecules.
Part B) Adsorbed state of class 2) proteins; molecules with
highly regular structure.
Part C) Adsorbed state of class 3) proteins; globular molecules.
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synthetic polymers) or heterogenous (as in inorganic crystals), or whether the surface
is electrically charged or not is also important. In most cases both the protein and
sorbent surface are charged and therefore electrostatic interactions play an important
role in the adsorption process.
It appears that most proteins interact with most surfaces, but general
conclusions regarding the interfacial behaviour of proteins and the actual mechanism
by which they adsorb are difficult to deduce (discussed in section 3.1.9). One of the
major reasons for this is that many studies have been performed under ill-defined
conditions, making comparison between systems almost impossible (Norde, 1986).
However, there are a few hypothetical models of adsorption that can be derived from
existing experimental information (reviewed by Horbett and Brash, 1987). One, or
a combination, of these proposed models may apply to any given protein/sorbent
system.
3.1.3 Methods of Studying Protein Adsorption
The interactions of proteins at the solid/liquid interface have been
investigated by various techniques: infra red spectroscopy (Lyman et al., 1968;
Morrissey and Stromberg, 1974; Matsui et al., 1978), fluorescence spectroscopy
(Watkins and Robertson, 1977; Walton and Maenpa, 1979), circular dichioism
spectroscopy, radiolabelling (Grant et al., 1977), electrochemical methods such as
electrophoresis (Chattoraj and Bull, 1959) and proton titration (Kochwa et al., 1967;
Norde and Lyklema, 1978), optical techniques such as ellipsometry (Morrissey and
Fenstermaker, 1976) and light scattering (Uzgiris and Fromageot, 1976; Morrissey
and Han, 1978) and lastly "thermodynamic" methods such as surface tension (Mitra
and Chattoraj, 1978) and contact angle (Vroman, 1967; van der Scheer and
Smolders, 1978; Absolom et al., 1987) measurements and calorimetry (Nyilas
et al., 1974; Koutsoukos et al., 1983). All these methods have provided information
on the type of binding, the thickness and structure of the adsorbed layer, the
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reversibility of the adsorption process and the amount of protein adsorbed per unit
area (r).
3.1.4 Adsorption Isotherms
If the amount of protein adsorbed per unit area, T, determined at constant
temperature, is plotted as a function of the protein concentration in solution, c, then
the resulting graph is called an adsorption isotherm. T is usually determined by
depletion of protein from the solution but a sufficiently large sorbent surface area
must be supplied to deplete the solution significantly. This is usually achieved by
use of a finely divided sorbent. V may also be determined directly, by labelling the
protein with radioactive (Niemann and Hoffmann, 1964; Kozin and McCarty, 1977)
or fluorescent (Beissinger and Leonard, 1982) chemicals, and by optical techniques
such as ellipsometry (Morrissey and Fenstermaker, 1976). However, radioactive
and fluorescent labels can influence the adsorption of the protein (Grant et al., 1977).
Protein adsorption differs from that of low molecular weight substances in
that proteins tend to adsorb via several segments (multi-point adsorption; Morrissey
and Fenstermaker, 1976). Although the adsorption free energy per segment may be
low, the adsorption free energy for the whole molecule is proportional to the number
of segments adsorbed (Silberberg, 1971). As a consequence most proteins have a
large negative free energy of adsorption and do not readily desorb on diluting the
system with solvent (cf. low molecular weight substances). This large free energy
of adsorption is reflected in the shape of the isotherm. The various isotherm shapes
were first classified by Giles and MacEwan (1957) but the majority of isotherms are
of two types (see Fig. 3.2): "high" and "low" affinity. High affinity isotherms (viz.
the initial part of the isotherm is very steep; see Fig. 3.2A) are almost always
observed with highly solvated and flexible molecules, reflecting the high number of
segments adsorbed. Also observed with highly solvated, flexible molecules is a
continuously increasing value, for T (i.e. no true adsoption plateau, rp). This
Figure 3.2 Schematic Diagram of the Two Types of Adsorption Isotherm
Associated with Protein Adsorption at the Solid/Liquid Interface
Part A) 'High' affinity isotherms; highly solvated and flexible
molecules.
Part B) 'Low' affinity isotherms; compact molecules.
r is the amount of protein adsorbed per unit area.
Reproduced from Norde et al., 1986
Equilibrium concentration
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phenomenon is usually explained in terms of structural re-arrangements occurring in
the adsorbed molecules as more molecules adsorb (Silberberg, 1971; Norde et al.,
1986). These re-arrangements can result in a decrease in the number of attached
segments per adsorbed molecule with a larger proportion of the protein as loops and
tails.
In contrast, the isotherms of compact molecules, such as globular proteins,
develop well-defined adsorption plateaux (rp) and the adsorption is not usually of
such high affinity (see Fig. 3.2B). The plateau usually corresponds to a close-
packed mono-layer of native molecules. However, with both "high" and "low"
affinity adsorption isotherms, the corresponding desorption isotherms are usually of
the high affinity type (Norde et al., 1986). This suggests that upon adsorption,
proteins undergo structural transitions and/or multi-point adsorption which enhances
binding.
Another common feature of adsorption isotherms (observed with various
proteins and surfaces) is the occurrence of a "kink" in the isotherm (Williams and
Choppin, 1951; see Fig. 3.2B). This has been interpreted as the formation of a
second layer of molecules (multi-layer adsorption; Williams and Choppin, 1951) or
coagulation (MacRitchie and Owens, 1969; MacRitchie, 1972) or a structural
transition in the adsorbed layer (Fair and Jamieson, 1980). The first interpretation
can be evaluated by dilution experiments; if dilution leads to a high degree of
desorption a multi-layer probably exists. However, multi-layer adsorption is to be
expected only for nearly saturated solutions when (amorphous) phase separation is
imminent (Hoeve, 1971). Coagulated protein at an interface will not desorb readily
upon dilution (MacRitchie and Owens, 1969; MacRitchie, 1972; see Fig 3.2B).
The structural transition model (third interpretation; Fair and Jamieson, 1980) which
is called the model of "bimodal adsorption", has three putative regimes of adsorbed
protein structure (see Fig 3.3). At low protein concentrations (region A of Fig. 3.3)
the molecules adsorb randomly. At high protein concentrations (region C of Fig.




Figure 3.3 Schematic Diagram of the Adsorption Isotherm Associated with
the Structural Transition Model of Protein Adsorption
at the Solid/Liquid Interface
In region A protein molecules adsorb randomly.
In region C intermolecular nucleation occurs.
B is the region of transition between the above two states.
T represents the amount of protein adsorbed per unit area.
Reproduced from Norde et ai, 1986
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formation of a two dimensional protein crystal. The kink in the isotherm represents
the transition between these states (region B of Fig. 3.3) with the protein layer
having a more or less unordered, glassy structure. Direct evidence of two-
dimensional protein crystallisation and ordering is now available for the case of
antibodies deposited on haptenated phospholipid monolayers (Uzgiris, 1985) and
from electron diffraction studies of two-dimensional crystals of light harvesting
complex -II from chloroplast membranes (Kuhlbrandt and Wang, 1991).
3.1.4.1 Description of Adsorption Isotherms
The adsorption isotherm is the most convenient form in which to plot
experimental data, and it is the form in which theoretical treatments are most often
developed (Adamson, 1983). In addition, the construction of an accurate adsorption
isotherm allows calculation of the energy and entropy of adsorption. The following
section deals with two theories (or models) for adsorption, the Langmuir model and
the Brunauer, Emmett and Teller (or BET) model. Both of these theories were
originally developed to describe the isotherms of gas adsorption to solids, but have
proved adequate for the description of isotherms constructed from protein adsorption
experiments at the solid/liquid interface.
The Langmuir Model
The adsorption of gasses onto solids was first described quantitatively by
Langmuir (1916, 1918). This model is based on the following assumptions: that
the surface contains a fixed number of adsorption sites, that each site holds only one
energy
molecule, that the freevof adsorption is the same for all sites and does not depend
upon the fraction of sites occupied and that there is no interaction between molecules
on different sites (lateral interaction).
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If the affinity constant, k, refers to the adsorption of a molecule at a single
site, and the state of any such site is represented by its degree of association, 0,




Where c is the equilibrium, free concentration. As T = n0, where n is the number of




Where T is the amount adsorbed per unit area. This theory is frequently used to
describe protein adsorption at the solid/liquid interface as it is the simplest
description of the isotherms obtained. This model can be expanded to account for
further families of non-interacting adsorption sites on the same surface by adding
further terms (Tanford, 1966), i.e.:
T = nkc + n'k'c + etc.
1 + kc 1 + k'c
However, Norde (1980) argues that as a consequence of the prerequisites
described above (i.e. reversible adsorption, a fixed number of adsorption sites and no
lateral interaction), the thermodynamics of adsorption derived from a Langmuirian
(or an analogous) analysis are without physical meaning. This argument is
supported in part by the work of Mura-Galelli et al. (1991). However, Moreno
et al. (1982) argue that thermodynamic quantities depend only on the initial and final
states and are independent of the path of integration and that thermodynamic
quantities are valid, whether the process is reversible or irreversible, provided a state
of equilibrium exists. Therefore, the question remains as to whether the




The observation of adsorption isotherms which show no saturation and a
marked increase in adsorption at higher equilibrium, free concentration are generally
interpreted as multi-layer formation. Generally, these isotherms are described using
the Brunauer, Emmett and Teller (BET) model (Brunauer et al., 1938). Brunauer,
Emmett and Teller extended Langmuir's approach to multi-layer adsorption by
assuming that the Langmuir equation applies to each layer of adsorbed molecules.
With the addition that the first layer of molecule's heat of adsorption may be some
special value and that the succeeding layers' heat of adsorption is different from the
first but are equal. The BET model can be represented by
0 = cx
(1 - x) [1 + (c -1) x]
where x = c/c° (c is the equilibrium, free concentration and c° is the solubility of the
adsorbate). Since the appearance of the BET model in 1938, the equation has
become the standard one for surface area estimation, usually using nitrogen or
krypton as the adsorbate.
Various modifications of the BET equation have been made in an attempt to
correct certain approximations and so give a better fit. For example, if the number
of layers formed is limited to n, the above equation becomes,
v = [vmcx/(l - x)][l - (n +l)xw + nx" + 1]/[1 + (c - l)x - cx» +
where v is the amount adsorbed per unit area (i.e. T) and vm is the amount adsorbed
per unit area at monolayer (i.e. rp).
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Cooperative Adsorption - The Hill Coefficient
In 1910, Hill showed that the sigmoidal dissociation curve of
oxyhaemoglobin could be described by the equation
y = kxh
1 + kxh
where y is the percentage saturation of binding sites (i.e. 0), x is the oxygen tension
in the solution (i.e. c, the equilibrium, free concentration), k is the affinity constant
and h is also a constant. The constant, h, is now called the Hill coefficient At
highly cooperative binding sites (complete cooperation) h is approximately equal to
the number of binding sites. At binding sites with some cooperativity the value of
h indicates the degree of interaction between sites. Therefore, the Hill equation
provides a semi-empirical means to describe a system where cooperative binding (or
adsorption) occurs. A system which exhibits positive cooperativity (such as oxygen
binding to heamoglobin) can be described by the above equation with h > 1 (in this
case k denotes an average affinity constant). A value of h < 1 describes a system
with either heterogeneity of binding sites or with negative cooperativity.
3.1.5 The Adsorbed Protein Laver
The attainment of a plateau in the adsorption isotherm (Tp) reflects a more or
less close-packed layer of native molecules (Lyman et al., 1968; Morrissey and
Stromberg, 1974; Kamyshnyi, 1981). Kinks (or no Tp) observed in the isotherm
are generally interpreted as a tilting or reorientation of non-spherical molecules (see
Fig 3.4) or as surface nucleation which allow more protein molecules to adsorb.
"Kinks" may also arise from changes in the structure of globular proteins (Norde
et al., 1986), although rarely does the protein completely unfold into a loose, loop
and tail -like structure.
As mentioned earlier (see section 3.1.4), adsorption of proteins is rarely
readily reversible. During adsorption studies the following anomalous features are
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Figure 3.4 Schematic Diagram Representing the Reorientation of Non-spherical
Protein Molecules at the Solid/Liquid Interface
'
represents a' non-spherical protein molecule.
represents the adsorbent surface.
69
observed: 1) none or only a fraction of the adsorbed protein molecules desorb on
diluting the system with solvent, 2) at rp, changing the pH, ionic strength or
temperature may result in additional adsorption whereas desorption on reversing
these conditions is limited, 3) exchange of molecules from adsorbed to free states
occurs, 4) adsorbed molecules can be exchanged/displaced by other (different)
protein molecules, and 5) molecules that have undergone structural changes upon
adsorption may not regain their native conformation upon desorption.
As the adsorbed molecule is attached via many segments and, once adsorbed,
the protein may alter its conformation, the desorption process is not simply a reversal
of the adsorption process. In order to desorb, the molecule has to overcome the sum
of the free energies of adsorption and any subsequent conformational change. The
following sections describe how electric charge, hydrophobicity, and temperature
influence the adsorbed protein layer.
3.1.6 The Effect of Electric Charge on Protein Adsorption
In many systems, both the protein and the sorbent possess charged groups,
the charge of each being dependant upon the pH of the solution. The cohesive
stability of a protein is highest at its isoelectric point. Protein adsorption at a
charged surface involves an overlap of electric double layers (Lyklema, 1985) which
results in attraction of the protein to the sorbent if the signs oppose and repulsion if
the signs are the same (Norde, 1986). Additionally, the charge of the molecule
affects its cohesive stability which can influence its adsorption behaviour.
Maximum values of Tp frequently occur at pH's close to the isoelectric point
of a protein molecule (MacRitchie, 1972; Morrissey and Stromberg, 1974; Mitra
and Chattoraj, 1978; Kamyshnyi, 1981; Koutsoukos et al., 1982). The reduction in
rp above and below the isoelectric point is thought to be due to structural
re-arrangements in the adsorbing molecules as opposed to an increase in lateral
replusion (Morrissey and Fenstermaker, 1976; Mitra and Chattoraj, 1978; Norde
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et al., 1986). The extent of the reduction in Tp reflects the cohesive stability of the
molecule (Norde et al., 1986). However, such changes in Tp are not solely due to
the instability of the protein; the charge carried by the sorbent surface plays an
important role.
As stated above, when a protein approaches a like-charged surface adsorption
is usually retarded but interaction between the like charges may be screened by low
molecular weight electrolytes. However, increasing the ionic strength of the
solution usually results in an increasing rp regardless of whether the charges of
protein and sorbent are like or opposed (Shastri and Roe, 1970; Mitra and Chattoraj,
1978; Susawa and Murakami, 1980; Kamyshnyi, 1981). This suggests that rp is
predominantly determined by intermolecular charge-charge interactions of protein
molecules (Koutsoukas et al., 1982; Norde, 1986). Furthermore, the adsorption
process is sensitive to the type of ion present (McLaren, 1954; Mizutani, 1981;
van Dulm et al., 1981) indicating that the role of small ions in the adsorption process
is more intricate than simple non-specific, screening of interacting charges.
3.1.7 The Effect of Hvdrophobicitv on Protein Adsorption
Most proteins have some hydrophobic regions that are exposed to the
aqueous environment in addition to those in the interior of the protein. As the
protein approaches an interface, dehydration of the hydrophobic parts of the protein,
and of the sorbent surface, is "driven" by an entropy gain which promotes
spontaneous adsorption. Adsorption is accompanied by a structural re-arrangement
allowing internal hydrophobic regions to interact with the interface and, as noted by
Birdi (1973), the greater the hydrophobicity of the protein, the greater the re¬
arrangement upon adsorption. The effect of the hydrophobicity of the sorbent has
been much more difficult to ascertain because varying the hydrophobicity of the
sorbent automatically involves varying its chemical composition. Generally
sorbents of greater hydrophobicity result in greater values of rp (MacRitchie, 1972).
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3.1.8 The Influence of Temperature on Protein Adsorption
Very few studies have been undertaken to investigate the influence of
temperature upon protein adsorption, consequently only generalisations can be made.
The influence of temperature on Tp varies depending upon the system studied, in
some systems (Kobamoto et al., 1966; Dillman and Millar, 1973; Nyilas et al.,
1974; Norde and Lyklema, 1978) an increase has been reported and in others
(Hummel and Anderson, 1965; Mitra and Chattoraj, 1978) a decrease on raising the
temperature. Nevertheless, a greater value of k (and Tp) at a higher temperature
implies an endothermic adsorption process with an increase in entropy being the
driving "force" behind the adsorption process (Norde et al., 1986)
3.1.9 Kinetics of Protein Adsorption
The mechanisms of protein adsorption at the solid/liquid interface are very
complex. In any study of protein adsorption, but particularly when the reversibility
and conformational aspects are being studied, it is important to know if an
equilibrium has been reached. This information is obtained by studying the kinetics
of the adsorption process. Kinetic constraints, due to proteins diffusing to the
interface, contribute to the overall complexity of the mechanism of the adsorption of
proteins at the solid/liquid interface. Additionally, the protein-surface interaction
typically appears to show a large number of time-dependent effects (Horbet and
Brash, 1987; Lundstrom and Elwing, 1990). Furthermore, adsorption may result in
one or more two-dimensional phase transitions which result in a crystalline packing
at the interface (see section 3.1.4).
The adsorption process can be broken down into five steps: 1) movement of
the protein towards the interface, 2) binding of the protein to the interface, 3)
re-arrangement of the protein structure in the adsorbed state, 4) desorption of the
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protein from the interface and 5) movement of the protein away from the interface.
Any one, or combination, of these steps can determine the rate of the overall
adsorption process. The general aspects concerning these five steps are established,
but the details of protein adsorption kinetics are still unresolved.
As discussed earlier (see section 3.1.4), proteins attach to the sorbent by
several segments which results in very poor desorbability, so that desorption and
retreat from the interface are not rate limiting for protein adsorption. Movement of
the protein molecule towards the interface (step 1) occurs simply by diffusion.
Therefore, it appears that under most experimental conditions, protein binding to the
interface and structural re-arrangements (steps 2 and 3) are the rate limiting steps in
protein adsorption. Several authors have proposed models that describe the kinetics
of protein adsorption, some of which are illustrated in Fig 3.5.
All these models, including the Langmuir theory (see section 3.1.4 and
Fig. 3.5A) make the assumption that the adsorption process is surface reaction
limited. The Lundstrom model (Lundstrom, 1983; Fig. 3.5B) proposes that the
protein adsorbs with a rate constant kA into state A (adsorbed but in its native
conformation) which may then change conformation to state B ("denatured"). This
model was expanded to allow for protein desorption (Fig 3.5C). The Beissinger and
Leonard (1982) model on the other hand accounts for desorption of both native and
"denatured" adsorbed species (states A and B respectively; Fig. 3.5C).
A model was proposed by Soderquist and Walton (1980) which accounted
for the time dependence of the surface reaction of protein adsorption (see Fig. 3.5D)
and the re-sorption of desorbed material (Fig. 3.5D). In principle, this model takes
into account the time dependence of the conformational changes of adsorbed
proteins. Soderquist and Walton suggested that there are three distinct processes or
states in the adsorption process;
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Figure 3.5 Kinetic Models of Single Protein Adsorption
at the Solid/Liquid Interface
The models illustrated in Fig. 3.5 A to F assume that the
adsorption process is surface reaction -limited (i.e. protein transport
to the interface is not rate limitimg)
Part A) illustrates the Langmuir Model
Part B) illustrates the Irreversible Lundstrom Model
Part C) illustrates the Beissinger and Leonard Model
Part D) illustrates the Soderquist and Walton Model
Part E) illustrates the Sevastianov et al. Model
Part F) illustrates the Andrade and Hlady Model
The nomenclature for the diagrams is as follows:
t Time
CG Bulk solution concentration
Cs(t) Adsorbed surface concentration at time t
(Cs)oo Plateau surface concentration at time » t
kj Rate constants
A, B and C represent the different adsorbed states of the
protein.
D represents centres of irreversible desorption.








State A) First, a rapid and reversible adsorption takes place that reaches a
pseudo-equilibrium during the first minute (Langmuir type
adsorption).
State B) Then there is a surface-induced change in conformation that
optimises protein-surface interactions and so decreases the
probability of desorption.
State C) As time elapses adsorbed protein is fully "denatured" and, if
desorption does occur, protein cannot readsorb (i.e. desorption from
state C is irreversible).
Serastianov et al. (1983; 1984) developed a model in which the effect of
surface heterogeneity on the adsorption process is described. They defined two
centres, P and D; P centres were of reversible adsorption and D centres were of
irreversible adsorption (see Fig. 3.5E). Serastianov et al. (1984) argued that
desorbed material is conformationally changed and thus cannot resorb (hence
desorption is irreversible). Andrade and Hlady (1986) proposed a more general
kinetic model (Fig. 3.5F). This model is essentially a simplified version of the
Soderquist and Walton model, with the additional assumption that desorbed protein
rapidly "re-natures" in solution and is therefore available for adsorption.
All of these models tend to fit specific experimental data reasonably well, but
relating such models to other systems is not always possible. Also, some of the
assumptions made are not entirely reasonable and some important phenomena that
take place are neglected (Andrade and Hlady, 1986; Horbet and Brash, 1987;
Lundstrom and Elwing, 1990). For example, it is reasonable to assume that
although proteins do undergo time-dependant, conformational changes at the
interface, they probably "re-nature" in solution and therefore become
indistinguishable from the proteins in free solution. Additionally, possible lateral
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interaction and binding cooperativity between molecules is neglected as well as the
influence of conformational changes within the molecule upon the rate constants
(Lundstrom and Elwing, 1990).
3.2 The Human Salivary Acidic Proline-Rich-Phosphoproteins
The relationship of the acidic proline-rich-phosphoproteins (acidic PRP's) of
human saliva with calcium ions and calcium minerals is one of the most extensively
characterised biological systems where phosphoprotein/calcium mineral interactions
occurs.
3.2.1 Introduction
The concentration of inorganic ions in human saliva indicates a state of
supersaturation with respect to basic calcium phosphates, such as hydroxyapatite
(Moreno et al., 1979). However, spontaneous precipitation does not normally
occur. The stability of saliva is attributed to the phosphoproteins statherin (Hay and
Schlesinger, 1977; Schlesinger and Hay, 1977; Hay et al., 1979) and the acidic
PRP's.
The acidic PRP's and statherin (along with other salivary constituents) are
adsorbed from saliva onto the tooth enamel to form the precursor molecules of the
acquired enamel pellicle (Kousvelari et al., 1980). The acquired enamel pellicle is
thought to have several functions. It is thought to act as a reservoir of calcium ions
which buffers the free calcium ion activity in saliva and therefore helps to maintain a
state of supersaturation with respect to calcium phosphates and carbonates (Bennick
et al., 1981; Saitoh et al., 1985). In addition, it is thought to retard enamel
demineralisation (Propas et al., 1977; Juriaanse, 1979) and to prevent crystal growth
on the enamel surface from the supersaturated saliva (Hay et al., 1979; Moreno
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et al., 1979). Finally, it affects the attachment of oral micro-organisms to the tooth
surface (Gibbons et al., 1976).
The acidic PRP's, which are a closely related group of proteins, constitute
approximately 30% of the protein in human parotid and submandibular saliva. The
primary amino acid sequences of four of the acidic PRP's (PRP's 1 - 4) are known
(Wong et al., 1979; Wong and Bennick, 1980; Hay et al., 1988; the Mr for PRP1
and 2 is 16,000, the Mr for PRP3 and 4 is 11,320). PRP1 has 150 amino acids
containing 2 phosphoseryl residues at positions 8 and 22. The first 30 amino acids
(known as the TX peptide) are highly acidic and hydrophilic, with the remainder of
the molecule being hydrophobic. This gives the molecule a polar character, like {3-
casein. PRP2 differs from PRP1 in the substitution of an asparagine for an aspartyl
residue at position 4. PRP3 consists of the first 106 amino acid residues of PRP1,
and PRP4 the first 106 residues of PRP2. It is thought that PRP3 and PRP4 may be
the result of proteolytic cleavage of PRP1 and PRP2 respectively, by the action of
kalikrein (Wong and Bennick, 1980). However, it is argued (Schlesinger and Hay,
1986) that partial gene duplication is responsible, rather than proteolysis; an
argument which is supported when genetic polymorphism is considered (Azen,
1978).
Circular dichroism spectra of the acidic PRP's suggest the presence of very
little secondary structure (Bennick, 1975). Two calcium binding sites, of different
affinity, have been identified, which involve the phosphoseryl and aspartyl residues
of the N-terminal (TX peptide; Bennick et al., 1979; 1981). However, amino acid
residues from the remainder of the protein are thought to interact with the calcium
binding site (Braulin et al., 1986).
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3.2.2 The Adsorption of the Human acidic Proline-Rich-Phosphoproteins
to Apatites
Human acidic PRP's (and statherin) inhibit seeded crystal growth of calcium
phosphate phases (Hay et al., 1979; Oppenheim et al., 1982). However, they do
not inhibit precipitation of basic calcium phosphate phases from a solution which is
supersaturated with respect to physiological concentrations. The acidic PRP's are
thought to inhibit seeded growth by adsorption to the crystal, the phosphorylated
TX peptide being of prime importance in the adsorption process (Hay et al., 1979,
1987). The behaviour of the acidic PRP's is similar to that of the caseins (see
section 3.3.2) except that they do not inhibit precipitation of calcium phosphate
phases.
The adsorption of the acidic PRP's has been investigated using two different
approaches: firstly by examining their adsorption to apatites and then constructing
adsorption isotherms and secondly by examining their inhibition of seeded crystal
growth. Most of this work was performed by E. C. Moreno and co-workers. They
investigated extensively the adsorption thermodynamics of PRP's 1-4 and the
TX peptide to hydroxyapatite and to fluorapatites (Moreno et al., 1978; 1982;
1984). The data obtained were fitted to a Langmuir model for adsorption (Moreno
et al., 1978; see sections 3.1.4 and 3.1.9).
These adsorption studies revealed that the four acidic PRP's adsorb to
hydroxyapatite and exhibit distinct differences in adsorption affinity despite their
similarity in primary structure. Moreno et al. (1982) showed that the affinity
constant of adsorption is determined by the N-terminal region alone, as the values
for the TX peptide, PRP1 and PRP3 are essentially the same (25.3, 26.7 and 26.0 x
106 lmol"1 respectively) despite the large differences in size. In addition, the
adsorption affinity constants for PRP2 and PRP4 are similar (18.1 and 21.0 x 106
lmol-1 respectively), but are lower than those of PRP1 and PRP3 because of the
substitution of an asparagine for an aspartyl residue at position 4. However, the two
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phosphoseryl residues (at positions 8 and 22) were also shown to play a vital role in
adsorption to hydroxyapatite (Moreno et al., 1984). Moreover, the role of the
phosphoseryl residues was shown to be of prime importance in inhibition of seeded
crystal growth as dephosphorylation of the acidic PRP's resulted in a reduction in
inhibition to 1% of the original activity (Hay and Moreno, 1979).
The areas occupied per molecule (A) for acidic PRP adsorbed to










The values for the two homologous pairs are quite similar, but in both cases, the area
occupied is larger for the smaller molecule. This is unexpected, as if the area
occupied is related to the packing of molecules on the surface, the smaller the
molecule, the lower the value of A (as examplified by the TX-peptide). PRP3 has a
calculated net negative charge of eight (Wong et al., 1979), whereas PRP1 has a
calculated net negative charge of five (Wong and Bennick, 1980). Therefore
Moreno et al., (1982) suggested that adsorption of PRP3 (with a higher charge
density) onto one adsorbent site may induce polarisation in the neighbouring sites to
a larger extent than PRP1. Which results in a lower adsorption of PRP3, thus
explaining the lower value of A.
Moreno et al. (1982) proposed the following model for acidic PRP
adsorption to apatites. The adsorption of the acidic PRP's is an endothermic process
and adsorption is therefore "driven" by an increase in entropy. Most of the entropy
increase originates from the adsorbing molecules, probably through disruption of
internal ion pairs and hydrogen bonds and by displacement of water molecules from
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both protein and sorbent surface. The acidic PRP's have a higher affinity for
fluorapatites than for hydroxyapatite, this being ascribed to the lower surface energy
of fluorapatites, which results in a decrease in the sorbent's affinity for water and, as
a consequence, an enhanced interaction between protein and adsorbent (Moreno et
al., 1982).
3.3 Milk Phosphoproteins: The Caseins
The biological function of milk, as well as providing a source of amino acids
for the suckling, is to provide a means of transporting calcium and phosphate, in a
readily assimilable form, from dam to young. Milk performs these functions by
virtue of the caseins. Other proposed functions of the caseins include protection of
the mammary gland from ectopic calcification (Holt and Sawyer, 1988) and the
production of biologically active peptides (e.g. the casomorphins; Maubois and
Leonil, 1989) during digestion.
3,3,1 Introduction
The caseins in cows' milk, and all other milks so far studied, are found in
colloidal spherical particles known as casein micelles. Bovine micelles range in size
from 20 to 600 nm in diameter and consist of about 93% casein (by dry weight) and
7% calcium phosphate. The latter is called colloidal calcium phosphate (CCP) and
plays an important role in maintaining micelle integrity.
The precise structure and dynamics of the casein micelle is unknown. A
typical micelle contains in the order of 10,000 polypeptide chains, but they are
variable in size, molecular weight and composition. There are two main schools of
thought concerning the substructure of casein micelles; the first supports the
submicelle model (proposed by Schmidt, 1982) and the second proposes that the
substructure results from aggregation of protein around calcium phosphate granules.
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Native casein micelles have a high voluminosity and are more-or-less
spherical, colloidal particles that contain the four casein types in an approximate
weight ratio of 3 : 0.8 : 3 : 1 (casein of asj-, a^-, P- and K-; Schmidt, 1982).
Dispersed throughout the micelle, and forming an intergral part of it, are small
granules of an amorphous calcium phosphate. The number frequency of micelle
sizes decreases steadily with increasing diameter up to 200 nm (Schmidt et al., 1973;
Dewan et al., 1974). Holt et al. (1978) and Kimber et al. (1978) observed a small,
second maximum in the size distribution at a diameter of 80 to 100 nm, and also
found a long 'tail' of size distribution which extended to a particle diameter of
600 nm.
Most of the casein monomers appear to be held in the micelle via links to
calcium phosphate ion clusters. Electron microscopy (Knoop et al., 1979) indicated
that the ions are distributed throughout the protein matrix as clusters of ions a few
nanometers in diameter. The caseins are thought to interact with the ion clusters,
via their phosphoseryl residues, although most of the evidence is indirect (Aoki
et al., 1987; Farrell and Thompson, 1988; Schmidt and Poll, 1989) and possibly via
the carboxyl groups of glutamyl and aspartyl residues (Byler and Farrell, 1989).
The milk salt system has been divided, historically, into micellar calcium phosphate
(MCP), which is in fact a mixture of calcium phosphate and casein derived
phosphopeptides, and colloidal calcium phosphate (CCP) which refers only to the
small ion clusters found within the micelle. A full description of the methods and
results of the chemical and physical characterisation of the calcium phosphate of
milk is beyond the scope of this discussion, and the reader is referred to Holt et al.
(1981, 1982) and Holt (1992).
The casein micelle is described as an almost spherical particle and is
proposed to possess substructure. This substructure, first recognised by electron
microscopy (Rose and Colvin, 1966; Carrol et al., 1968; Schmidt et al., 1973;
Kalab et al., 1982) and ultracentrifugation investigations (Morr, 1967; Slattery and
Evard, 1973), and later confirmed by small angle neutron scattering work (Stothart
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and Cebula, 1982; Stothart, 1989), has been ascribed to the existence of submicelles
of 8 to 20 nm in diameter (Buchheim and Welsch, 1973; Farrell, 1973; Creamer
and Berry, 1975; Schmidt, 1982). The existence of substructure led Morr (1967) to
postulate the submicelle model for casein micelle structure, which was later modified
by Slattery and Evard (1973) and then by Schmidt (1980).
The modified submicelle model (Schmidt, 1982) proposes that the
submicelles have a hydrophobic core, covered with a hydrophilic coat in which the
polar moieties of the K-casein molecule are accumulated in one or more areas on the
submicelle surface. The remaining parts of the submicelle surface are composed of
the polar parts of the other caseins, notably the phosphoseryl residues. The
submicelles are then assumed to aggregate into micelles by interaction of the
phosphoseryl residues with finely divided colloidal calcium phosphate (CCP).
Submicelles with low levels of or no K-casein are buried in the interior of the
micelle. As the K-casein content of the surface "shell" of the submicelles increases,
with a concomitant decrease in phosphoseryl residues, micelle growth will ultimately
come to an end. The weak point of this model is the requirement of the K-casein to
be unevenly distributed on the surface of the submicelle (Schmidt, 1982).
A second model, argued for by Holt and Hukins (1991) and Holt (1992),
proposes that the substructure results from casein adsorbing to small calcium
phosphate ion clusters. As more casein monomers associate, either with other
caseins or with ion clusters, the casein micelle forms. The advantage of this model
is that K-casein does not have to be located at specific surface sites of the submicelle.
3-3-2 The Casein?
Mammary epithelial cells are responsible for the synthesis and secretion of
milk proteins. Messenger RNA's encoding the secretory proteins are translated by
polysomes bound to the rough endoplasmic reticulum (Palade, 1975; Blobel, 1980)
and the polypeptides enter the Golgi apparatus for further post-translational
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modification and eventual secretion. As the caseins travel through the rough
endoplasmic reticulum and on to the Golgi apparatus, the asi-, aS2-» and K-
caseins are post-translationally modified by phosphorylation (Merrier and Gaye,
1983) and K-casein is glycosylated. From the distal face of the Golgi apparatus
secretory vesicles break off and begin to migrate to the apical membrane. It is at
this stage that the micelles are thought to form. Once the vesicles arrive at the
apical membrane, exocytosis occurs and the micelles are released into the mammary
gland alveolus.
Phosphorylation of the caseins is necessary for their major biological
function of calcium and phosphate transport from dam to young. Caseins interact
with colloidal calcium phosphate and in doing so maintain the integrity of the casein
micelle. At least two different protein kinases are involved in phosphorylation of
the caseins (Bingham, 1987). The casein kinases of the mammary gland are highly
specialised and specific: they phosphorylate seryl residues and, to a much lesser
extent, threonyl residues at primary recognition sites that invariably have the
sequence Ser/Thr-X-Y. Where Y is either a glutamyl or sometimes an aspartyl
residue and X is any amino acid. However, if X is particularly basic or bulky it may
reduce the extent of phosphorylation (Merrier, 1981). Glycosylation is conferred
upon K-casein only. K-Casein is glycosylated via the O-glycosyl mechanism,
probably in the golgi apparatus (Takeuchi, 1984).
Knowledge of the physico-chemical properties of the caseins is of great
relevance to our understanding of the interactions of caseins with calcium phosphate.
The subject matter of this section has been comprehensively covered in several
reviews (Payens and Vreeman, 1982; Schmidt, 1982; Swaisgood, 1982; Farrell and
Thompson, 1988; Holt, 1992), to which the reader is referred for an account of the
physico-chemical properties of the caseins.
The caseins form a family of proteins with a high degree of genetic
divergence. The most conserved regions of the casein genes are the sequences
encoding the "5'-untranslated regions" of the messenger RNA's and the sequences
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encoding the signal peptides and phosphorylation sites of the proteins. Caseins fall
into four main categories; asp, as2-, (3- and k-casein. Bovine caseins, and
probably all other caseins, can be separated into the calcium-sensitve (otsi-, ot^-, (3-)
and the calcium-insensitive (k-) caseins. There follows a brief review of the
physico-chemical properties of (3-casein, as it was this casein which was used
throughout my investigation.
There is a total of seven known genetic variants of |3-casein: the three "A"
variants predominate in western breeds of cattle. Typically (3-casein accounts for
33.6% (molar) of casein in milk, but this varies, especially at the onset of lactation
and during involution. The complete primary sequences of the major |3-casein
variants have been determined (Mercier et al., 1971) and five phosphoseryl residues
have been identified; four in a cluster at positions 15, 17, 18 and 19 and the fifth at







The amino acid sequence of |3-casein is such that the molecule has a hydrophilic
head (the acidic N-terminal peptide containing four of the five phosphoseryl
residues) and a hydrophobic tail, thus giving the molecule a polar character,
somewhat like a surfactant. At near-neutral pH, (3-casein possesses a net negative
charge of about -12, which largely resides in the N-terminal 47 residues (the
hydrophilic head).
In free solution [3-casein behaves as an expanded coil of low axial ratio with a
radius of gyration (assuming a "random coil" structure) of about 5.1 nm (Payens and
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Vreeman, 1982). This value is only a little larger than the value found from low
angle X-ray scattering (4.6 nm) and is not apparendy changed in the presence of
6 M guanidium chloride. However, there is experimental evidence for some regular
secondary structure within the p-casein molecule. Investigation by optical rotatory
dispersion and circular dichroism spectroscopy indicates that the P-casein primary
sequence is composed of 7 % a-helix, 33 % P-strand and 19 % p-turn (Andrews
et al., 1979; Graham et al., 1984). When the temperature is raised from 25 to 60°C
a decrease in the magnitude of the circular dichroism band at 220 nm results
(Graham et al., 1984). This might be interpreted as an increase in p-strand content
at the expense of aperiodic structure with a constant proportion of a-helix. In
addition, some secondary structure in the presence of high concentrations of urea or
guanidium chloride appears to persist (Creamer et al., 1981; Graham et al., 1984).
Secondary structure prediction methods have also been applied to P-casein, which
suggest a structure with a similar degree of order (Creamer et al., 1981; Graham et
al., 1984; Holt and Sawyer, 1988; Kumosinski et al., 1991a,b).
A high degree of side chain mobility in the P-casein molecule is indicated by
both *H- and 31P-n.m.r. spectroscopy. The ratio of the intensities of the aliphatic
and aromatic protons agrees fairly closely with that expected from the amino acid
composition (Andrews et al., 1979; Sleigh et al., 1983). However, the absolute
intensities are lower in 8 M urea than in trifluoroacetic acid solution and lower still
in 2H20 solution. The latter indicates that a proportion of the amino acid side
chains are in fairly fixed conformational states (Andrews et al., 1979).
In solution, P-casein monomers associate to form micelles above a critical
micelle concentration of 0.5g/l (at 21°C, ionic strength 0.2 M in the absence of
calcium ions). The P-casein molecules behave like simple surfactants, to form
spheroidal, soap-like micelles (Payens and Vreeman, 1982). Various findings
support a monomer/polymer equilibrium model, with the number of monomers
being fairly large. For example, in the analytical ultracentrifuge there is good
separation between monomer and micelle peaks (Payens and Vreeman, 1982).
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This peptide has a calculated net charge of -12 at pH 6.6, and circular dichroism
spectral analysis indicates no regular secondary structure. Lack of a-helix is
attributed to the structure-breaking properties of the prolyl residue at position 9 and
to charge repulsion by the four phosphoseryl residues at positions 15, 17, 18 and 19
(Creamer etal., 1981; Chaplinetal., 1988).
3,3,3 Casein Interaction with Calgium Phosphate Minerals
At the pH of milk, 37°C and at free calcium and phosphate concentrations
similar to those in milk, but without magnesium ions, rapid precipitation of
amorphous calcium phosphate occurs (van Kemenade and de Bruyn, 1987, 1989).
Addition of whole casein at very low concentrations (< 10"8 M) results in a dramatic
increase in the time that elapses before the onset of precipitation. However, the rate
of crystal growth thereafter is hardly affected by casein. At casein concentrations
exceeding 5 x 10 8 M, octacalcium phosphate forms instead of hydroxyapatite (van
Kemenade, 1988).
The inhibitory effects of casein on the precipitation kinetics can be
understood in terms of adsorption of casein onto the active growth sites of the crystal
surface, using the Langmuirian theory of adsorption (van Kemenade, 1988). For
whole casein, this model of adsorption indicates a very high adsorption affinity and
virtually complete site occupancy. In addition, for most of the caseins (oCsi-, {$- and
K-) there is a linear relationship of increasing affinity for apatite crystals as
phosphoserine content increases. When the phosphoserine content was decreased
(by partial dephosphorylation of (3-casein) the ability of casein to inhibit apatite
precipitation was also decreased (Holt and van Kemenade, 1989) indicating the
importance of the phosphoseryl residues. However, at very low casein
concentrations there was a reduction in the time taken for precipitation to occur
indicating that casein stimulated nucleation in vitro which suggests a possible role
for casein as a nucleation centre in milk. Similar experiments showed that
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phosphoserine also markedly reduced the time for amorphous calcium phosphate
precipitation to occur (van Kemenade, 1988) but, at the same time, this amino acid
(at higher concentrations) also inhibited crystal growth by adsorption at the growth
sites (Schmidt, 1987; Schmidt et al., 1987). These studies suggest that the
phosphoseryl residues of casein may act as nucleation centres for calcium phosphate
crystals.
This observation led Holt and van Kemenade (1989) to propose the
hypothesis for casein micelle formation in the Golgi apparatus, that calcium
phosphate can precipitate directly onto the casein in a controlled way so that a highly
dispersed, large surface area, amorphous calcium phosphate is produced. Further
casein interactions could then result in micelle formation. Alternatively, nucleation
of calcium phosphate occurs (without casein), then casein rapidly adsorbs preventing
further growth of the mineral phase, resulting in the same highly dispersed calcium
phosphate phase found in micelles.
Stabilisation of thermodynamically unstable calcium phosphate phases is
commonly observed in biological mineralisation processes. This phenomenon is
believed to be the result of adsorption of ions or macromolecules on the growth sites
of such crystalline phases. The effect of asi-, P- and k-casein on the seeded growth
of hydroxyapatite, octacalcium phosphate and dicalcium phosphate dihydrate
crystals has been studied (van Kemenade, 1988). In carefully controlled, seeded
crystal growth experiments, all three caseins, at pH values 7.4, 6.4 and 5.5, reduced
the growth rate of calcium phosphate crystals in the order hydroxyapatite <
octacalcium phosphate < dicalcium phosphate dihydrate. The growth of the
thermodynamically most stable phase (hydroxyapatite) was least affected. The
order of the degree of inhibition was the order of phosphoseryl residue content of the
casein (i.e. k- < P- < asl-casein) for all mineral phases studied. Complete
suppression of crystal growth at much less than monolayer coverage was also
observed.
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3.3.3.1 Interaction of Caseins with Dicalcium Phosphate Dihvdrate Crystals
Large, near perfect dicalcium phosphate dihydrate (DCPD) crystals can be
grown by diffusion in acid solution (Legeros and Legeros, 1972; Legeros et al.,
1983). A representation of a single crystal of DCPD is given in Fig. 3.6 which
shows its typical "platey" habit with well developed (010) faces whereas the fast
growing (121) and (110) faces are hardly developed at all. The crystal structure of
DCPD is known (Curry and Jones, 1971): DCPD contains compact, corrugated
sheets, consisting of parallel chains (each composed of alternating anions and
cations) normal to the (010) face, in which calcium ions are coordinated by six
oxygen atoms of the anions and by two oxygen atoms of the water molecules.
Electron micrographs of the DCPD crystals used throughout this study are shown in
Fig. 3.7.
The crystal habit of DCPD is affected by the method of growth, by
temperature and by the presence of. impurities such as fluoride, magnesium,
strontium, CO32" and P2O34" ions (Marshall and Nancollas, 1969; Legeros and
Legeros, 1972).
Crystal habit can also be influenced by macromolecules (Addadi and Weiner,
1985; Addadi et al., 1985) which are thought to adsorb selectively to certain crystal
faces present during growth and therefore to alter the crystal's habit When DCPD
crystals are grown in the presence of whole casein, the morphological importance of
the edge faces in the (010) zone increases markedly, indicating a preferential
adsorption at these planes (van Kemenade, 1988). In addition to enlarging these
faces, casein has the effect of producing sawtoothed structures on the edges of the
crystal (van Kemenade, 1988). van Kemenade (1988) also examined the influence
of p-CN A on the rate of seeded growth of DCPD crystals. The fractional reduction
in relative growth rate of DCPD crystals in the presence of P-CN A (10~7 to 10"6 M)










Figure 3.6 Sketch of a Perfect. Single Crystal
of Dicalcium Phosphate Dihvdrate ( DCPD)
Each crystal face is given its Miller index.
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Figure 3.7 Electron Micrographs of the Dicalcium Phosphate Dihvdrate Crystals
used Throughout this Investigation
DCPD crystals were prepared as described in section 3.4.3. A sample was
prepared for electron microscopy and the micrographs were kindly prepared by Mr. J.
Findlay (Science Faculty - E.M. Facility, University of Edinburgh)
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Langmuirian adsorption model. The affinity constant of P-CN A at pH 5.5 and
37°C for DCPD crystals was 2.1 x 10~8 M.
3.4 General Methods
All chemicals were of "Analar" grade and were purchased from BDH Ltd.
unless otherwise stated. All solutions were made with de-ionised water and the pH
was measured with a Radiometer combination glass electrode type GK 2401C. Free
calcium ion concentrations were determined using a Radoimeter selective calcium
ion electrode, type 93-3209, calibrated with freshly-prepared standard solutions
having the same ionic strengh as the unknowns. [14C]Formaldehyde was purchased
from Sigma Chemical Company, Poole, Dorset (1 mCi/ml with a specific activity of
51.1 mCi/mmol).
Pure bovine P-casein A (P-CN A) was prepared using the method of
Aschaffenburg (1963) by Mrs. E. Little (Hannah Research Institute). Crude
p-CN (fl-25) was prepared from bovine P-CN A by tryptic digestion, essentially as
described by Manson and Annan (1971), by Dr. C. Holt and Mrs E. Little.
Concentrations of bovine P-CN A and P-CN (fl-25) were determined
spectrophotometrically by the bicinchoninic acid protein assay (BCA assay; Pierce
Ltd.) in accordance with the manufacturer's instructions. The assay was calibrated
with standard solutions of P~CN A or P~CN (fl-25) as appropriate.
Specific surface areas of DCPD samples were determined by the multi-point
'BET' method (krypton adsorption) performed by MCA Services, Melbourn Science
Park, Cambridge. Amino acid analyses were kindly performed by Dr. J. Leaver
(Hannah Research Institute) and amino acid sequencing by the WELMET Protein
Sequencing Service, University of Edinburgh.
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3.4.1 The Purification of Bovine (3-CN ffl-251
Purification of the phosphopeptide P-CN (fl-25) was a two step process;
first, ion-exchange chromatography and secondly de-salting of the purified
phosphopeptide.
3.4.1.1 Purification of p-CN (f1-251 bv Ion-Exchange Chromatography.
The peptide was purified by ion-exchange chromatography using DEAE
Sephadex A50 (Pharmacia Ltd.) equilibrated in O.lmM sodium dihydrogen
phosphate (pH 2.6). Elution was effected by a linear pH gradient (pH 2.6 to 1.6)
using O.lmM potassium chloride (pH 1.6) of 1 litre volume.
Crude phosphopeptide (500 mg) was applied to the column (dimentions
26 x 230 mm), the flow rate being 9.0 mlh^cnr2, and 10 ml fractions were
collected. The absorbance of each fraction was measured at 230 nm (A230nm) *n
2.0 mm optical path length silica cuvettes and two peaks were detected (see Fig.
3.8). Pooled fractions (as indicated in Fig. 3.8) were lyophilised and a total amino
acid analysis performed as a means of identification. Peak 1 was found to be
p-CN (fl-25) and peak 2 to be either P-CN (f2-25) or P-CN (fl-24).
3.4.1.2 De-salting of P-CN (fl-25)
Contaminating salt was removed from peak 1 by gel filtration using
Sephadex G-10 (Pharmacia Ltd.) equilibrated with de-ionised water. A column of
dimensions 12 x 260 mm was prepared and packed according to the manufacturer's
instructions. A flow rate of 21.0 mlh^cnr2 was used and 1.0 ml fractions were
collected. The absorbance of each fraction was measured at A230 nm instead of
A28o nm as the peptide contains no tyrosine, tryptophan or phenylalanine residues. A
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Figure 3.8 Elution Profile from the DEAE A50 Ion-Exchange Column
for the Purification of fi-CN (fl-25)
Crude B-CN (fl-25) was applied to the ion-exchange column as described in section
3.4.1.1. The absorbance of the fractions was measured at A23o nm> pH of the
fractions was measured with a Radiometer combination glass electrode type GK
2401C.
indicates absorbance at A230nm
■ indicates the pH gradient
The horizontal bar indicates pooling of fractions.
Peak 1 = B-CN (fl-25)










Figure 3.9 Elution Profile from the Sephadex G-10 De-Salting Column
for B-CN ff1-251
Peak 1 (B-CN (fl-25)) from the DEAE A50 ion-exchange column (see section
3.4.1.1) was de-salted as described (in section 3.4.1.2). The absorbance of the
fractions was measured at A230 nm an^ the presence of salt was determined by the
turbidity (estimated by eye and then rated on a scale of 0 to 5) resulting from the
addition of silver nitrate solution (see section 3.4.1.2).
indicates absorbance at A230 nm-
d indicates turbidity.
The horizontal bar indicates pooling of fractions absorbing at A230nm-
Salt
Content
10 .20 30 40
Elution volume (ml)
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salt eluting from the column was detected by the turbidity (estimated by eye)
resulting from the addition of 1 drop of a silver nitrate solution (1% w/v; see Fig.
3.9).
The peak absorbing at A23onm was collected as indicated (Fig. 3.9) and
lyophilised to give pure P-CN (fl-25). A second total amino acid analysis was
performed on the de-salted, lyophilised phosphopeptide and as a final check the
sequence of the first five amino acids was determined (Welmet Protein Sequencing
Service, University of Edinburgh). The P-CN (fl-25) was then lyophilised and
stored at -15°C.
3.4.2 The Radiolabelling of p-CN A and p-CN If1-251
As an alternative, and more sensitive, means of estimating protein
concentration both J3-CN A and p-CN (fl-25) were 14C-radiolabelled by the
reductive methylation of their primary amino groups.
3.4.2.1 p-CN (fl-25)
P-CN (fl-25) was radiolabeled by reductive alkylation following the method
used by Dottovio-Martin and Ravel (1978). This method utilises [14C]formaldehyde
and sodium cyanoborohydride as reducing agent.
To 56 pi of a 10 mg/ml solution of P-CN (fl-25) (in 40 mM phosphate buffer
pH 7.0) was added 18 pi of [14C]formaldehyde (0.35 pmol, 18 pCi). To this mixture
was added 36 pi of a freshly-made solution of sodium cyanoborohybride (6.0 mg/ml;
in 40 mM phosphate buffer pH 7.0), the solutions were mixed and the reaction
allowed to proceed at room temperature for 2 hrs. Below is a chemical equation for
the reaction:
R-NH2 + HCHO + NaBH3CN »• R-NH(CH3) + HCN + NaH2B03
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The reaction mixture was de-salted by gel filtration using a Bio-Gel P2 gel
filtration column (Bio-Rad Ltd.) of dimensions 13 x 460 mm, which was prepared
and packed according to the manufacturer's instructions. A flow rate of
8.6 mlh^cm-2 was used and the absorbance of each 1.0 ml fraction was measured at
A230 nm (see Fig- 3.10). Radioactivity in the fractions was determined by liquid
scintillation spectrometry (in a Beckman LS 2800 counter) using 10 |ll of each
fraction in 5.0 ml of "Emulsi-safe" scintillation fluid. Fractions were pooled as
indicated (see Fig. 3.10), lyophilised, and prepared for adsorption assays as
described (see section 3.4.5).
3.4.2.2 Radiolahellingof ft-CN A
P-CN A was also radiolabeled by the method of Dottovio-Martin and Ravel
(1978). Briefly, to 3.39 ml of a 10 mg/ml solution of (3-CN A (in 40 mM
phosphate buffer pH 7.0) was added 72 |il of [14C]formaldehyde (1.411 jimol, 72
|iCi). To this mixture was added 148 |il of a freshly-made solution of sodium
cyanoborohydride (6.0 mg/ml; in 40 mM phosphate buffer pH 7.0), the solutions
were mixed and the reaction was allowed to proceed at room temperature for three
hours. Then a further 148 |il of sodium cyanoborohydride was added, the solutions
mixed and the reaction allowed to proceed for a further 2 hrs. The reaction mixture
was then dialysed extensively against de-ionised water for 2 days at 4°C to remove
any unreacted [14C]formaldehyde and sodium cyanoborohydride. The specific
activity of the 14C-p-CN A product was then determined by liquid scintillation
spectrometry. Radioactivity was determined by liquid scintillation spectrometry
(in a Beckman LS 2800 counter) by using two 100 |il aliquots of the dialysed protein




Figure 3.10 Elution Profile from the Bio-Gel P2 De-Salting Column
for 14C-R-CN ffl-25)
14C-B-CN (fl-25)) was prepared and de-salted as described (in section 3.4.2.1). The
absorbance of the fractions was measured at A230 nm and associated radioactivity was
determined by liquid scintillation spectrometry as described (in section 3.4.2.1).
■ indicates absorbance at A23o nm
■ indicates associated radioactivity as cpm














. 700 - -
1 4C-B-CN (fl-25) 9.03 x 106 0.43 2.558
Table 3.2 Radioactivity associated with 14C-B-CN A1 and 14C-B-CN (fl-25)
Radioactivity associated with 14C-B-CN A1 and 14C-B-CN (fl-25) was determined
by liquid scintilation spectrometry as described (in sections 3.5.2.1 and 3.5.2.2).
Protein estimations were performed using the BCA assay (see section 3.5).
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To confirm that radioactivity was associated with |3-CN A, a 300 |i.l aliquot was
mixed with 300 (il of trichloroacetic acid (20% w/v) to precipitate the (5-CN A and
then centrifuged for ten minutes in a bench top micro-centrifuge at full speed to
pellet the precipitated protein. Two 100 |il aliquots were subsequently added to two
5.0 ml aliquots of "Emulsi-safe" scintillation fluid and their radioactivity (see Table.
3.2) determined as above. These results indicate that the radioactivity is associated
with the protein fraction.
3.4.2.3 Dilution of 14C-(3-CN A for Adsorption Experiments
To 45.37 mg of un-radiolabelled (3-CN A, 4.63ml of a 1.5mg/ml solution of
14C-(5-CN A was added. This mixture was dialysed against 1.0 litre of adsorption
assay buffer (see section 3.4.4) for 16 hours at 20°C and was used as the stock
protein solution.
3.4.3 Preparation of Dicalcium Phosphate Dihvdrate Crystals (DCPDt
Two preparations of DCPD, designated A and B, both prepared by the
method of Jensen and Rathley (1953), were used for the adsorption experiments.
Briefly, 1 litre of 0.5 M disodium hydrogen orthophosphate and 0.037 M potassium
dihydrogen orthophosphate, and 1 litre of 0.5 M calcium chloride were added slowly
to 0.5 litre of 0.147 M potassium dihydrogen orthophosphate at room temperature
with rapid mechanical strirring over a period of approximately three hours. The
DCPD crystals were harvested by collection onto filter paper (Whatman No. 1) and
then washed three times with 330 ml portions of phosphoric acid (0.16 ml of 45 %
orthophosphoric acid in 1 litre of water) and then once with 250 ml of ethanol. The
crystals were then dried in vacuuo over silica gel in a dessicator. The identity of
DCPD from each preparation was verified by infrared spectroscopy (by Dr. C. Holt,
Hannah Research Institute) and the yield of DCPD from each was 96%. The
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specific surface areas of the two DCPD preparations were determined by the
multipoint 'BET' method and were found to be:
Preparation A = 0.684 m2g_1
Preparation B = 0.919 m2g"1
3.4.4 Preparation of Buffers to he used in Adsorption Experiments
It is essential with all adsorption experiments that the environment of the
system (i.e. that of the solid and the liquid phases) is fully defined so that meaningful
results can be obtained. The buffers used in these adsorption experiments were
chosen to have properties in common with milk. They were carefully designed to
ensure that their ionic strength, pH and free calcium ion activities were similar to
those found in bovine milk serum (Holt et al., 1981). A free calcium ion
concentration of approximately 4.0 mM was selected for the reason above and
because free calcium ions are essential for caseins to bind to calcium phosphate
phases (Holt et al., 1986). As DCPD is slightly soluble (Moreno et al., 1960a,b),
buffers saturated with respect to DCPD must be used during experimentation to
avoid crystal dissolution and the concomitant change in surface area and calcium ion
activity. Buffers had an ionic strength of approximately 80 mM and a free calcium
ion concentration of approximately 4.0 mM (see Table 3.3). Buffers were saturated
with respect to DCPD after 48 hour's equilibration with excess of the salt at the
appropriate temperature.
Four different buffers were prepared (summarised in Table 3.3) using
calcium and potassium nitrate stock solutions. Their pH's were checked and
adjusted with nitric acid before dilution with deionised water to their final
concentrations. Buffers were equilibrated with 2.0 g/litre of DCPD, at the
temperature intended for the adsorption experiments, in a water bath for 48 hours.

















20 6.5 4.02 20 60 0.0
20 7.0 3.91 20 60 0.0
3.0 7.0 3.76 20 60 0.0
20 7.0 4.78 20 60 6.0
Table 3.3 Composition of Buffers used in Adsorption Experiments
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buffers were then stored (in a water bath) again at the temperature intended for the
adsorption experiments (either 20°C or 3°C). Free calcium ion concentrations were
measured, after equilibration with the DCPD crystals, using the selective calcium ion
electrode and were found to be approximately 4.0 mM (see Table 3.3).
During the equilibration period the initial calcium ion concentration rose
from 3.0 mM to approximately 4.0 mM due to dissolution of a portion of the DCPD
crystals. Equilibration for 48 hours was found to be sufficient as no further increase
in calcium ion activity was observed when equilibration was continued for a further
five days (results not shown).
3.4.5 Preparation of Stock p-CN A and p-CN (fl-25) Solutions
Stock solutions of P-CN A and P-CN (fl-25) were prepared, just prior to
each adsorption experiment, as follows.
3.4.5.1 p-CN A
A 10.0 mg/ml stock solution of P-CN A was prepared using the appropriate
buffer for the conditions of each adsorption experiment (see Table 3.3). After
passing each stock solution through a filter of pore size 0.8 |J.m (Millipore S.A.,
Molsheim, France), it was diluted with buffer to its final concentration used for
adsorption experiments.
3.4.5.2 P-CN (fl-25)
A 20.0 mg/ml solution, of 10 ml volume, of P-CN (fl-25) was made using
the appropriate buffer for the conditions of each adsorption experiment (see Table
3.3). The free calcium ion activity was measured with a freshly-calibrated, selective
calcium ion electrode and was found to be negligeable. Calcium nitrate solution
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(100 mM) was then added dropwise until the mV reading of the electrode was the
same as that of a solution with 4.0 mM calcium nitrate and an ionic strength of 80
mM. The pH of this stock solution was adjusted to pH 7.0 with 1.0 M sodium
hydroxide. It was then diluted to a total volume of 20 ml with fresh buffer, giving a
10 mg/ml stock solution. The stock solution was then passed through a filter of
pore size 0.8 (im and diluted to the final concentrations to be used in the adsorption
experiment.
As expected upon addition of (10.0 mg/ml, 6.4 x 10"6 M) |}-CN (fl-25) to
the buffer the initial concentration of free calcium ions fell to very low levels (as
indicated by the fall in mV reading of the selective calcium ion electrode) because of
calcium ions binding to the peptide (Baumy et al., 1989). (3-CN (fl-25) has the
potential to bind 4 mol of calcium ions per mol of peptide. Therefore the addition
of 6.4 x 10"6 mol of peptide per ml of buffer, containing 4 x 10"6 mol of calcium
ions, will result in the binding of most of free calcium ions. As I wished to have
similar calcium ion concentrations, so that results between experiments could be
compared, and because free calcium ions are required for binding to calcium
phosphate minerals, it was essential that the calcium ion concentration be restored to
4.0 mM. This was achieved by addition (as described above) of calcium nitrate
solution.
Addition of f)-CN A also resulted in a decrease in free calcium ion
concentration, but to a much lesser extent. f)-CN A has the potential to bind 5 mol
of calcium ions per mol of protein. Therefore addition of 4.17 x 10"7 mol of protein
per ml of buffer, containing 4 x 10'6 mol of calcium ions, will result in a decrease in
calcium ion concentration but to a much lesser extent than addition of the [5-CN
(fl-25) solution. However, upon dilution to 3.0 mg/ml (the most concentrated
solution used during adsorption assay) only a very small proportion (approximately
7%) of the free calcium ions will be bound to the protein (as indicated by the mV
reading of the selective calcium ion electrode). As the fall in free calcium ions was
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minimal it was not considered pertinant to restore the free calcium ion concentration
as this would cause an unnecessary perturbation of the buffer system.
3,4,6 Adsorption Experiments
In order to examine the binding of (J-CN A and (3-CN (fl-25) to DCPD an
adsorption assay was developed so that adsorption isotherms could be constructed.
The adsorption assay had to fulfill certain requirements: it had to be simple to
perform, accurate and be easily adaptable to other phosphoproteins.
Portions of DCPD were accurately weighed (100 mg or 200 mg) into ten
screw cap bottles (20 ml volume). To each bottle was added an accurately measured
volume (by micro-pipette) of stock protein or stock peptide solution (see section
3.4.5). The contents of the bottles were then mixed thoroughly, to disperse the
DCPD, and incubated in a rocking water bath at the appropriate temperature (see
Table 3.4 for 1 hour. Reference assays, without DCPD, were prepared and
performed in parallel with each adsorption assay. Adsorption isotherms were
determined at each of two DCPD / buffer ratios: 100 mg / 3.0 ml and 200 mg / 2.0
ml. For any given set of conditions (see Table 3.4) the resulting adsorption
isotherms for each of the two ratios were similar.
After each incubation, a 1 ml aliquot was taken from each bottle and
(xlOOOg)
centrifuged in a bench-top micro-centrifuge at full speed for 2 minutes to pellet any
suspended DCPD. The supernatant was then collected and protein estimations
performed using the bicinchoninic acid protein assay (BCA assay). The amount of
(3-CN A or (3-CN (fl-25) adsorbed to the DCPD was calculated by subtraction as
follows:
^-casein A ^-casein A Amount
or (3-phosphopeptide 1-25 - or P-phosphopeptide 1-25 = adsorbed to
in reference assay in "test" assay DCPD
supernatant supernatant
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Experimental Conditions Number of experiments
performed with B-CN A
Number of experiments
performed with B-CN (fl-25)
Temperature of
















20 6.5 0.0 3 - - -
20 7.0 0.0 5 3 9 4
3 7.0 0.0 - - - 3
20 7.0 6.0 - 3 - -
Table 3.4 Summary of the Adsorption Experiments:
Experimental Conditions and the Number of Experiments Performed
for each set of Conditions
Experimental conditions were achieved as described in the text (section 3.4.6).
3.4.7 Adsorption Equilibrium Determinations
In order to ensure that adsorption in the above experiments had reached
equilibrium within the one hour incubation period, a time course experiment was
performed for each set of conditions (see Table 3.4) resulting in a graph of time of
incubation versus amount adsorbed (see Fig. 3.11). DCPD (100 mg) was
accurately weighed into glass screw cap bottles (20 ml volume). To each was added
3.0 ml of a 1.0 mg/ml protein or peptide solution. The contents of the bottles were
thoroughly mixed and incubated for a fixed time (15, 30, 60, 120 and 240 min.).
Appropriate reference assays (no DCPD) were performed in parallel with each
adsorption assay. After incubation each bottle was treated as previously described
(section 3.4.6).
3.5 Results and Discussion
In order to examine the adsorption of the milk phosphoprotein JJ-CN A and
its tryptic phosphopeptide [3-CN (fl-25) a binding assay was developed (see section
3.4.6). DCPD was the mineral chosen for these studies because it is considered to
be closely related to the amorphous calcium phosphate mineral that forms colloidal
calcium phosphate in milk (Holt et al., 1982). In addition, DCPD can be easily
prepared as well-formed (large) crystals with perfect stoichiometry. DCPD was
prepared using the standard method for bulk preparation (see section 3.4.3) and its
purity confirmed by infra-red sprctroscopy. Contamination of the DCPD by other
calcium phosphate phases was not expected as care was taken to ensure that the pH
was kept well below 7.0 during crystal growth. Above pH 7 the crystal growth
solution may become saturated with respect to other calcium phosphate phases such
as octacalcium phosphate (Moreno et al., 1960a,b).
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(Boratynski, 1985; Krystal et al., 1985; Krystal, 1987) and the modified Lowry
assay (Polacheck and Cabib, 1981); none of which was found to be suitable.
Eventually the BCA assay (Smith et al., 1985; Redinbaugh et al., 1986) was
adopted because it was sensitive within the protein/peptide concentration range used
and was found to be unaffected by the assay buffers (results not shown).
The time required for adsorption equilibrium to be reached was determined
for each set of adsorption conditions used (see Table 3.4) and the results obtained are
shown in Fig. 3.11. These results indicate that equilibrium was reached within 15
minutes. Therefore, adsorption experiments were incubated for 1 hour, at least four
times the time required to reach equilibrium, to ensure that equilibrium was well
established. Later experiments with (3-CN A, performed by Mrs. E. Little (Hannah
Research Institute), confirmed that adsorption was complete within 1 min. In
addition, desorption experiments (by dilution) indicated that there was no significant
desorption of (3-CN A after 2 hr.
During these time course, adsorption assays, and in subsequent experiments,
it was found that the protein solution added to the DCPD crystals was only just
depleted sufficiently. This was a result of the relatively small specific surface area
of the DCPD crystals (see section 3.4.3). Therefore, the fact that DCPD forms large
crystals was a disadvantage. This problem was circumvented to some extent by
using a low buffer/mineral ratio so that the standard errors of the assays became
acceptable.
To increase the sensitivity and accuracy of the adsorption assay, an
alternative method of protein estimation was assessed; that of radiolabelling (see
section 3.4.2). Methylation of the lysine residues was chosen as it has little or no
effect on the size, shape, charge or secondary structure of P-casein (Evans et al.,
197 la,b). Specific activities of radiolabelled (3-CN A and (i-CN (fl-25) were 1.3
mCi/g and 2.558 mCi/g respectively. Knowing the specific activity of the
[14C]formaldehyde (51.1 mCi/mmol) the number of mol of 14C atoms per mol of
protein or peptide can be calculated and hence the average level of labelling (table
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Figure 3.11 Determination of the Time Taken to Reach Adsorption Equilibrium
A time course experiment was performed as described (in section 3.4.7) for each set
of adsorption experiment conditions (see Table 3.4) using the buffers described (in
Table 3.3). All these experiments were performed with DCPD preparation A.
r = x 10"7 moles of B-CN A or B-CN (fl-25) adsorbed per m2 of DCPD.
o— indicates B-CN A adsorption at pH 6.5 and 20°C.
—□ indicates 6-CN A adsorption at pH 7.0 and 20°C.
*— indicates B-CN (fl-25) adsorption at pH 7.0 and 20°C.
•— indicates B-CN (fl-25) adsorption at pH 7.0 and 3°C.
Values are the means + half the range of duplicate determinations of an experiment.
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3.2): 0.155 mol/mol for P-CN (f1-25) and 0.61 mol/mol for P-CN A. These low
levels of radiolabelling were desired (P-CN A has the potential to be labelled by 21
carbon atoms) to minimise the effects that radiolabelling can have on protein
adsorption (Grant et al., 1977).
The adsorption isotherms obtained using the BCA assay and by using
14C-P-CN A both at pH 7.0, 20°C and using DCPD preparation B are compared in
Fig 3.12. The adsorption isotherm obtained using the BCA assay is typical of those
obtained for highly-solvated and flexible molecules such as P-CN A (discussed in
section 3.1.4). The steep gradient of the initial part of the isotherms reflects a
relatively high adsorption affinity (see Table 3.5) which is approximately 80 fold
less than those of the acidic PRP's (see section 3.2.2 and Table 3.5). The adsorption
isotherm obtained using 14C-P-CN A shows a similar high adsorption affinity. The
most striking difference between the two isotherms (see Fig. 3.12) is in the positions
of Tp. When radiolabelled P-CN A was used, the adsorption plateau (measured at
6 x 10"5 molar free P-CN A) was approximately 25% lower than when the BCA
assay was used in spite of the low average level of radiolabelling. This implies that
methylation perturbs the structure of the adsorbed layer of P-CN A.
The lower Tp suggests that the 14C-P-CN A molecules do not pack as closely
together at the interface, possibly due to disruption of intermolecular interactions or
by inducing a conformational change in the protein. However, with such a low
average level of radiolabelling it is difficult to explain such a large decrease in Tp
(approximately 25%) by disruption of intermolecular interactions and/or
conformational changes alone. In view of the observed effect of radiolabelling on
the adsorption isotherm (see Fig. 3.12) further use of the radiolabelled
protein/peptide in binding studies was considered unsuitable for our purposes and
was therefore discontinued.
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Figure 3.12 Comparison of the Adsorption Isotherms obtained for B-CN A
using the BCA assay and by using 14C-B-CN A
Two methods of protein estimation were used to determine the amount of protein
adsorbed: the BCA assay and the use of 14C-B-CN A. They were compared in the
adsorption experiments described (in section 3.4.6) performed at pH 7.0 and 20°C
using DCPD preparation B. 14C-B-CN A was prepared as described (in section
3.4.2.2) and diluted for use in adsorption experiments as described (in section
3.4.2.3). Radioactivity of 14C-B-CN A was determined by liquid scintillation
spectrometry as described (in section 3.4.2.2). Curves were fitted to the results
using the computer program REGRESSION as described (see section 3.5.2) and the
parameters of the curve are summarised in Table 3.5. Results are plotted as T
(amount adsorbed per unit area; T = xlO 7 moles B-CN A adsorbed per m2 DCPD)
versus C (equilibrium, free concentration x 10"5 M).
—o— indicates B-CN A determined by BCA assay.
—□—- indicates 14C-B-CN A determined by liquid scintillation spectrometry
of 14C-G-CN A.
Values for B-CN A determined by BCA assay are the mean + S.E.M. of duplicate
determinations of three separate adsorption experiments. Values for 14C-B-CN A
determined by liquid scintillation spectrometry are the mean + half the range of





3.5.2 Differences between DCPD Preparations
with respect tQ Adsprpfipn pf (3-CN A jtnd [3-CN (fl-25)
In the present study two preparations of DCPD were used, designated A and
B, with specific surface areas of 0.684 and 0.919 m2g~l respectively. The
adsorption isotherms for (3-CN A and (3-CN (fl-25), measured at pH 7.0 and at 20°C,
for the two DCPD preparations are shown in Figs. 3.13 and 3.14. As expected for
(3-CN A, both isotherms (Fig. 3.13) show the typical pattern observed for highly
solvated and flexible molecules (see section 3.1.4), but there is a difference of
approximately 25% in the adsorption plateau (rp; measured at 4 x 10*5 M free (3-CN
A) between preparations A and B. The isotherms for (3-CN (fl-25) have a plateau
(see Fig. 3.14; at about 2 x 10-4 M free (3-CN (fl-25)) followed by an upward
curvature from about 3 x 10"4 M free (3-CN (fl-25). Again there is a difference of
approximately 25% in Tp for the (3-CN (fl-25) isotherms between preparations A
and B.
A model was sought to describe the isotherms mathematically. The
Langmuir model has been used to describe protein adsorption at the solid/liquid
interface (discussed in sections 3.1.4, 3.1.9 and 3.2.1). The Langmuir theory can be
expressed by the equation:
T = nkc (1)
1 + kc
Where T is the adsorbed amount per unit area, n is the number of binding sites per
unit area, k is the affinity or association constant for a site and c is the equilibrium,
free concentration. This one-site model proved adequate for describing the
isotherms obtained with (3-CN A but inadequate for describing (3-CN (fl-25)
adsorption isotherms and therefore a two-site model was developed by Dr. C. Holt
(Hannah Research Institute). This model was adopted because it is the simplest
explanation of the upward curvature observed in the (3-CN (fl-25) adsorption
isotherm. Alternative reasons for this upward curvature, such as multi-layer
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Figure 3.13 Comparison of the Adsorption Isotherms for B-CN A
for DCPD Preparations A and B
The adsorption isotherms were prepared from the results of experiments (see section
3.4.6) performed at pH 7.0 and 20°C (see Table 3.4). Curves were fitted to the
results using the computer program REGRESSION as described (in section 3.5.2) and
the parameters of the curve are summarised in Table 3.5. Results are plotted as T
(amount adsorbed per unit area; T x 10"7 moles B-CN A adsorbed per m2 DCPD)
versus C (equilibrium, free concentration x 10~5 M).
—o— indicates B-CN A adsorption isotherm for DCPD preparation B
—-a— indicates B-CN A adsorption isotherm for DCPD preparation A
The amount of protein adsorbed at each equilibrium concentration was determined in
duplicate.
Plotted points are the mean + S.E.M. of four separate adsorption experiments. The
















Figure 3.14 Comparison of the Adsorption Isotherms for fi-CN (fl-25)
for DCPD Preparations A and B
The adsorption isotherms were prepared from experiments (see section 3.4.6)
performed at pH 7.0 and 20°C (see Table 3.4). Curves were fitted to the results
using the computer program REGRESSION as described (in section 3.5.2) and the
parameters of the curve are summarised in Table 3.5. Results are plotted as T
(amount adsorbed per unit area; T x 10~7 moles B-CN (fl-25) adsorbed per m2
DCPD) versus C (equilibrium, free concentration x 10~4 M).
—o— indicates B-CN (fl-25) adsorption isotherm for DCPD preparation B
—□— indicates B-CN (fl-25) adsorption isotherm for DCPD preparation A
The amount of protein adsorbed at each equilibrium concentration was determined in
duplicate. Plotted points are the mean + S.E.M. of of four separate adsorption
experiments. The S.E.M. not shown are smaller than the symbol.
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formation or coagulation, are not expected for P-CN (fl-25) as it shows no tendency
to associate and is very hydrophilic.
Examination of the adsorption isotherms appeared to show a small number of
high affinity binding sites and a larger number of intrinsically lower affinity binding
sites. The simplest model that describes this situation is one of two sets of non-
interacting binding sites with the following relationship:
r = nkc + mlc (2)
1 + kc 1 + lc
Where m is the number of low affinity binding sites and 1 their affinity constant
However, as lc « 1 (within the concentration range used) equation (2) reduces to:
r = nkc + p.c (3)
1 + kc
Where p = ml
To represent cooperative, low affinity binding, a type of Hill coefficient was
introduced, hence equation (3) becomes:
T = nkc + (p.c)Y (4)
1 + kc
provided p.c « 1.
The four parameters n, k, p and y, were determined using the non-linear, least
squares procedure using the computer program REGRESSION (Blackwell Scientific
Publications) which employs a simplex minimisation algorithm. Curve fitting was
tested by using different initial estimates of the parameters. Parameters were
eliminated if the F statistic of the fitted curve changed by a significant amount
(p< 0.001) when y or p were removed from the model. The results of curve fitting,
using the theoretical equations (1) and (4), are summarised in Table 3.5.
The curves fitted to the isotherms (for P-CN A and P-CN (fl-25); see Fig.













B-CN A, pH 7.0
20° C, DCPD-A 1.282 + 0.046 1.31 + 0.19
-
- 8.86 + 0.33
B-CN A, pH 7.0
20° C, DCPD-B 1.95 + 0.130 3.0 + 1.03 - - 8.50 +0.128
14C-B-CN A,
pH 7.0, 20° C,
DCPD-B
1.411 + 0.040 6.31 + 1.17 - - 10.8 + 0.30
B-CN A, pH 6.5
20° C, DCPD-A 0.741 + 0.032 5.21 + 1.30
- - 15.3 + 0.70
B-CN A, pH 7.0
20° C, 6 M urea,
DCPD-B








2.316 + 0.069 17.1 + 14.2 1.88 +0.12 1.72 + 0.20 6.60 + 0.20
B-CN (fl-25),
pH 7.0, 3.0 "C,
DCPD-B
2.75 + 0.100 2.92 + 0.59 2.12 + 0.15 1.58 +0.41 5.60 + 0.20
Table 3.5 Parameters for the Adsorption Isotherms for B-CN A and
B-CN If1-25) Calculated using the Program REGRESSION
Parameters for the adsorption isotherms were calculated as described in section 3.5.2
n represents the number of adsorption sites per unit area
k represents the affinity constant
p represents the product term, where p=m.l
y represents the Hill type coefficient
A represents the area occupied per molecule
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of high affinity sites was approximately the same for both crystal preparations
(A and B), whether p-CN A or P-CN (fl-25) was the adsorbate.
If the protein molecules had adsorbed to DCPD in a uniform monolayer the
isotherms, resulting from the two DCPD preparations, would be superimposable.
The observed difference in Tp of 25% suggests therefore, that crystal shape is an
important factor. As discussed in section 3.3.3.1, DCPD crystals have a thin, platy
habit and therefore, as their size increases the edge faces account for proportionally
less of the total surface area. These results suggest that the adsorption sites for
p-CN A and P-CN (fl-25) may be concentrated on the edge faces of the DCPD
crystals. The selective adsorption of proteins to specific crystal faces is not a unique
observation (Addadi and Weiner, 1985). Selective adsorption is also observed to
organic crystals, accompanied by a concomitant change in crystal morphology
(Addadi et al., 1985). In addition, selective adsorption of proteins (and also nucleic
acids and nucleotides) to specific hydroxyapatite crystal faces has been reported
(Kawasaki et al., 1990). The theory that adsorption sites are concentrated on the
edge faces is supported by the work of van Kemenade (1988). She observed an
increase in the morphological importance of the edge faces of the crystals when they
are grown in the presence of whole casein, indicating a preferential adsorption to
these planes (see section 3.3.3).
There is an apparent difference in the adsorption affinity of P-CN A between
the two DCPD preparations. However, determination of the affinity constant (k) is
dependant on two or three data points (the average of four adsorption assays) at the
lowest concentration of P-CN A used. From curve fitting experiments (see section
3.5.2; results not shown) it was found that the affinity constant could be varied
between 1.31 - 8.3 x 105 ImoH and the curve would still fit within one standard
deviation of the experimental points.
From Tp the area occupied by each adsorbed molecule can be calculated.
The area of occupancy for P-CN A and P-CN (fl-25) for each isotherm is listed in
Table 3.5. The area of occupancy is calculated as an average area assuming
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monolayer coverage of the whole crystal. If the adsorption sites are concentrated on
the edge faces, the actual areas of occupancy would be considerably less than those
calculated.
P-CN A molecules, under the buffer conditions used during this study, will
probably associate to form micelles. It is impossible, however, to calculate the
extent of polymerisation, but it is likely to be high (see section 3.3.2). Adsorption
of p-CN A may therefore occur as whole micelles, resulting in a rapid dissociation of
the micelle at the crystal surface with a concomitant spreading of P-CN A
monomers over the crystal surface. Alternatively, P-CN A adsorption may occur as
monomers from solution, resulting in a shift in the equilibrium of monomer/polymer
causing a gradual dissociation of micelles. From the results presented here it is
impossible to determine the balance between these processes. The shape of the
isotherm will not be influenced by the processes described above because
equilibrium is already established when the isotherms are measured.
There is no tertiary, structural information for P-caseins (see section 3.3.2)
but from the radius of gyration (Rg) in solution, estimated to be about 5.1 nm
(Payens and Vreeman, 1982), and the assumption that the molecule is a uniform
sphere, the cross-sectional area of P-casein is about 136 nm2. This is considerably
greater than the calculated area per molecule from Tp of the adsorption isotherm,
suggesting that only a fraction of the P-CN A molecule binds to the crystal. The
area per molecule (calculated from the plateau region of the isotherm; 2 x 1(H M
free P-CN (fl-25), see Fig. 3.14) for P-CN (fl-25) is about the same as that for
P-CN A (see Table 3.5) despite the difference in size. This suggests that the
N-terminal region is the fraction of the molecule that binds to the DCPD crystal with
the remainder of the molecule dangling free in solution. If the affinity constants for
p-CN A and P-CN (fl-25) are compared (see Table 3.5), there is no significant
difference, supporting the conclusion that adsorption occurs via the N-terminal
segment, with the C-terminal segment playing only a minor role.
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affinity binding sites. In the light of the present results it is not possible to confirm
which of these is the case. However, it is unlikely that a highly acidic and
hydrophilic phosphopeptide such as (3-CN (fl-25) would associate to form
multilayers and the condition associated with coagulation at the interface (e.g. very
high concentrations) are not encountered. Structural transitions may occur upon
adsorption, but (3-CN (fl-25) has so little secondary structure that changes to its
conformation would not be expected to cause such a dramatic effect Therefore it is
proposed that the upward curvature (see Fig. 3.14) is a result of adsorption to a
second family of intrinsically lower affinity adsorption sites.
If the upward curvature of the (3-CN (fl-25) isotherm is due to a second
family of adsorption sites, such sites may be present on other crystal faces or may be
the result of non-specific binding. Curve fitting was performed using the two-site
model (see section 3.5.2). The number and affinity of this putative second family of
adsorption sites could not be determined separately (see section 3.5.2), and therefore,
the product term (p.c)Y was used. However, this type of binding site appears to be
more abundant than the high affinity sites. A Hill-type coefficient was calculated
and found to be much greater than unity, indicating cooperative interaction between
binding sites. The presence of lower affinity adsorption sites for (3-CN A on DCPD
crystals could not be tested as the isotherms did not cover a wide enough
concentration range (see Fig. 3.15).
3.5.3 The Effect of pH
upon the Adsorption of (3-CN A to DCPD Crystals
In Fig. 3.16, the isotherm obtained at pH 6.5 is compared with that obtained
at pH 7.0 for the adsorption of (3-CN A to DCPD preparation A at 20°C. An
increase in pH from 6.5 to 7.0 is within the range of the pK's of the phosphoseryl
residues of (3-CN A, as these range from 6.4 to 6.95 (Shrageref al., 1972;
Humphrey and Jolley, 1982; Baumy et al., 1989). As the phosphoseryl residues of
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Figure 3.15 Comparison of the Adsorption Isotherms
for B-CN A arid B-CN If1-251
The adsorption isotherms were prepared from experiments (see section 3.4.6)
performed at pH 7.0 and 20°C using DCPD preparation B (see Table 3.4). Curves
were fitted to the results using the computer program REGRESSION as described in
section 3.5.2 and the parameters of the curves are summarised in Table 3.5. Results
are plotted as T (amount adsorbed per unit area; T = x 107 moles B-CN A or B-CN
(fl-25) adsorbed per m2 DCPD) versus C (equilibrium, free concentration x 10~4 M).
—M3— indicates B-CN A adsorption isotherm.
—a— indicates B-CN (fl-25) adsorption isotherm.
The amount of protein adsorbed at each protein concentration was determined in
duplicate. Plotted points are the mean + S.E.M. of four separate adsorption









Figure 3.16 Comparison of the Adsorption Isotherms
at nH 6.5 and nH 7.0 for fi-CN A
The adsorption isotherms were prepared from adsorption experiments (see section
3.4.6) performed at 20°C using DCPD preparation A (see Table 3.4). Curves were
fitted to the results using the computer program REGRESSION as described (in
section 3.5.2) and the parameters of the curves are summarised in Table 3.5. Results
are plotted as T (amount adsorbed per unit area; T - x lO7 moles B-CN A adsorbed
per m2 DCPD) versus C (equilibrium, free concentration x 10~5 M).
—o— indicates B-CN A adsorption isotherm at pH 6.5.
—□— indicates B-CN A adsorption isotherm at pH 7.0.
The amount of protein adsorbed at each equilibrium concentration was determined in
duplicate. Plotted points are the mean + S.E.M. of of three separate adsorption
experiments performed at pH 6.5 and four adsorption experiments performed at pH








phosphoproteins are generally considered to play a major role in calcium ion and
calcium mineral adsorption (see section 3.3.3) this increase in net negative charge
should contribute to an increase in adsorption. This expected increase was observed
in the adsorption isotherm (see Fig. 3.16), with an increase in Tp of some 20%
(measured at 5 x 10"5 molar free (3-CN A). The results of curve fitting, using the
one site model are summarised in Table 3.5. The apparent number of binding sites
is less at pH 6.5 than at pH 7.0, and the area of occupancy for P-CN A molecules is
greater. The increase in Tp demonstrates that electrostatic interactions play an
important role in adsorption of molecules at the solid/liquid interface (see section
3.1.6). The surface charge of the DCPD may also be altered, the surface being less
likely to be protonated at pH 7.0 than 6.5, possibly making adsorption sites more
available to the adsorbing molecule. In the above curve fitting experiments the
lower number of binding sites, at pH 6.5, is accompanied by a greater affinity.
However, examination of the fitted curves indicated that both curves could be
described by a single affinity constant and still be within one standard deviation of
the experimental results. To confirm whether a change in pH results in a change in
affinity, adsorption isotherms would have to be constructed which include more data
points below 1 x 10-5 M free P-CN A.
3.5.4 The Effect of Urea
upon the Adsorption of P-CN A to DCPD Crystals
The effect of urea on the adsorption of P-CN A to DCPD crystals was
investigated by performing adsorption experiments with buffers containing 6.0 M
urea (see section 3.4.4). Urea totally disrupts the hydrophobic interactions that
occur between P-CN A monomers so preventing the formation of micelles (see
section 3.3.2), by increasing the aqueous solubility of the hydrophobic portions of
the polypeptide chain (Nozaki and Tanford, 1963; Wetlaufer et al., 1964; Franks
and England, 1975). This effect is observed in the dissociation of casein aggregates
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in 4.0 M urea (Ono et al., 1976). In addition, the secondary structure of P-CN A
molecules will be disrupted almost completely by 6.0 M urea. Therefore, the
adsorption of (5-CN A to DCPD in the presence of urea will occur only via
electrostatic interactions, with hydrogen bonds and van der Waals bonds being the
only intermolecular interactions.
The adsorption isotherms for P-CN A, measured at pH 7.0 and 20°C, in the
presence or absence of 6.0 M urea are compared in Fig. 3.17. In the presence of
urea the value of Tp is 50% less than in the absence of urea. In addition, the
adsorption sites are completely saturated throughout the concentration range used.
Therefore, intermolecular hydrophobic interactions may play an important role in the
process by which P-CN A adsorbs to DCPD. However, protein adsorption is
proposed to be "driven" by the entropy gain as water molecules leave the sorbent
surface and the protein, and from disruption of secondary and tertiary protein
structure (see section 3.1.4). As urea will disrupt the hydration state of both DCPD
and P-CN A, and the structure of the p-CN A molecule, the entropy gain will be
reduced in the presence of urea thus making adsorption less favourable.
3.5.5 The Effect of Temperature
on the Adsorption of p-CN (f1-251 to DCPD Crystals
The influence of temperature on an adsorption isotherm can give an insight
into the adsorption process through a consideration of the thermodynamics involved
(see section 3.1.8). A determination of the effect of temperature on an isotherm can,
by application of the Gibbs-Helmholtz equation, determine the enthalpy of binding
of the system (Tanford, 1966). Therefore, a final study was performed on
P-CN (fl-25), in which the effect of temperature upon adsorption was investigated.
In Fig. 3.18 the isotherms for p-CN (fl-25) obtained at 3°C and 20°C (measured at
pH 7.0 on DCPD preparation B) are compared. At 20°C the isotherm is as
previously described: initially a high affinity adsorption followed by a plateau at
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Figure 3.17 Comparison of the Adsorption Isotherms
for B-CN A in the Presence and Absence of 6.0 M Urea
The adsorption isotherms were prepared from experiments (see section 3.4.6)
performed at pH 7.0 and 20°C using DCPD preparation B (see Table 3.4). Curves
were fitted to the results using the computer program REGRESSION as described (in
section 3.5.2) and the parameters of the curves are summarised in Table 3.5. Results
are plotted as T (amount adsorbed per unit area; F = x 10-7 moles B-CN A adsorbed
per m2 DCPD) versus C (equilibrium, free concentration, x 10 5 M).
—o— indicates B-CN A adsorption isotherm in the absence of 6.0 M urea.
—□— indicates B-CN A adsorption isotherm in the presence of 6.0 M urea.
The amont of protein adsorbed at each equilibrium concentration was determined in
duplicate. Plotted points are the mean + S.E.M. of of three separate adsorption








Figure 3.18 Comparison of the Adsorption Isotherms
at 20°C and at 3°C for B-CN (f1-251
The adsorption isotherms were prepared from experiments (see section 3.4.6)
performed at pH 7.0 using DCPD preparation B (see Table 3.4). Curves were fitted
to the results using the computer program REGRESSION as described (in section
3.5.2) and the parameters of the curves are summarised in Table 3.5. Results are
plotted as T (amount adsorbed per unit area; T = x 1(F7 moles B-CN (fl-25)
adsorbed per m2 DCPD) versus C (equilibrim, free concentration, x 10~5 M).
—o— indicates B-CN (fl-25) adsorption isotherm at 20°C.
—□— indicates B-CN (fl-25) adsorption isotherm at 3°C.
The amount of protein adsorbed at each equilibrium concentration was determined in
duplicate. Plotted points are the mean + S.E.M. of of three separate adsorption
experiments performed at 3°C and of four separate determinations performed at
20°C. The S.E.M. not shown are smaller than the symbol.
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as the error bars from the two isotherms overlap. This implies that the adsorption
process for (3-CN (f1-25) is athermal and is "driven" by an entropy gain.
However, all the data points for the adsorption isotherm obtained at 3°C are
higher than those obtained at 20°C (see Fig. 3.18). If the errors were random, and
there was no effect of temperature upon adsorption, this would not be observed.
Therefore the adsorption of (3-CN (fl-25) may be exothermic, but further
experimentation would be required to confirm this.
Summary
Adsorption of (3-CN A occurs to high affinity sites which may be
concentrated on the edge faces of the DCPD crystals (see section 3.5.2). Adsorption
probably occurs via the N-terminal region of the molecule (first 25 amino acids;
(3-CN (fl-25) segment) with the remainder of the molecule dangling free in solution.
Inclusion of urea in the adsorption assay buffers results in a dramatic decrease in Tp
(see section 3.5.4). This may indicate that either intermolecular, lateral interactions
occur between adsorbed molecules or that adsorption is "driven" by an entropy gain
(see section 3.5.4).
Adsorption of (3-CN (fl-25) appears to be very similar to that of (3-CN A.
However, at higher peptide concentrations (above 3 x 1(H M free (3-CN (fl-25)) an
increase in adsorption is observed (see section 3.5.2). This increase in adsorption is
attributed to a second family of intrinsically lower affinity adsorption sites.
Adsorption of (3-CN (fl-25) to these lower affinity sites is cooperative, as
demonstrated by a Hill coefficient (y) much greater than unity (see Table 3.5).
Adsorption of (3-CN (fl-25) is not significantly affected by temperature, indicating





AND THE DETERMINATION OF THE STRUCTURES
OF TWO SMALL MOLECULES
BY X-RAY CRYSTALLOGRAPHIC METHODS
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4.1 Introduction
Much of our knowledge of the architecture of many types of molecules (e.g.
drugs, peptides, hormones and enzymes) comes from the technique of X-ray
crystallography. Molecules in crystals can have their precise structure determined;
by understanding the relationship between the arrangement of the molecule within
the crystal and the diffraction pattern obtained as the paths of X-rays are altered by
passing through the crystal.
Prior to X-ray crystallographic analysis it is necessary to grow a single
crystal of minimum dimensions (typically 0.1 mm). A crystal is a regular, repeating
array of atoms or molecules in three dimensions. For the purpose of X-ray
crystallography it is convenient to describe a crystal with the aid of a lattice. A
crystal lattice is a regular, three dimensional arrangement of "points", such that the
view in a given direction from each point in the lattice is identical with the view in
the same direction from any other lattice point. The lattice can be defined by three
axes with three angles between them, along each axis a point will repeat at a distance
referred to as the unit translation or unit cell repeat. The axes are labelled a, b and c
and the angles between b and c, a and c and a and b are called a, P and y
respectively. The crystal is composed of billions of identical unit cells and a
description of the contents of any one unit cell is all that is required to describe the
complete crystal structure. To aid the description of the diffraction process, and
hence the determination of the contents of the unit cell, it is convenient to be able to
divide the lattice into a series of planes. These lattice planes intersect the crystal
lattice in a regular, uniform way and have an integral number of repeats per unit cell.
In order to "see" the individual atoms of the molecule, radiation of similar
wavelength to the interatomic distances (typically 0.15 nm) is required. Radiation
of this wavelength lies in the X-ray region of the electromagnetic spectrum. The
way X-rays are scattered by the electrons of the atoms (i.e. diffraction) is
conveniently described by the Bragg equation:
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nX = 2dsin0 (1)
In the equation, X is the radiation wavelengh, n is an integer, d is the perpendicular
spacing between the lattice planes and 0 is the angle the X-ray beam makes with the
lattice plane. Fig. 4.1 gives a diagrammatic representation of the Bragg equation.
The crystal lattice is represented by a row of points A, B and C. For the scattered
X-rays from row B to enhance those scattered from row A there must be an integral
number of wavelengths difference. Bragg's law (equation 1) represents the
relationship between the lattice spacing d, the wavelength X and 0, the angle the
emergent beam makes relative to the direction of the rows. Provided there is a large
enough number of lattice planes contributing (that enhance the scattered X-ray
beam), the position in space at which the scattered beam is observed is highly
defined.
The scattered (or diffracted) X-ray radiation emerging from the crystal
produces a diffraction pattern, which can be observed as a series of spots on
photographic film. The symmetry and positions of the spots of the diffraction
pattern give the dimensions and symmetry of the unit cell in the crystal. The
intensities of the spots are related to the arrangment of the atoms within the unit cell.
It is convenient to use the analogy of the light (and electron) microscope
when trying to understand the principle of X-ray diffraction. In an ordinary optical
microscope the radiation (light) scattered by the object can be recombined by the
lens system of the microscope to give a magnified image. In a similar way X-rays
are scattered by the electrons of the molecule, but X-rays cannot be recombined as in
the light microscope to give a magnified image of the molecule. Therefore, the
diffracted X-rays are recombined mathematically, by use of Fourier syntheses. The
lens system of the light microscope collects all the scattered light waves and, using
the amplitudes and phases of the waves, recombines them to form a magnified
image. In the same way, the Fourier synthesis uses the position, intensity and the
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Figure 4.1 Diagrammatic Representation of the Bragg Equation
The diagram illustrates the fulfilment of the conditions required to satisfy the
Bragg equation. The lattice planes A, B and C are separated by the
perpendicular distance d. X-rays Xl5 X2 and X3 are incident at an angle of 0
with respect to the lattice planes. The X-rays, scattered from plane A (Xj),
are enhanced by those from plane B (X2) provided that the extra distance
travelled by X2 is a integer number of wavelengths (n).
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calculated phase (as the actual phase cannot be recorded directly) of the diffracted
X-ray waves to calculate a three dimensional electron density map of the molecule
(the magnified picture of the object) and hence determine its structure.
4.2 Co-crvstallisation Experiments with Phosphoserine and Calcium ions
The binding of calcium ions by the phosphoseryl residues of phosphopnoteins
is well documented (Holt et al., 1986; Aoki et al., 1987; Farrell and Thompson,
1988; Schmidt and Poll, 1989). However, no precise structural information about
this interaction is available. The crystal structures of the calcium salts of phospho-
amino acids (i.e. Ser(P) and Thr(P)) and short phosphopeptides would give this
information. Therefore, co-crystallisation trials of phosphoserine and calcium salts
were initiated.
4.2.1 Materials and Methods
All chemicals were purchased from Sigma (Poole, Dorset) unless otherwise
stated. All solutions were made with distilled water and their pH's (measured with a
Gallenkamp combination glass electrode) adjusted with 2.0 M sodium hydroxide,
potassium hydroxide or hydrochloric acid. Finally, solutions were passed through
0.2 |im filters (Millipore, USA).
4,2.1.1 Co-crvstallisation Experiments of Phosphoserine
with Water-Soluble Calcium Salts
Growth of co-crystals of phosphoserine and calcium ions was attempted
using the simplest method, that of slow solvent evaporation. Crystal trials were
performed in plastic 24 (flat bottomed) well tissue culture plates (Flow Laboratories,




2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 6.0 6.1 6.2 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
20 : 1 P P P
18 : 1 P P P
16 : 1 P P P
14 : 1 P P P
12 : 1 P P P
11 : 1 P P P











7 1 P P P
6 1 P P P
5 1 P P P
4 1 P P P N N N T T
3 1 P P P N N N T T * * * * * * * * * * * T T T
2 1 P P P N N N T T * * * * * * * * * * * T T T T T T T T
1 1 P P P N N N T T * * * * * * * * * * * T T T T T T T T
1 2 P P P N N N T T * * * * * * * * * * * T T T T T T T T
1 3 P P P N N N T T * * * * * * * * * * * T T T
1 4 P P P N N N T T
1 5 P P P N N N N N N T T T T T T T T T T T T T T T T T T
1 6 P P P
1 7 P P P
1 8 P P P
1 9 P P P
1 10 P P P
1 12 P P P
1 14 P P P
1 16 P P P
1 18 P P P
1 20 P P P
Table 4.1 Summary of Co-Crvstallisation Experiments
using Phosphoserine and Water-Soluble Calcium Salts.
Trials were conducted with various combinations of pH and
Phosphoserine/Calcium ion ratio.
Conditions under which crystals composed entirely of phosphoserine formed
are indicated P.
Conditions under which non-crystalline precipitates formed are indicated T.
Conditions under which neither crystals nor precipitate formed are indicated
N.
Conditions under which micro-crystals of a phosphoserine : calcium complex
formed are indicated *.
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co-crystallisation trials. All trials were performed at three different temperatures
(3.0, 10.0 and 20.0°C) using three different calcium salts: calcium chloride
(CaCl2-2H20; 6.0 M), calcium nitrate (Ca(N03)2-4H20; 2.0 M) and calcium
hydroxide (Ca(OH)2; 0.2 M). Each optical isomer of phosphoserine was tested (i.e.
L-Ser(P) and D-Ser(P)) as well as the racemic mix, each at six different
concentrations: 17.0 mM, 20.0 mM, 25.0 mM, 100 mM, 130 mM and 150 mM.
Crystal trials were conducted at various pH's (see Table 4.1). The pH's of the
phosphoserine solutions were adjusted, in separate trials, with sodium hydroxide and
with potassium hydroxide, except when calcium hydroxide was used as calcium salt
when no pH adjustment was necessary.
The crystal trials were constructed as follows. To 1 ml of a phosphoserine
solution at the appropriate pH was added, dropwise, a solution of the calcium salt
such that the desired phosphoserine : calcium ion ratio was obtained. The pH of the
resulting solution was measured and re-adjusted as necessary (with either sodium
hydroxide or potassium hydroxide). The solution was then left undisturbed at either
3.0, 10.0 or 20.0°C to crystallise.
4.2.1.2 Co-crvstallisation Experiments of Phosphoserine with Calcium Carbonate
Addition of base to acid (in solution) causes a reaction resulting in the
formation of the corresponding salt and water. Therefore, addition of calcium
carbonate (base) to a solution of phosphoserine (acid; pH 2.0) should result in the
formation of the corresponding phosphoserine/calcium salt and water with the
liberation of carbon dioxide gas. Briefly, to a 0.1 M solution of phosphoserine
(25 ml) was added an excess of solid calcium carbonate (3 g), the solution was then
stirred for 12 hr at room temperature. The solid calcium carbonate remaining was
removed by filtration (Whatman No. 1) and the resulting solution then left
undisturbed at either 3.0, 10.0 or 20.0°C to crystallise. The pH of the final solution
was 4.2.
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4.3 Results and Discussion
In order to determine a molecule's structure a well-formed, single crystal is
required. The co-crystallisation trials failed to yield any such crystals. Therefore
the determination of the structure of the calcium salt of phosphoserine by X-ray
diffraction techniques was not possible.
The results of the co-crystallisation trials using the water-soluble calcium
salts are summarised in Table 4.1. At pH's between 2.0 and 3.5 crystals grew but
when they were analysed by X-ray powder diffraction, they were found to be
composed entirely of phosphoserine regardless of the calcium salt concentration.
Between approximately pH 3.5 and 5.0 neither crystals nor precipitate formed and,
upon complete evaporation of the solvent (after 9-12 months), a white
non-crystalline (determined by X-ray powder diffraction) solid was observed.
Between pH 5.1 and 6.2, and approximately 30 min after the addition of the calcium
salt, a rapid crystallisation process began which was complete within 4 hr and
resulted in the formation of micro-crystals. These micro-crystals had approximate
dimensions of 0.05 x 0.01 x 0.01 mm, were needle-shaped and tended to form
spherules. The crystals remained stable for up to 12 hr at room temperature and up
to 24 hr at 4°C. After this time the crystal lattice had decayed to such an extent that
the crystals no longer diffracted X-rays. The crystals were characterised using
X-ray powder diffraction techniques immediately after their growth and were shown
to consist not only of phosphoserine (see Fig. 4.2). It is therefore likely that they
were co-crystals of calcium and phosphoserine. Unfortunately, the powder
diffraction data collected were unsuitable for structure determination because of the
poor quality of the crystals. An elemental analysis for "C, H, N" and calcium was
performed upon the micro-crystals which formed between pH 5.1 and 6.2, the results
of which are reported in Table 4.2. By use of the molar percentage of carbon and
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Figure 4.2 X-rav Powder Diffraction Patterns of D.L-Phosphoserine and
the Phosphoserine/Calcium Complex
A Hagg-Guinier camera was used to obtain the powder diffraction photographs.
A) X-ray powder diffraction pattern of D,L-Ser(P) crystals grown at 20°C.
Exposure time (to X-rays) was 30 minutes.
B) X-ray powder diffraction pattern of the D,L-Ser(P)/Calcium complex. These





Calculated molar percent for
the theoretical empirical formula
Ser(P): Ca : 2HaO
Carbon 13.88 ± 0.04 13.84
Hydrogen 3.60 + 0.02 3.87
Nitrogen 5.355 + 0.005 5.38
Calcium 10.0 + 3.0 15.40
Table 4.2 Elemental Analysis of Micro-Crvstals
of a Phosphoserine/Calcium Complex
The trials which yielded the micro-crystals are described in section 4.2.1.1.
The molar percentages resulting from "C, H, N" analysis and from Calcium
analysis of the micro-crystals are presented.
The calculated molar percentages for a theoretical complex possessing the
empirical formula Ser-(P): Ca : 2H20 are shown in the column on the right.
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molar percentage of nitrogen it is possible to propose a tentative empirical formula
for this calcium salt of phosphoserine:
Ser(P) : Ca : 2H20
However, the molar percentage of calcium (10 ± 3 %) is less than the theoretical
15.4% required for this complex (see Table 4.2). This could be due to the presence
of other ions contaminating the sample, such as sodium, chloride or hydroxyl ions.
It was not possible to determine the structure of these crystals using standard X-ray
diffraction techniques because of their small size and their instability. However, use
of a synchrotron radiation source might allow a crystal structure to be elucidated
from the powder diffraction pattern. When the pH was above 6.2 a white, non¬
crystalline (by X-ray powder diffraction studies) precipitate formed quickly after
addition of the calcium salt.
A structural investigation into the theory of the intermolecular chelation of
phosphoserine and calcium ions has been performed by Gresh (1980). Gresh
inferred that the (calculated) two most stable complexes were Ser(P):Ca and
Ser(P):Ca:Ser(P). The more stable complex was Ser(P):Ca, in which calcium ions
interact simultaneously with the four anionic oxygens of the ligand (i.e. two oxygens
from the phosphate group and two oxygens from the carboxyl group). This work
is in agreement with the empirical formula (above) suggested in this work.
Co-crystallisation trials using calcium carbonate as calcium ion source
instead of the water-soluble calcium salts resulted in no crystals forming. Upon
complete evaporation of the solvent a white, non-crystalline (determined by X-ray
powder diffraction) solid remained.
If co-crystals of phosphoserine/calcium and Ser(P)-Ser(P)/calcium had been
grown the geometric information obtained could be useful in understanding
phosphoprotein/calcium mineral interactions. At present, no information is
available for calcium ion/phosphate group interaction. For example, bond lengths
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Summary
The results obtained with both soluble and insoluble calcium salts may be
interpreted as follows. The complex between calcium ions and phosphoserine begins
to form above pH 5.0. As no solid complex is observed at a pH less than 5.0 and as
the pK value of the phosphate group of phosphoserine is 5.65 (Osterberg, 1957), it is
likely therefore that the phosphate group must be ionised for calcium ion binding to
occur with sufficient "strength" for a solid complex to form. Once the complex has
formed in solution, rapid precipitation/crystallisation occurs (depending upon pH),
the solid complex being very insoluble in water, methanol and in ethanol once
formed. Elemental analysis indicates that each calcium ion is chelated by one
phosphoserine molecule.
4.4 The Solving of Two Small Molecule Structures
bv X-rav Crvstallographic Methods
The following section describes the elucidation of the structures of two small
molecules of pharmacological importance (see Fig. 4.3). These structures were
solved as an exercise in familiarisation with the crystallographic process.
4.4.1 l-(2-Methoxvphenyl)-4-r4-(2-phthalimido')but-2E-ynyllpiperazine. HBr
q-MPPi
The 5-hydroxytryptophan (5-HTia) receptor is believed to be involved in
thermoregulation, adenylate cyclase modulation and in the control of blood pressure
(Peroutka, 1988). 1- (2-methoxyphenyl)-4- [4- (2-phthalimido)butyl]piperazine
(NAN-190) is a partial agonist of the 5-HT1A with a high affinity (Ki = 1.0 nM;
Glennon et al., 1988a,b). Alkenyl and alkynyl derivatives of NAN-190 have been
synthesised interalia (Dawson et al., 1991), by appropriate replacements
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l-(2-methoxyphenyl)-4-[4-(2-phthalimido)but-2E-ynyl]piperazine . HBr (1-MPP)
O
l-aza-5-oxa-6-(r,3'-dithianyl)-7,8-benzo-9-oxobicyclo[4.3.0]nonane (1-ATN)
Figure 4.3 Structural Diagrams of the Two Small Molecules of
Pharmacological Importance whose Structures were Solved
bv X-rav Crvstallographic Techniques.
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of the 4-bromo-l-phthalimido butane synthon in the reaction with
l,4(2'-methoxyphenyl)piperazine, in an attempt to increase the affinity of NAN-190
for the 5-HTja receptor. However, the binding affinities for the alkenyl and
alkynyl ligands were 10.0 nM and 270.0 nM respectively. Therefore the change in
geometry and rigidity of the phthalimido side chain as a result of the modifications
does not confer a higher affinity for the 5-HT1A receptor. Below is the
crystallographic structure determination of the alkynyl derivative
l-(2-methoxyphenyl)-4-[4-(2-phthalimido)but-2E-ynyl]piperazine. HBr (1-MPP).
4.4.1,1 Method of Structure Solution and Refinement
Crystals (supplied by Dr. I Dawson, Department of Pharmacology,
University of Edinburgh) of 1-MPP were prepared by diffusion of ether into a
methanolic solvation of the hydrobromide salt at 293 K. A crystal of dimensions
0.2 x 0.5 x 0.1 mm was used for data collection. The crystals were characterised by
Weissenberg photography, which revealed the likely space group as C 2/c, and then
data was collected on a Stoe STADI-4 diffractometer (with the help of Dr. A. J.
Blake, Dept. of Chemistry, University of Edinburgh). An orientation matrix was
calculated using 7 reflections in the 20 range of 10 to 20 degrees. Accurate cell
dimensions were determined using 28 reflections at ± CO in the same 20 range. Data
were collected over -26 <h >26, 0 < & >16, 0 < / >16 (excluding h+k = odd as
the space group was C 2/c) with 7 reflections being measured every 2 hours to check
for crystal decay or movement. During data reduction, 3107 reflections of the 4988
measured were rejected as they had I < 2a(I) and were therefore considered
unobserved. During refinement 1881 reflections were used out of the 4988
measured during data collection.
A trial position for the Bromine atom was located using a Patterson synthesis,
phases obtained from this atom were sufficient to reveal all non-hydrogen atoms.
The structure was then refined using the program SHELX76 (Sheldrick, 1976).
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Atoms were refined anisotropically before the addition of hydrogen atoms, which
were further refined with fixed isotropic temperature factors and site occupancies.
These were allowed to ride on the atoms to which they were attached. The
o
maximum atom shift on the final refinement cycle was 0.002 A. A weighting
scheme was not adopted in the structure refinement because it gave no improvement.
A total of 295 parameters were refined resulting in a final R factor of 0.048. The
O
o
final difference map gave maximum and minimum values of 0.435 and -0.291 eA"3
o
respectively and the maximum sinO/X, was 0.5946 A"1.
Final atomic parameters are given in Table 4.3. Table 4.4 gives a summary
of the data collected and the structure solution. The program CALC (Gould and
Taylor, 1983) was used to provide the molecular geometry data presented in Tables
4.5, 4.6 and 4.7. Crystal structure diagrams (Fig. 4.4) were prepared using the
program ORTEP (Johnson, 1965; Mallinson and Muir, 1985), and crystal packing
diagrams (Fig. 4.5) were prepared using the program PLUTO (Motherwell, 1972).
4.4.1.2 Discussion
The crystal structure of 1-MPP is shown in Fig. 4.4, the bond lengths and
angles for this structure are as expected (see Tables 4.5, 4.6 and 4.7). The
molecular packing (see Fig. 4.5) indicates few close contacts between molecules.
The aromatic rings of the molecules appear to overlap, the A ring of one overlapping
with the B ring of another, in a translation along the b axis. There are two
significantly short carbon carbon intermolecular distances which may indicate weak
intermolecular interactions between the stacked aromatic rings. Two of the latter
occur between carbon 6A of one molecule and carbon 5B of another and carbon 3B
©
of one molecule and carbon 5A of another (these being 3.469(18) and 3.719(16) A
respectively) related by the symmetry operations x,l+y,z and x,-l+y,z respectively.
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Figure 4.4 Crystal Structure of the Pharmacological Compound 1-MPP
The crystal structure diagram was prepared using the computer
program ORTEP. Nitrogen (small) and Bromine (large) atoms are
shaded.
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Crystal Packing Diagram of the Pharmacological Compound 1-MPP
The packing diagram was generated using the computer program
PLUTO. The view is taken down the a axis
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Fractional Coordinates of Atoms with Standard Deviations
Ueq
Br (1) 0.080451 4) -0.06717( 9) 0.618561 6) 0.0675( 6)
N<4) 0.1032( 3) 0.0193( 5) 0.9058( 5) 0.0461 4)
0(1) 0.26191 3) 0.21991 5) 0.78391 4) 0.071( 5)
C(l') 0.0807( 4) -0.0799( 6) 0.8852( 6) 0.056( 6)
N (2) 0.1217( 4) -0.34531 6) 1.10371 5) 0.064( 6)
N(l) 0.1544( 3) 0.1938( 5) 0.84701 5) 0.054( 5)
0(3) 0.03191 3) -0.29391 6) 1.1418( 5) 0.092( 6)
0(2) 0.2001 ( 3) -0.4394( 7) 1.0716( 5) 0.109( 6)
COB) 0.1495( 5) -0.4324( 9) 1.0901( 6) 0.073( 7)
C (1A) 0.1782( 4) 0.2864( 7) 0 . 8 4 3 6 ( 6) 0.0551 6)
C (5) 0.16881 3) 0.02941 6) 0.8977( 6) 0.058( 6)
C(4B) 0.10401 5) -0.5075( 9) 1.0998 ( 7) 0.067( 7)
C (2) 0.0913( 3) 0 .1884 ( 7) 0.85991 6) 0.058 1 6)
C(2A) 0.2347( 4) 0.2997( 7) 0.8115 < 6) 0.057( 6)
C(3') 0.12751 4) -0.1965( 7) 1.0188 ( 6) 0.063< 6)
C (6A) 0.14801 5) 0.3678( 8) 0.8663( 7) 0.079( a>
C(3A) 0.2578( 5) 0.39011 ft) 0.8084 ( 7) 0.070( 7)
C (9B) 0.0524 ( 5) -0.4619( 8) 1.11931 7) 0.066( 7)
C(2') 0.10821 4) -0.1464( 7) 0.9571( 7) 0.061( 6)
COB) 0.0041< 8) -0.6115(12) 1.1206( 9) 0.105(12)
C<4' ) 0.15031 5) -0.2548( 8) 1.1008 ( 7) 0.077( 8)
C (6) 0.1890( 4) 0.12891 6) 0.9156( 6) 0.053( 6)
C (IB) 0.0636( 4) -0.3587( ft) 1.12381 6) 0.0651 7)
C (7) 0.31141 4) 0.2347 ( 8) 0.7311( 8) 0.0861 8)
C(5A> 0.17201 6) 0.4581( 8) 0.8592( 8) 0.093( 9)
C (5B) 0.1055( 7) -0.6048(11) 1.0906( 9) 0.100(11)
COB) 0.0016( 6) -0.5135(11) 1.1304( 8) 0.087( 9)
C(4A) 0.2267( 6) 0.4690( 9) 0.83051 9) 0.089( 9)
COB) 0.0547( 9) -0.6554 (11) 1 .10141 9) 0.112(13)
C (3) 0.0687( 3) 0.0892( 6) 0.8419( 6) 0.0551 6)
Anisotropic Vibration Parameters with Standard Deviations



























































































































































































































































































Table 4.4 Summary of the Data Collected and the Structure Solution for the
Pharmacological Compounds 1-MPP and 1-ATN
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N(4) -C(l') 1.500(11) C (1A) -C (6A) 1.393(14)N(4) - C(5) 1.509(11) C (5) - C (6) 1.483(12)N(4) - C(3) 1.487(11) C(4B) -C (9B) 1.391(15)0(1) -C(2A) 1.361 (11) C(4B) -C(5B) 1.375(18)0(1) - C (7) 1.442(13) C (2) - C (3) 1.495(12)C(l') -C(2') 1.462 (13) C(2A) -C(3A) 1.376(14)N (2) -C(3B) 1.402 (14) C(3') -C(2') 1.164(14)N(2) -C(4') 1.430 (13) C(3') ~C(4') 1.462(14)N(2) -C(1B) 1.393(13) C(6A) —C (5A) 1.389(16)N (1) -C(1A) 1.411(11) C(3A) -C(4A) 1.372(16)N (1) - C (2) 1.467 (11) C(9B) -C(1B) 1.473(15)N (1) - C (6) 1.482(11) C(9B) -C(8B) 1.387(17)0(3) -C(1B) 1.208 (13) C(7B) -C(8B) 1.386(21)0(2) -C(3B) 1.211(14) C(7B) -C (6B) 1.361(23)C(3B) -C(4B) 1.493 (16) C(5A) -C(4A) 1.361(17)C(1A) -C(2A) 1.426 (13) C(5B) -C(6B) 1.378(22)
Table 4.5 Calculated Bong Lengths
for the Pharmacological Compound 1-MPP
Atoms are labelled as shown in Fig. 4.4 and bond lengths are given in A with
standard deviations in parentheses. Bond lengths for hydrogen atoms have
been omitted.
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C(l') - N (4) - C (5) 112.7 6) 0(1) -C (2A) -C(3A) 124.3( 9)
C(l') - N (4) - C (3) 110.9 6) C (1A) -C (2A) -C(3A) 119.4( 9)
C (5) - N (4) - C (3) 109.5 6) C (2f ) -C(3') -C(4') 176.1(10)
C(2A) - 0(1) - C (7) 116.2 7) C (1A) -C(6A) -C(5A) 121.6(10)
N (4) -C(l') -C(2') 110.8 7) C(2A) -C(3A) -C(4A) 122.1(10)
C(3B) - N (2) -C(4') 124.1 8) C(4B) -C(9B) -C(1B) 108.5( 9)
C(3B) - N (2) -C(1B) 111.3 8) C(4B) -C(9B) -C(8B) 120.8(10)
C(4') - N (2) -C(1B) 124.6 8) C (IB) -C(9B) -C(8B) 130.6(10)
C(1A) - N (1) - C (2) 115.8 7) C(l') -C(2') -C(3') 175.0(10)
C (1A) - N (1) - C (6) 114.8 7) C(8B) -C(7B) -C(6B) 121.2(15)
C (2) - N (1) - C (6) 109.0 6) N(2) -C(4') -C(3') 114.1( 9)
N (2) -C(3B) - 0(2) 123.7 10) . N (1) - C(6) - C (5) 110.1( 7)
N (2) -C(3B) -C(4B) 106.1 9) N (2) -C(IB) - 0(3) 122.9( 9)
0(2) -C(3B) -C(4B) 130.2 10) N (2) -C(IB) -C(9B) 106.6( 8)
N (1) -C(1A) -C(2A) 119.6 8) 0(3) -C(IB) -C (9B) 130.5(10)
N (1) -C(1A) -C(6A) 123.3 8) C(6A) -C(5A) -H(5A) 119.8(13)
C(2A) -C(1A) -C(6A) 117.1 9) C(6A) -C(5A) -C(4A) 120.3(11)
N (4) - C (5) - C (6) 111.1 7) C(4B) -C(5B) -C (6B) 118.2(13)
C(3B) -C(4B) -C(9B) 107.5 9) C(9B) -C(8B) -C(7B) 117.5(12)
C(3B) -C(4B) -C(5B) 131.9 11) C(3A) -C(4A) -C(5A) 119.5(11)
C(9B) -C(4B) -C(5B) 120.6 11) C(7B) -C(6B) -C(5B) 121.6(15)
N(l) - C (2) - C (3) 110.1 7) N (4) - C (3) - C (2) 111.8( 7)
0(1) -C(2A) -C(1A) 116.3 8)
Table 4.6 Calculated Bond Angles
for the Pharmacological compound 1-MPP
Atoms are labelled as shown in Fig. 4.4 and bond angles are given in degrees
with standard deviations in parentheses. Bond angles including hydrogen
atoms have been omitted.
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c (5) - N (4) -C(l') —C (2') 65.6 9) 0(2) -C(3B) -C (4B) -C(5B) -0.1(22)
C (3) - N(4) -C(l') -C(2') -171.2 7) N(l) -C(1A) -C(2A) - 0(1) 1.3(12)
C(l') - N(4) - C (5) - C(6) 178.3 7) N(l) -C(1A) -C(2A) -C(3A) -179.9 ( 9)
C (3) - N(4) - C (5) - C(6) 54.4 9) C(6A) -C(1A) -C(2A) - 0(1) -176.0( 8)
C(l') - N<4) - C (3) - C(2) -178.9 7) C(6A) -C(1A) -C(2A) -C(3A) 2.8(14)
C (5) - N(4) - C (3) - C(2) -53.9 8) N(l) -C(1A) -C(6A) -C(5A) -177.9(10)
C (7) - 0(1) -C(2A) -C(1A) 165.9 8) C(2A) -C(1A) -C(6A) -C(5A) -0.7(15)
C (7) - 0(1) -C(2A) -C(3A) -12.8 13) N(4) - C (5) - C (6) - N(l) -58.7 ( 9)
N<4) -C(l') -C<2') -C(3') 73.0 11) COB) -C(4B) -C(9B) -C(IB) -0.8(12)
C(4' ) - N (2) -COB) - 0(2) -2.4 16) C(3B) -C(4B) -COB) -COB) 178.9(10)
C(4') - N (2) -C(3B) -C(4B) 179.6 9) COB) -C(4B) -C(9B) -C(IB) -179.3(11)
C (IB) - N(2) -C(3B) - 0(2) 179.8 10) C(5B) -C(4B) -C(9B) -C(8B) 0.3(18)
C (IB) - N(2) -C(3B) -C (4B) 1.8 11) C(3B) -C(4B) -C(5B) -C(6B) -178.2(13)
COB) - N(2) -C (4') -C(3') 110.3 11) C(9B) -C(4B) -COB) -C(6B) 0.0(20)
C (IB) - N(2) -C(4') -C (3') -71.7 12) 0(1) -C(2A) -C(3A) -C(4A) 175.2(10)
COB) - N(2) -COB) - 0(3) 177.0 10) C(1A) -C(2A) -C(3A) -C(4A) -3.5(16)
C OB) - N(2) -C(1B) -C(9B) -2.3 11) C<4') -C(3') -C(2') -C(l') -19.0(25)
C (4' ) - N (2) -C(IB) - 0(3) -0.8 16) C(2' ) -C(3') -C (4') - N(2) 114.3(15)
C (4' ) - N (2) -C(IB) -C(9B) 180.0 9) C(1A) -C(6A) -C (5A) -C(4A) -0.9(18)
C (2) - N(l) -C(1A) -C (2A) -166.7 8) C(4B) -C(9B) -C(IB) - N(2) 1.8(12)
C (2) - N (1) -C(1A) -C(6A) 10.4 12) C(4B) -C(9B) -COB) - 0(3) -177.3(11)
C (6) - N (1) -C(IA) -C(2A) 64.9 10) C(8B) -C(9B) -C(1B) - N(2) -177.8(12)
C (6) - N (1) -C(IA) -C(6A) -118.0 10) C(8B) -C(9B) -C(IB) - 0(3) 3.1(20)
C(1A) - N (1) - C (2) - C (3) 168.1 7) C(4B) -COB) -C(8B) -C(7B> -0.5(18)
C (6) - N(l) - C (2) - C (3) -60.7 3) COB) -COB) -C(8B) -C(7B) 179.0(12)
C(1A) - N(l) - C (6) - C (5) -166.8 7) C(6B) -C(7B) -C(8B) -C(9B) 0.4(22)
C (2) - N(l) - C (6) - C(5) 61.5 9) C(8B) -C(7B) -COB) -C(5B) -0.1(25)
N(2) -C(3B) -C(4B) -COB) -0.6 12) C(6A) -C(5A) -C(4A) -C(3A) 0.3(18)
N<2) -C(3B) -C(4B) -C(5B) 177.7 13) C(4B) -C(5B) -C(6B) -C(7B) -0.1(23)
0(2) -C(3B) -COB) -C(9B) -178.4 12)
Table 4.7 Calculated Torsion Angles
for the Pharmacological Compound 1-MPP
Atoms are labelled as shown in Fig. 4.4 and torsion angles are given in
degrees with standard deviations in parentheses. Torsion angles involving
hydrogen atoms have been omitted.
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4.4.2 1 -Aza-5-oxa-6-(T.3'-dithianvlV7.8-benzo-9-oxobicvclo 14 3
(l-ATN)
N-(3-Bromopropyl)-phthalimide was reacted with 1 equivalent of lithnated
1,3-dithiane in an attempt to synthesise N-(3-dithianylpxopyl)-phthalimide (by Dr. I
Dawson, Dept. of Pharmacology, University of Edinburgh). The latter was to be
used as a synthon in the Fisher-Indole synthesis of a novel serotonergic agent related
to the NAN-190 compounds but with sulphur in the ring system rather than nitrogen.
The outcome of this reaction was uncertain therefore the crystal structure of the
major reaction product was solved as a means of verification.
In the event, addition of the dithiane anion to the carboxyl group of the
phthalimide group occurred preferentially, under these conditions (refluxing in
THF), with concomitant intramolecular O-alkylation by the bromopropyl group to
form the bicyclic product 1-ATN (see Fig. 4.6).
4.4.2.1 Method of Structure Solution and Refinement
Crystals (supplied by Dr. I. Dawson) of 1-ATN were prepared from
ethylacetate/hexane by the evaporation of a nearly-saturated solution at 293 K. A
crystal of dimensions 0.2 x 0.2 x 0.2 mm was used for data collection. Data were
collected on a Stoe STADI-4 difffactometer (with the help of Dr. L. Sawyer). An
orientation matrix was calculated using 20 reflections in a 20 range of 10 to 20
degrees. Accurate cell dimensions were determined using 20 reflections at ± to in a
20 range of 30 to 32 degrees. Data were collected over -11 < h >13,
0 <k >8, 0 < I >16, with 9 reflections being measured every 2 hours to check for
crystal decay or movement. During data reduction, 337 of the 2130 measured
reflections had a I < 2o(I) and were therefore considered unobserved. During
refinement 1793 reflections were used out of the 2130 measured during data
collection.
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Figure 4.6 Synthesis of the Pharmacological compound 1-ATN
Diagram showing how the reaction of N-(3-Bromopropyl)-phthalimide with lithnated
dithiane results in the formation of the bicyclic product 1-ATN.
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Trial positons for the sulphur atoms were located using a Patterson map but
the difference Fourier calculated was uninterpretable. However, direct methods
using SHELXS86 (Sheldrick, 1986) did successfully locate the positions of all the
non-hydrogen atoms. Atoms were refined anisotropically before addition of
hydrogen atoms, with fixed isotropic temperature factors and site occupancies.
These were allowed to ride on the atom to which they were attached. The
O
maximum atom shift in the final refinement cycle was 0.001 A. A weighting
scheme of the form 9.9123/(o2(F) + 0.000060(F2)) was employed to improve final
structure solution.
A total of 181 parameters were refined resulting in a final R factor of 0.035.
The final difference map gave maximum and minimum values of 0.257 and -0.279
» O
eA"3 respectively and the maximum sinOA, was 0.5382 A-1.
Final atomic parameters are given in Table 4.8. Table 4.4 gives a summary
of the data collected and the structure solution. The program CALC (Gould and
Taylor, 1983) was used to provide molecular geometry data presented in Tables 4.9,
4.10 and 4.11. Crystal structure diagrams (Fig. 4.7) were prepared using the
program ORTEP (Johnson, 1965; Mallinson and Muir, 1985) and crystal packing
diagrams (Fig. 4.8) were prepared using the program PLUTO (Motherwell, 1972).
4.4.2.2 Discussion
The crystal structure of 1-ATN is shown in Fig. 4.7. The bond lengths for
this structure are as expected (see Table 4.7). The bond lengths and angles (see
Table 4.9 and 4.10) for the benzene ring form a near perfect ring structure. The
angles through the nitrogen atom (see Table 4.10) are slightly distorted from a true
tetrahedron, which is probably due to the strain caused by cyclising carbons 1, 2 and
3 and oxygen 4 (see Fig. 4.7 and Tables 4.9,4.10 and 4.11).
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The molecular packing (see Fig. 4.8) indicates few close contacts between
molecules. The molecules form infinite stacks, parallel to the b axis, with a
herringbone pattern typical of planar aromatic systems. There are four significantly
short carbon and oxygen atom intermolecular distances which may indicate very
weak intermolecular interactions. Two of these occur between oxygen 6 (carbonyl
group) of one molecule and carbon 1 and carbon 3 of two different molecules (these
o
being 3.308(3) and 3.468(3) A respectively) related by the symmetry operations
x,-l/2-y,l/2+z and -x,l/2+y,l/2-z respectively. The other two short intermolecular
distances occur between oxygen 14 of one molecule and carbons 18 and 19 of
o
another (these being 3.479(4) and 3.315(3) A respectively) related by the symmetry
operation x,l+y,z. These may help in the formation of the stacks (described above)
that are parallel to the b axis.
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Figure 4.7 Crystal Structure of the Pharmacological Compound 1-ATN
The crystal structure diagram was prepared using the program
ORTEP. Sulphur atoms are shaded.
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Crystal Packing Diagram of the Pharmacological Compound 1-ATN
The packing diagram was generated using the computer program
PLUTO. The view is taken down the a axis
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fractional Coordinates of Atoms with Standard Deviations
X y z Ueq
C(l) 0.08798(22) -0.1679 < 4) 0.45593(17) 0.0505(17)
C (2) -0.00961(22) -0.1888( 4) 0.38304(18) 0.0516(17)
C (3) -0.00601(19) -0.0593( 3) 0.31189(17) 0.0440(15)
N (4) 0.10402(15) -0.06385(24) 0.28621(12) 0.0340(11)
C (5) 0.12484(20) -0.1238( 3) 0.20782(16) 0.0365(14)
0(6) 0.05559(15) -0.14692(24) 0.14251(11) 0.0524(12)
C (7) 0.24594(20) -0.1561( 3) 0.21934(16) 0.0384(15)
C (8) 0.30853(24) -0.2214( 3) 0.16014(18) 0.0519(17)
C (9) 0 . 4204 ( 3) -0.2447( 4) 0.18893(21) 0.0632(21)
C(10) 0.46653(24) -0.20461 4) 0.27443(22) 0.0613(20)
C (11) 0.40296(20) -0.1416( 3) 0.33475(18) 0.0476(17)
C(12) 0.29152(19) -0.1184( 3) 0.30553(15) 0.0353(14)
C (13) 0.20147(18) -0.0593( 3) 0.35495(14) 0.0329 (13)
0(14) 0.19167(14) -0.17680(20) 0.42223(10) 0.0398(10)
C (15) 0.21661(20) 0.12001 3) 0.39186(15) 0.0352(14)
S (16) 0.30770( 7) 0.121211 9) 0.49747( 5) 0.0596( 5)
C (17) 0.3015( 3) 0.34201 4) 0.52080(20) 0.0675(21)
C (18) 0.3399( 3) 0.45391 4) 0.45272(21) 0.0647 (20)
C (19) 0.26530(24) 0.4483( 3) 0.36402(19) 0.0551(18)
S (20) 0.264981 6) 0.249261 8) 0.30941( 4) 0.0431( 4)
Aniaotropic Vibration Parameters with Standard Deviatlona














































































































































Table 4.8 Final Atomic Parameters for the Pharmacological Compound
1-ATN
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C(l) - C (2) 1.513( 4) C(10) -C(ll) 1.395 ( 4)
C(l) -0(14) 1.446 ( 3) C(ll) -C(12) 1.380( 4)
C (2) - C (3) 1.516 ( 4) C (12) -C(13) 1.510 ( 3)
C (3) - N (4) 1.462 ( 3) C (13) -0(14) 1.420 ( 3)
N(4) - C (5) 1.358 ( 3) C (13) -C(15) 1.552( 3)
N (4) -C(13) 1.464 ( 3) C (15) -S(16) 1.819 ( 3)
C (5) - 0(6) 1.222 ( 3) C (15) -S(20) 1.8090(24)
C (5) - C (7) 1.488 ( 3) S (16) -C(17) 1.819( 3)
C (7) - C (8) 1.381 ( 4) C (17) -C(18) 1.510 ( 5)
C (7) -C(12) 1.387 ( 3) C (18) -C(19) 1.518 ( 4)
C (8) - C (9) 1.384 ( 4) C (19) -S(20) 1.809 ( 3)
C (9) -C(10) 1.384 ( 4)
Table 4.9 Calculated Bong Lengths
for the Pharmacological Compound 1-ATN
Atoms are labelled as shown in Fig. 4.7 and bond lengths are given in A with
standard deviations in parentheses. Bond lengths for hydrogen atoms have
been omitted.
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C (2) - C(l) -0(14) 111.44(22) C (7) -C(12) -C(13) 109.40(20)
C(l) - C (2) - C (3) 110.35(22) C(ll) -C(12) -C(13) 129.90(21)
C (2) - C (3) - N (4) 107.98(20) N<4) -C(13) -C(12) 101.90(17)
C (3) - N (4) - C (5) 123.83(20) N<4) -C(13) -0(14) 110.82(17)
C (3) - N (4) -C(13) 119.08 (18) N(4) -C(13) -C(15) 108.91(18)
C (5) - N (4) -C(13) 113.78(18) C (12) -C(13) -0(14) 107.85(18)
N (4) - C (5) - 0(6) 125.42(22) C(12) -C(13) -C(15) 114.98(19)
N (4) - C (5) - C (7) 106.17(20) 0(14) -C(13) -C(15) 111.94(18)
0(6) - C (5) - C (7) 128.41(22) C(1) -0(14) -C(13) 113.96(18)
C (5) - C (7) - C (8) 129.28 (23) C(13) -C (15) -S(16) 110.62(16)
C (5) - C (7) -C(12) 108.65(20) C (13) -C(15) -S(20) 108.28(16)
C (8) - C (7) -C(12) 121.97(23) S (16) -C(15) -S (20) 113.50(13)
C (7) - C (8) - C (9) 117.7( 3) C(15) -S(16) -C(17) 98.18(13)
C (8) - C (9) -C(10) 120.5( 3) S(16) -C(17) -C(18) 114.85(23)
C (9) -COLO) -C(ll) 121.8 ( 3.) C(17) -C (18) -C(19) 113.2( 3)
c (10) -C(ll) -C(12) 117.31(24) C(18) -C(19) -S (20) 113.55(20)
C (7) -C(12) -C(ll) 120.67(22) C(15) -S(20) -C(19) 99.39(12)
Table 4.10 Calculated Bond Angles
for the Pharmacological compound 1-ATN
Atoms are labelled as shown in Fig. 4.7 and bond angles are given in degrees
with standard deviations in parentheses. Bond angles including hydrogen
atoms have been omitted.
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0(14) - 0(1) - C (2) - 0(3) -56.9( 3) C<9) -0 10) -C 11) -C(12) -0.8 { 4)
C (2) - C(l) -0(14) -C (13) 56.8 ( 3) C(10) -C 11) -C 12) " 0(7) -0.3( 4)
C(l) - C (2) - C (3) - N<4) 51.2 ( 3) C(10) -C 11) -C 12) -C(13) 177.45(25)
C (2) - C (3) - N(4) - 0(5) 108.6( 3) 0(7) -C 12) -c 13) - N<4) -1.74(24)
C (2) - C<3) - N(4) -0(13) -49.5( 3) 0(7) -C 12) -c 13) -0(14) 114.98(21)
C (3) - N (4) - C (5) - 0(6) 16.9( 4) 0(7) -C 12) -c 13) -C(15) -119.35(22)
C (3) - N (4) - C (5) - 0(7) -162.30 (21) C(ll) -C 12) -c 13) - N(4) -179.70(24)
C (13) - N(4) - C (5) - 0(6) 176.10 (23) C(ll) -C 12) -c 13) -OU4) -63.0( 3)
C (13) - N<4) - C (5) - 0(7) -3.1 ( 3) 0(11) -0 12) -c 13) -C (15) 62.7 ( 3)
C (3) - N<4) -C(13) -0(12) 163.32 (19) N(4) -C 13) -o 14) - 0(1) -50.18(24)
C (3) - N (4) -C(13) -0(14) 48.8( 3) 0(12) -C 13) -o 14) - 0(1) -160.93(19)
C (3) - N(4) -C(13) -0(15) -74.78 (24) 0(15) -C 13) -0 14) - 0(1) 71.62(24)
C (5) - N<4) -C(13) -0(12) 3.06 (24) N(4) -C 13) -c 15) -S(16) 162.71(15)
C (5) - N (4) -C(13) -0(14) -111.48 (21) N (4) -c 13) -c 15) -S(20) -72.33(19)
C (5) - N(4) -C(13) -0(15) 124.96 (20) 0(12) -c 13) -c 15) -S (16) -83.71(21)
N (4) - C (5) - C (7) - 0(8) 178.2( 3) 0(12) -c 13) -c 15) -S(20) 41.25(23)
N(4) - C (5) - C (7) -0(12) 1-8 ( 3) 0(14) -c 13) -c 15) -S(16) 39.81(22)
0(6) - C (5) - C (7) - 0(8) -1-0 ( 4) 0(14) -c 13) -c 15) -S(20) 164.77(15)
0(6) - C (5) - C (7) -0(12) -177.36 (25) 0(13) -c 15) -s 16) -0(17) -178.06(18)
C (5) - C (7) - C (8) - 0(9) -177.5< 3) S (20) -c 15) -s 16) -C (17) 60.00(16)
C (12) - C (7) - C (8) - 0(9) -1 - 6 ( 4) 0(13) -c 15) -s 20) -C(19) 175.84(16)
C (5) - C (7) -C(12) -C (11) 178.23 (22) S (16) -c 15) -s 20) -C(19) -60.92(16)
C (5) - C (7) —C(12) -0(13) 0.1 ( 3) 0(15) -s 16) -c 17) -C (18) -59.19(25)
C (8) - C (7) -C(12) -C(ll) 1 - 6 ( 4) S (16) -0 17) -c 18) -C(19) 66.4( 3)
C (8) - C (7) -C(12) -0(13) -176.62 (23) C<17) -c 18) -c 19) -S(20) -65.9( 3)
C (7) - C (8) - C (9) -C(10) 0.5 ( 4) 0(18) -c 19) -s 20) -C(15) 59.49(22)
C (8) - C (9) -c(10) -C<11) 0.7 ( 5)
Table 4.11 Calculated Torsion Angles
for the Pharmacological Compound 1-ATN
Atoms are labelled as shown in Fig. 4.7 and torsion angles are given in
degrees with standard deviations in parentheses. Torsion angles involving





5.1 Summary and Conclusions
This project was designed to investigate the interaction of the bovine caseins
with calcium phosphate minerals. Two different approaches were adopted: the
construction of adsorption isotherms (Chapter 3) and the growth of co-crystals of
phosphoserine- containing peptides, after purification or chemical synthesis (Chapter
2), with calcium ions (Chapter 4). Precise tertiary and quaternary structural
information about the caseins and their peptide derivatives together with
thermodynamic information from adsorption experiments would allow a model of
casein interaction with calcium phosphate minerals to be developed. As such
information is presently unavailable, it was hoped that the above approaches would
give an insight into the mechanism and stereochemistry of casein interaction with
calcium phosphate minerals and hence help understand the structure of the casein
micelle.
None of the caseins has yet been crystallised and their lack of regular
secondary and tertiary structure makes their crystallisation unlikely in the near
future. Growth of crystals of the peptide (i-CN (fl-25) has also been attempted (by
Miss S Fawcett, Department of Biochemistry, University of Edinburgh) but was
unsuccessful both in the absence and presence of calcium ions. If smaller
phosphopeptides could be co-crystallised with calcium ions, the structural
information obtained would form the basis for the development of a model of
phosphoprotein/calcium mineral interaction.
As a starting point, growth of co-crystals of phosphoserine and calcium ions
was attempted, this being the simplest possible system that would provide a
structural basis for the interaction between phosphoproteins and calcium. It was
hoped that the peptides of two, three or four phosphoserine residues (and possibly
other acidic amino acids) could be chemically synthesised and co-crystallised with
calcium ions thus expanding and refining the model of interaction.
Co-crystallisation of phosphoserine with calcium ions proved to be very difficult but
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micro-crystals were obtained. Unfortunately, they were not suitable for structural
determination by the conventional X-ray diffraction techniques available at
Edinburgh (Chapter 4). The technique of X-ray powder diffraction might be used
as an alternative but, for such a structure as this, it might well not be able to provide
a unique solution. The chemical synthesis of the dipeptide Ser(P)-Ser(P) was
successfully completed (Chapter 2), but, to date no crystals of the dipeptide or
co-crystals with calcium ions have been obtained.
The two most extensively characterised phosphoprotein/calcium mineral
systems in biology are, arguably, the acidic proline-rich-phosphoproteins (acidic
PRP's) of human saliva and the caseins of milk. Adsorption experiments, as
described in Chapter 3, have been performed for the acidic PRP's but have not been
previously performed with the caseins. The adsorption of these relatively large
molecules is a complex process, the understanding of which would be aided by the
use, in adsorption experiments, of small, synthetic phosphopeptides. The findings
of the adsorption experiments and the isotherms constructed (Chapter 3) are
summarised below.
Adsorption of p-CN A and P-CN (fl-25) to dicalcium phosphate dihydrate
(DCPD) occurs at low, equilibrium, free concentrations (approximately 1 x 10"5 M)
to relatively high affinity sites on the DCPD crystals. At higher, equilibrium, free
concentrations of P-CN A (approximately 4 x 10-5 M) cooperative, lateral
interactions between P-CN A molecules may occur which appear to be disrupted
when 6.0 M urea is present in the buffer. At even higher, equilibrium, free
concentrations of P-CN (fl-25) (approximately 3 x 10"4 M) an increase in adsorption
is observed which is attributed to a second family of intrinsically lower affinity
adsorption sites which are more abundant than the high affinity sites. In addition,
the adsorption of p-CN (fl-25) is athermal, implying that the adsorption process is
"driven" by an entropy gain.
The only comparable experiments to these (Chapter 3) were performed by
E. C. Moreno and co-workers with the acidic PRP's adsorbing to hydroxyapatite and
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fluorapatite (see section 3.2). The acidic PRP's, like the caseins, are highly solvated
and flexible molecules (see section 3.3.2). However, the acidic PRP's have only
two phosphoseryl residues, at positions 8 and 22 (see section 3.2.2), whereas
P-CN A has five phosphoseryl residues at positions 15, 17, 18, 19 and 35 (see
section 3.3.2). Moreno and co-workers found that the acidic PRP's and the
TX-peptide (the N-terminal of 30 amino acids which contains both phosphoseryl
residues; see section 3.2.1) adsorbed to both hydroxyapatite and fluorapatite and the
isotherms produced were adequately described by the Langmuir theory (see section
3.2.2). In contrast, the adsorption of P-CN (fl-25) to DCPD was not adequately
described by the Langmuir theory whereas the adsorption of P-CN A was.
The adsorption affinity of the acidic PRP's is determined entirely by the
TX-peptide sequence. The present work suggests that the adsorption affinity for
p-CN A is determined by the P-CN (fl-25) sequence (see section 3.5.2) because the
affinity constants and surface areas per molecule are essentially the same (see Table
3.5). The adsorption affinities for P-CN A and P-CN (fl-25) to DCPD are lower
than those of the acidic PRP's to hydroxyapatite and fluorapatite (approximately 80
fold lower; see section 3.2.2 and Table 3.5). A higher adsorption affinity for the
caseins than for the acidic PRP's was expected as their phosphoseryl residues are
clustered together, unlike the acidic PRP's whose phosphoseryl residues are
separated by thirteen amino acids (of the primary sequence). Clustering of
phosphoseryl residues has been shown to increase the affinity of casein adsorption to
hydroxyapatite (Sleigh et al., 1979). Therefore, the type of calcium phosphate
mineral must have a major influence upon the adsorption affinity.
van Kemenade (1988) examined the influence of p-CN A on seeded growth
of calcium phosphates (hydroxyapatite, octacalcium phosphate and DCPD). She
proposed that the fractional reduction of relative growth rates could be interpreted in
terms of the blocking of active growth sites through a Langmuirian adsorption
model. From this model van Kemenade was able to calculate the affinity constants
for P-CN A adsorption to hydroxyapatite, octacalcium phosphate and DCPD which
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were 1 x 106, 7 x 106 and 4.76 x 107 ImoH respectively, van Kemenade's affinity
constant for (3-CN A adsorption to DCPD is approximately 100 fold greater than the
affinities calculated during this study (see Table 3.5). However, van Kemenade's
experiments examined the influence of (3-CN A on seeded crystal growth and
therefore the affinity constants are for adsorption to active growth sites only.
Moreover, these experiments were performed under different conditions (at pH 5.5
and 37°C). The pH of the latter experiments may have a significant effect upon
adsorption affinity, as inferred by the results presented here (see section 3.5.3 and
Table 3.5). Adsorption affinities for active growth sites will probably be higher
than those for other areas of the crystal as they will have a higher surface energy
(Chernov, 1984).
The area occupied by a protein in the adsorbed state (A) is related to the
packing of the molecules at the surface, therefore, the smaller the molecule the
smaller the value of A. In the adsorbed state, the area occupied by a P-CN A
molecule (Mr. 26,000) is quite similar to that of a (3-CN (fl-25) molecule
(Mr. 3,125; see Table 3.5) despite the large difference in size. This suggests that
the N-terminal region is the fraction of the molecule that binds to the DCPD crystal.
This is not the case for the acidic PRP's (see section 3.2.2 and Table 3.1) where the
TX-peptide occupies a smaller area in the adsorbed state than the parent protein
(PRP 1). Moreover, Moreno et al. (1982) noted that PRP 3 molecules (Mr. 11,320)
occupied a larger area in the adsorbed state than PRP 1 molecules (Mr. 16,000);
which is unexpected if A depends upon molecular size. This anomaly was
explained (Moreno et al., 1982) as follows: PRP 3 has a higher charge density than
PRP 1, therefore the adsorption of PRP 3 onto one site, on the hydroxyapatite
crystal, induces polarisation in neigbouring sites to a greater extent than PRP 1.
This results in a lower adsorption of PRP 3 (see section 3.2.2).
(3-CN (fl-25) has a much greater charge density than the parent protein
molecule (5-CN A (each carries a net negative charge of 12). However, the negative
charge of (3-CN A resides largely in the N-terminal region of the molecule (see
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section 3.3.2.) which is the region proposed to bind to DCPD crystals. Therefore,
upon adsorption, the extent of polarisation of neighbouring sites will be similar for
both P-CN A and P-CN (fl-25) and, therefore, the amount adsorbed will also be
similar (and the area occupied).
The experiments comparing the two preparations of DCPD crystals suggested
that P-CN A and p-CN (fl-25) adsorb to high affinity sites which may be
concentrated on the edge faces of the DCPD crystals (see section 3.5.2). However,
high affinity adsorption sites could also be located at defects in the crystal surface,
caused either by surface geometry (i.e. steps or holes), blocked growth sites or
non-stoichiometry (Chernov, 1984).
The possibility of selective adsorption to specific DCPD crystal faces raises
the question: why does the phosphoprotein prefer certain specific crystal faces?
This question may be answered by the molecular modelling of protein adsorption.
Since the crystal structure of DCPD is known, a model can be constructed such that
the geometry of the atoms of each crystal face can be determined. However, as
there is no tertiary structural information available for the caseins, a three
dimensional model of P-CN A, P-CN (fl-25) or related phosphopeptides must be
constructed. This information may then be used to propose a detailed molecular
model of phosphoprotein binding to the crystal surface.
In contrast to P-CN A and P-CN (fl-25), acidic PRP adsorption to
hydroxyapatite and fluorapatite showed no such selective adsorption to any one
crystal face. However, selective adsorption, of various proteins, to specific
hydroxyapatite crystal faces has been inferred from chromatographic experiments
using different crystal preparations (Kawasaki et al., 1990). This apparently non¬
selective adsorption of the acidic PRP's may be explained as follows. Perfect
hydroxyapatite crystals are columnar in habit with a hexagonal cross section, thus
each of the crystal faces accounts for an approximately equal proportion of the total
surface area. In consequence, a large change in crystal size will result in only a
small change in the relative surface area of each crystal face. Thus selective
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adsorption would not be observed in the adsorption experiments used by Moreno and
co-workers because such experiments are not sensitve enough to slight changes in
relative surface area. In addition, formation of well-formed hydroxyapatite crystals
under laboratory conditions has been found to be impossible (Dr. C. Holt, personal
communication), with non-stoichiometry being the major problem. To observe
selective adsorption to a particular crystal face well-formed crystals are required
with near perfect stoichiometry, thus selective adsorption to hydroxyapatite crystals
may never be observed.
Moreno et al. (1982) showed that the acidic PRP's adsorb by an endothermic
process, adsorption being "driven" by an entropy gain which arises from the
breaking of the secondary structure of the adsorbent and the displacement of water
from both protein and mineral. In the present study, the influence of temperature
upon the adsorption of (3-CN (fl-25) to DCPD indicated an athermal process. Such
an adsorption process must also be "driven" by an entropy gain, possibly from the
displacement of water molecules from both peptide and mineral as occurs with the
acidic PRP's. The effect of urea upon the adsorption isotherm for P-CN A (a
reduction of 50% in Tp; see Fig 3.21) may be the result of either or both of two
phenomena. Either the hydrophobic interactions between adsorbed molecules,
which stabilise the adsorbed layer, are disrupted by urea or the entropy gain, caused
by a disruption in the hydration state of both DCPD and the protein molecules, is
reduced. As the effect of temperature on p-CN (fl-25) indicates a process "driven"
by an entropy gain, the effect of urea upon P-CN A adsorption may possibly be
understood in terms of an effect upon water structure rather than on intermolecular
interactions.
5.2 Future Work
Co-crystallisation of phosphoserine and calcium ions proved, unexpectedly,
to be very troublesome. Future crystal trials should be directed at small,
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phosphoserine-containing peptides, both in the presence and absence of calcium
ions, where a more stable structure might be expected. For example, a larger
peptide (e.g. five to eight amino acids with only one phosphoseryl residue), designed
so that intermolecular interactions should form (e.g. hydrogen bonds), might interact
with calcium ions in a stable enough way to form crystals. These crystal trials
(as well as the adsorption experiments) would require a ready source of highly pure
peptide (obtained by chemical synthesis).
The synthesis of the dipeptide Ser(P)-Ser(P) was successful. In addition, the
use of the novel peptide phosphorylating agent Bis-(2,2,2-trichloroethyl)phosphoryl
chloride (see section 2.5.2.3)alleviated some of the problems associated with the use
of diphenylphosphoryl chloride (see section 2.5.2.1). However, purification of the
newly-synthesised phosphopeptide was still laborious and, more importantly, the
final yields were low. Recently (see section 2.5.3), new methods of phosphopeptide
synthesis have been developed that employ more reactive phosphorylating agents
(e.g. di-t-butyl N,N-diethylphosphoramidite (Perich and Johns, 1990b) or dibenzyl
N,N-diethylphosphoramidite (Perich and Johns, 1990c)) and allow synthesis to be
performed in the solid phase (Staerkear et al., 1991). These innovations would
improve both the yield of peptide and its purity. In addition, purification of
phosphopeptides by high performance liquid chromatography has been developed
(Murthy and Iqbal, 1991) which would allow efficient purification of the synthetic
phosphopeptides.
Further experiments which may add more detail to the present model of
adsorption of casein to DCPD crystals are outlined below. First, the adsorption
affinities (k) for both J3-CN A and (3-CN (fl-25) binding to DCPD could be
confirmed by constructing isotherms that cover a range of lower equilibrium, free
concentrations (< 1 x 10"5 M). Accurate determination of the shape of the isotherm
at lower concentrations would be a critical test of the Langmuir model, revealing any
cooperative or anti-cooperative adsorption. If the adsorption affinities are found to
be the same, the hypothesis that adsorption occurs mainly via the phosphoseryl
176
residues of the protein would be substantiated. Moreno et al. (1984) observed that
the adsorption affinity of the acidic PRP's is conferred by the TX-peptide sequence
(N-terminal 30 amino acid residues containing the two phosphoseryl residues).
Similar results were obtained in this study of p-CN A and P-CN (fl-25) adsorption
to DCPD crystals. If the affinities are found to be different then other amino acids
must play an important role in adsorption. Such amino acids might include
glutamyl and aspartyl residues. Direct evidence for the interaction of these residues
with calcium ions does exist (Byler and Farrell, 1989).
Expansion of the p-CN A isotherm to encompass the same, higher
concentration range as that employed in the experiments with P-CN (fl-25) would, if
the isotherms have a similar pattern, also help to substantiate the hypothesis that
adsorption occurs via the first 25 amino acids of P-CN A. Accurate determination
of the adsorption affinity would also greatly facilitate the fitting of a curve to the
results (see section 3.5.2) and hence the mathematical description of the adsorption
process.
Results using DCPD preparations of different specific surface areas suggest
that adsorption of both P-CN A and P-CN (fl-25) may occur to adsorption sites
concentrated on the edge faces of the DCPD crystals (see section 3.5.2). Such
preferential adsorption could be established by use of indirect immunofluorescence
staining. This involves allowing P-CN (fl-25) to adsorb to the DCPD crystals.
Then antibodies (e.g. raised in rats) specific to P-CN (fl-25) are introduced to the
system and then fluorescently labelled, anti-rat antibodies (e.g. raised in goats) are
added (the protein may be fixed during one of these stages with e.g. glutaraldehyde
to facilitate future manipulations). Preferential adsorption of the aspartic acid-rich
proteins (from the calcific or the aragonitic layer of the bivalve Mytilus
californianus) to specific faces of calcite crystals has been confirmed in this way
(Addadi and Weiner, 1985).
From the effects of temperature and urea on the adsorption of P-CN (fl-25)
and P-CN A (respectively) it is difficult to determine the relative contributions of
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intermolecular, hydrophobic interactions and of the entropy gain to the adsorption
process. J3-CN (f1-25) has no hydrophobic tail and so the adsorbed layer cannot be
stabilised by hydrophobic interactions (cf. P-CN A; see section 3.3.2). Performing
adsorption experiments with P-CN (fl-25) in the presence of urea would therefore,
help to determine which of these two phenomena is most important for adsorption.
A large reduction in Tp would imply that urea is disrupting the water structure
(causing a reduction in entropy gain) rather than affecting lateral (hydrophobic)
interactions. This in turn would imply the hydrophobic interactions are not
important for p-CN A adsorption. In addition, performing adsorption experiments
with p-CN A in the presence of urea over a range of concentrations which
encompass the concentration (4 M urea) at which P-CN A micelles dissociate would
help to clarify this point. If a sudden decrease in Tp is observed at approximately 4
M urea, the importance of hydrophobic interactions in the adsorption process would
be further supported. Finally, the effect of temperature on p-CN A adsorption
should be determined to ensure that its adsorption is athermal.
The adsorption of proteins at the solid/liquid interface is influenced greatly
by the pH of the system (see section 3.1.6) as Tp tends to be at a maximum at the
isoelectric point of the protein. When adsorption experiments with P-CN A were
performed at pH 6.5 and 7.0, which is in the range of the pKs of the phosphoseryl
residues of P-CN A, Tp was found to be less at the lower pH value of 6.5 (see Fig
3.19). Performing adsorption experiments over a wider pH range might give
information on the contribution of other amino acid residues to the adsorption
process. If adsorption experiments were performed at pH 4.6; the pK of P-CN A,
and Tp continued to decrease to a minimum this would imply that the phosphoseryl
residues are predominantly involved in the adsorption of P-CN A to DCPD.
However, if such a decrease was not observed, this would imply a contribution by
other amino acids to P-CN A adsorption to DCPD. Similar experiments with
P-CN (fl-25) would have to be performed to verify such suggestions.
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Unfortunately, performing adsorption experiments above pH 7.0 is not
possible if DCPD is to be used as adsorbent, as DCPD is unstable above pH 7. In
addition, performing adsorption experiments below pH 6.0 is not possible. For
these adsorption experiments it is necessary to maintain a saturated solution of
DCPD to prevent crystal dissolution and growth; below pH 6.0 calcium phosphate is
too soluble to maintain a saturated solution. Saturation might be maintained at very
high phosphate concentrations (Dr. C. Holt, personnal communication), but the ionic
strength would increase, and must increase if the free calcium ion concentration is to
be held constant. Therefore, conditions below pH 6.0 would be so different from
those at pH's between 6.0 and 7.0 that the results obtained would not be comparable
and would therefore be uninformative.
Further insight into the role of phosphoseryl residues in the adsorption
process might be gained by use of synthetic peptides. A series of phosphopeptides
could be synthesised that are related to the amino acid sequence that encompasses
the phosphoseryl residues of P-CN (fl-25) (i.e. between positions 12 and 21). The
effect of substitution or deletion of an amino acid, or phosphate group, from the
parent sequence could then be determined, which might give an insight into which
residues actually participate in adsorption to the crystal surface. The p-CN (fl-25)
peptide has been proteolytically cleaved with pepsin, to produce P-CN (f12-24)
(results not shown). However, production of p-CN (fl2-24) by this method is very
inefficient. Chemical synthesis would probably be more economical and efficient.
The adsorption assay developed (described in section 3.4.6) to examine
P-CN A adsorption to DCPD worked on the principle of depletion of protein from
solution (see section 3.1.4). However, because of the low specific surface area of
the DCPD crystals, significant depletion of the protein solution was only just
achieved. As a result, accurate determination of the adsorption affinity of P-CN A
and P-CN (fl-25) was not possible (see section 3.5.2). Theoretically, this problem
can be circumvented, either by increasing the specific surface area of DCPD crystals
or by using an alternative method of protein estimation in which the amount of
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adsorbed protein is measured directly rather than by difference. Increasing the
specific surface area of the DCPD crystals is possible by using rapid precipitation
techniques, but there is some risk of forming an amorphous, precursor calcium
phosphate phase rather than pure DCPD crystals (Dr. C. Holt, personal
communication). Alternative colorometric methods would probably suffer from the
same disadvantages as the BCA assay, as the amount of protein depleted from the
solution is small. Several alternative methods of protein estimation (both
colorometric and "non-colorometric") were evaluated (see section 3.5.1) but none
were suitable for use with the adsorption assay. Therefore, the way forward with
these investigations is to produce well-formed crystals of DCPD with a much larger
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